document_id	entity_type	entity_text	entity_span
25591652_en	DISO	non IGE	1586-1593
25591652_en	FINDING	seizure aggravation	202-221
25591652_en	FINDING	epileptic seizure aggravation	22-51
25591652_en	DISO	seizure	32-39
25591652_en	DISO	epileptic seizure	22-39
25591652_en	DISO	seizures	276-284
25591652_en	CHEM	antiepileptic drugs	68-87
25591652_en	CHEM	AED	89-92
25591652_en	PHYS	adult	97-102
25591652_en	DISO	Seizure	1137-1144
25591652_en	DISO	seizure	1448-1455
25591652_en	DISO	seizure	202-209
25591652_en	FINDING	Seizures aggravation	1683-1703
25591652_en	FINDING	Aggravated seizures	265-284
25591652_en	FINDING	Seizure aggravation	1775-1794
25591652_en	DISO	resistant epilepsy	1096-1114
25591652_en	CHEM	topiramate	352-362
25591652_en	CHEM	TPM	364-367
25591652_en	CHEM	valproates	389-399
25591652_en	CHEM	VPA	401-404
25591652_en	CHEM	carbamazepine	413-426
25591652_en	CHEM	CBZ	428-431
25591652_en	CHEM	lamotrigine	440-451
25591652_en	CHEM	LTG	453-456
25591652_en	CHEM	levetiracetam	468-481
25591652_en	CHEM	LEV	483-486
25591652_en	DISO	epilepsies	533-543
25591652_en	DISO	seizure	1903-1910
25591652_en	DISO	idiopathic generalized epilepsies	510-543
25591652_en	DISO	IGE	545-548
25591652_en	FINDING	aggravation	1064-1075
25591652_en	LABPROC	titration	2038-2047
25591652_en	CHEM	CBZ	576-579
25591652_en	CHEM	VPA	593-596
25591652_en	CHEM	TPM	605-608
25591652_en	CHEM	LTG	617-620
25591652_en	CHEM	LEV	632-635
25591652_en	CHEM	CBZ	645-648
25591652_en	FINDING	poor prognosis	1119-1133
25591652_en	PHYS	childhood	760-769
25591652_en	DISO	epilepsy	703-711
25591652_en	DISO	juvenile absence epilepsy	686-711
25591652_en	DISO	JAE	713-716
25591652_en	DISO	epilepsy	778-786
25591652_en	DISO	Seizure	976-983
25591652_en	DISO	childhood absence epilepsy	760-786
25591652_en	DISO	CAE	788-791
25591652_en	DISO	myoclonic jerks	827-842
25591652_en	FINDING	risk of aggravation	2007-2026
25591652_en	DISO	epilepsy	865-873
25591652_en	DISO	myoclonic	855-864
25591652_en	DISO	myoclonic epilepsy	855-873
25591652_en	DISO	juvenile myoclonic epilepsy	846-873
25591652_en	DISO	JME	875-878
25591652_en	FINDING	reduce the risk of aggravation	1996-2026
25591652_en	FINDING	aggravation	559-570
25591652_en	ANATOMY	eyelid	916-922
25591652_en	DISO	myoclonus	923-932
25591652_en	DISO	eyelid myoclonus	916-932
25591652_en	DISO	Jeavons syndrome	934-950
25591652_en	FINDING	poor outcome	1874-1886
25591652_en	FINDING	Seizure aggravations	976-996
25591652_en	FINDING	aggravated absences	649-668
25591652_en	CHEM	AEDs	1012-1016
25591652_en	FINDING	"True" aggravation	1272-1290
25591652_en	DISO	absences	814-822
25591652_en	DISO	epilepsy	1106-1114
25591652_en	DISO	absences	660-668
25591652_en	DISO	absences	902-910
25591652_en	FINDING	Seizure aggravation	1137-1156
25591652_en	DISO	epileptic	22-31
25591652_en	FINDING	pattern of aggravation	1053-1075
25591652_en	FINDING	aggravation	1669-1680
25591652_en	CHEM	AEDs	1187-1191
25591652_en	FINDING	aggravation	2015-2026
25591652_en	DISO	epilepsy	1244-1252
25591652_en	DISO	resistant epilepsy	1234-1252
25591652_en	FINDING	poor outcome	1257-1269
25591652_en	CHEM	CBZ	1311-1314
25591652_en	DISO	IGE	1344-1347
25591652_en	CHEM	TPM	1363-1366
25591652_en	CHEM	VPA	1376-1379
25591652_en	CHEM	LTG	1385-1388
25591652_en	CHEM	LEV	1394-1397
25591652_en	CHEM	clonazepam	1411-1421
25591652_en	FINDING	seizure aggravation	1448-1467
25591652_en	CHEM	CBZ	1488-1491
25591652_en	DISO	IGE	1495-1498
25591652_en	CHEM	LTG	1525-1528
25591652_en	CHEM	TPM	1530-1533
25591652_en	CHEM	CBZ	1538-1541
25591652_en	DISO	epileptic syndromes	1565-1584
25591652_en	DISO	IGE	1590-1593
25591652_en	CHEM	AEDs	1654-1658
25591652_en	DISO	Seizures	1683-1691
25591652_en	CHEM	TPM	1753-1756
25591652_en	DISO	Seizure	1775-1782
25591652_en	CHEM	AEDs	1810-1814
25591652_en	CHEM	AEDs	1849-1853
25591652_en	FINDING	seizure aggravation	1903-1922
25591652_en	CHEM	LTG	1953-1956
25591652_en	CHEM	CBZ	1965-1968
25591652_en	CHEM	TPM	1980-1983
25591652_en	CHEM	AEDs	2033-2037
25591652_en	DISO	seizures	2071-2079
25726786_en	DISO	cognitive impairment	6-26
25726786_en	DISO	Mild cognitive impairment	1-26
25726786_en	ANATOMY	coronary	44-52
25726786_en	ANATOMY	artery	53-59
25726786_en	FINDING	lower cardiac contractility	786-813
25726786_en	ANATOMY	coronary artery	44-59
25726786_en	DISO	coronary artery disease	44-67
25726786_en	LABPROC	EEG	94-97
25726786_en	FINDING	low cardiac contractility	1193-1218
25726786_en	DISO	cognitive impairment	181-201
25726786_en	DISO	mild cognitive impairment	176-201
25726786_en	DISO	MCI	203-206
25726786_en	LABPROC	electroencephalogram	242-262
25726786_en	LABPROC	EEG	264-267
25726786_en	ANATOMY	coronary	301-309
25726786_en	ANATOMY	artery	310-316
25726786_en	ANATOMY	coronary artery	301-316
25726786_en	DISO	coronary artery disease	301-324
25726786_en	FINDING	EEG power	1304-1313
25726786_en	DISO	CAD	326-329
25726786_en	DISO	MCI	371-374
25726786_en	PHYS	male	424-428
25726786_en	DISO	CAD	443-446
25726786_en	FINDING	severity of coronary artery lesions	1153-1188
25726786_en	DISO	MCI	499-502
25726786_en	FINDING	an important factor to preserve cognitive abilities	1061-1112
25726786_en	ANATOMY	Frontal	607-614
25726786_en	PHYS	cardiac contractility	1197-1218
25726786_en	FINDING	higher spectral power	826-847
25726786_en	PHYS	theta activity	879-893
25726786_en	PHYS	parietooccipital theta activity	862-893
25726786_en	PHYS	Θ-rhythm	849-857
25726786_en	ANATOMY	coronary	765-773
25726786_en	DISO	lesions	774-781
25726786_en	FINDING	more severe coronary lesions	753-781
25726786_en	FINDING	clinical factors	127-159
25726786_en	ANATOMY	cardiac	792-799
25726786_en	FINDING	topographical features	216-238
25726786_en	ANATOMY	parietooccipital	862-878
25726786_en	DISO	CAD	913-916
25726786_en	DISO	MCI	931-934
25726786_en	DISO	MCI	964-967
25726786_en	DISO	MCI	995-998
25726786_en	DISO	CAD	1130-1133
25726786_en	ANATOMY	coronary	1165-1173
25726786_en	ANATOMY	artery	1174-1180
25726786_en	DISO	lesions	1181-1188
25726786_en	ANATOMY	coronary artery	1165-1180
25726786_en	DISO	coronary artery lesions	1165-1188
25726786_en	ANATOMY	cardiac	1197-1204
25726786_en	DISO	coronary lesions	765-781
25726786_en	ANATOMY	cerebral	1240-1248
25726786_en	DISO	ischemia	1249-1257
25726786_en	DISO	cerebral ischemia	1240-1257
25726786_en	FINDING	demographic factors	140-159
25726786_en	ANATOMY	neuronal	1262-1270
25726786_en	DISO	dysfunction	1271-1282
25726786_en	DISO	neuronal dysfunction	1262-1282
25726786_en	FINDING	lower level of education	727-751
25726786_en	LABPROC	EEG	1304-1307
25726786_en	LABPROC	EEG	1345-1348
25726786_en	FINDING	efficacy of quantitative EEG analysis	1320-1357
25726786_en	DISO	cognitive disorders	1404-1423
25726786_en	DISO	CAD	1427-1430
25726786_en	PHYS	cardiac contractility	792-813
25726786_en	PHYS	healthy	543-550
25726786_en	DISO	depression	686-696
25823269_en	FINDING	elevated mean pulmonary artery pressure	174-213
25823269_en	PHYS	pressure	659-667
25823269_en	PHYS	pressure	737-745
25823269_en	ANATOMY	pulmonary	46-55
25823269_en	DISO	hypertension	56-68
25823269_en	DISO	stress-induced pulmonary hypertension	31-68
25823269_en	DISO	sclerosis	95-104
25823269_en	DISO	systemic sclerosis	86-104
25823269_en	ANATOMY	pulmonary	188-197
25823269_en	ANATOMY	artery	198-204
25823269_en	ANATOMY	pulmonary artery	188-204
25823269_en	PHYS	mean pulmonary artery pressure	183-213
25823269_en	PHYS	MPAP	215-219
25823269_en	LABPROC	lung test	1926-1935
25823269_en	PHYS	diastolic pressure	688-706
25823269_en	CHEM	acid	1768-1772
25823269_en	ANATOMY	pulmonary	301-310
25823269_en	DISO	hypertension	311-323
25823269_en	DISO	stress-induced pulmonary hypertension	286-323
25823269_en	DISO	SIPH	325-329
25823269_en	ANATOMY	pulmonary artery	565-581
25823269_en	PHYS	hemodynamic	124-135
25823269_en	DISO	sclerosis	400-409
25823269_en	DISO	systemic sclerosis	391-409
25823269_en	DISO	SDS	411-414
25823269_en	ANATOMY	pulmonary	443-452
25823269_en	DISO	hypertension	453-465
25823269_en	DISO	pulmonary hypertension	443-465
25823269_en	DISO	PH	467-469
25823269_en	ANATOMY	lung	472-476
25823269_en	ANATOMY	heart	486-491
25823269_en	ANATOMY	left heart	481-491
25823269_en	DISO	heart injuries	486-500
25823269_en	DISO	left heart injuries	481-500
25823269_en	DISO	thromboembolism	505-520
25823269_en	ANATOMY	pulmonary	565-574
25823269_en	ANATOMY	artery	575-581
25823269_en	PHYS	hemodynamic	633-644
25823269_en	ANATOMY	atrial	652-658
25823269_en	ANATOMY	right atrial	646-658
25823269_en	PHYS	right atrial pressure	646-667
25823269_en	PHYS	RAP	669-672
25823269_en	PHYS	systolic pressure	675-706
25823269_en	PHYS	MPAP	708-712
25823269_en	ANATOMY	pulmonary	714-723
25823269_en	ANATOMY	artery	724-730
25823269_en	ANATOMY	pulmonary artery	714-730
25823269_en	PHYS	pulmonary artery wedge pressure	714-745
25823269_en	PHYS	PAWP	747-751
25823269_en	ANATOMY	cardiac	754-761
25823269_en	PHYS	cardiac output	754-768
25823269_en	PHYS	CO	770-772
25823269_en	PHYS	level of uric acid	1754-1772
25823269_en	LABPROC	thermodilution technique	779-803
25823269_en	ANATOMY	pulmonary arterial	903-921
25823269_en	DISO	SDS-associated PAH	2406-2424
25823269_en	ANATOMY	pulmonary	903-912
25823269_en	ANATOMY	arterial	913-921
25823269_en	DISO	hypertension	922-934
25823269_en	DISO	pulmonary arterial hypertension	903-934
25823269_en	DISO	PAH	936-939
25823269_en	PHYS	lifetime	2370-2378
25823269_en	DISO	SIPH	978-982
25823269_en	LABPROC	exercise test	1458-1471
25823269_en	PHYS	NT-proBNP levels	1845-1861
25823269_en	FINDING	decrease	2003-2011
25823269_en	FINDING	tended to decrease	2109-2127
25823269_en	FINDING	improve lifetime prognosis	2362-2388
25823269_en	DISO	PAH	1115-1118
25823269_en	CHEM	anti-centromere antibodies	1883-1909
25823269_en	PHYS	clinical changes	140-156
25823269_en	DISO	PH	1172-1174
25823269_en	DISO	pulmonary hypertension	46-68
25823269_en	PHYS	MPAP	1241-1245
25823269_en	DISO	pulmonary hypertension	301-323
25823269_en	DISO	SIPH	1324-1328
25823269_en	PHYS	MPAP	1339-1343
25823269_en	CHEM	bosentan	266-274
25823269_en	CHEM	bosentan	11-19
25823269_en	CHEM	bosentan	1000-1008
25823269_en	CHEM	bosentan	1961-1969
25823269_en	FINDING	prognosis	2379-2388
25823269_en	FINDING	risk for PAH	1106-1118
25823269_en	FINDING	increased risk for PAH	1096-1118
25823269_en	DISO	lung injuries	472-500
25823269_en	PHYS	MPAP	1506-1510
25823269_en	FINDING	risk of pulmonary arterial hypertension	895-934
25823269_en	FINDING	correlations	1485-1497
25823269_en	FINDING	no signs of PH	1160-1174
25823269_en	DISO	SIPH	1565-1569
25823269_en	FINDING	signs of PH	1163-1174
25823269_en	PHYS	MPAP	1613-1617
25823269_en	ANATOMY	pulmonary	1631-1640
25823269_en	ANATOMY	vascular	1641-1649
25823269_en	PHYS	pulmonary vascular resistance	1631-1660
25823269_en	PHYS	PVR	1662-1665
25823269_en	PHYS	PAWP	1671-1675
25823269_en	ANATOMY	pulmonary vascular	1631-1649
25823269_en	FINDING	higher levels	1588-1601
25823269_en	DISO	SIPH	1737-1741
25823269_en	FINDING	calculated DETECT risk was significantly higher	1682-1729
25823269_en	CHEM	uric acid	1763-1772
25823269_en	FINDING	level of uric acid was also higher	1754-1788
25823269_en	FINDING	no changes	1831-1841
25823269_en	DISO	SIPH	1796-1800
25823269_en	CHEM	antibodies	1899-1909
25823269_en	PHYS	telangiectasias	1863-1878
25823269_en	LABPROC	EchoCG	1915-1921
25823269_en	ANATOMY	lung	1926-1930
25823269_en	PHYS	NT-proBNP levels	2092-2108
25823269_en	PHYS	PVR	2069-2072
25823269_en	PHYS	MPAP/CO ratio	2074-2087
25823269_en	FINDING	precedes the development of clinical PAH	2218-2258
25823269_en	CHEM	PAH-specific drugs	2280-2298
25823269_en	PHYS	MPAP	2015-2019
25823269_en	PHYS	transpulmonary gradient	2024-2047
25823269_en	PHYS	MPAP	2074-2078
25823269_en	PHYS	CO	2079-2081
25823269_en	FINDING	no diagnostic changes	1387-1408
25823269_en	CHEM	NT-proBNP	2092-2101
25823269_en	CHEM	NT-proBNP	1845-1854
25823269_en	DISO	SDS	2162-2165
25823269_en	DISO	SIPH	2167-2171
25823269_en	ANATOMY	pulmonary	2190-2199
25823269_en	DISO	vasculopathy	2200-2212
25823269_en	DISO	pulmonary vasculopathy	2190-2212
25823269_en	DISO	PAH	2255-2258
25823269_en	DISO	PAH	2280-2283
25823269_en	DISO	SDS	2406-2409
25823269_en	DISO	PAH	2421-2424
25823273_en	ANATOMY	Cardiovascular	1-15
25823273_en	ANATOMY	cardiovascular	173-187
25823273_en	DISO	cardiovascular diseases	173-196
25823273_en	DISO	Cardiovascular diseases	1-24
25823273_en	FINDING	high concentration of sulfur dioxide	881-917
25823273_en	FINDING	high levels of nitrogen dioxide	1040-1071
25823273_en	DISO	chronic diseases	511-527
25823273_en	FINDING	may result from the influence of EFs	1277-1313
25823273_en	FINDING	development of hypertension	830-857
25823273_en	LABPROC	blood general tests	580-617
25823273_en	CHEM	dioxide	910-917
25823273_en	CHEM	dioxide	1064-1071
25823273_en	FINDING	development of cardiovascular diseases	158-196
25823273_en	ANATOMY	blood	580-585
25823273_en	LABPROC	immunological tests	598-617
25823273_en	LABPROC	electrocardiography	623-642
25823273_en	DISO	heart disease	1002-1015
25823273_en	FINDING	influence of environmental factors (EFs)	110-150
25823273_en	PHYS	adult	332-337
25823273_en	ANATOMY	blood	728-733
25823273_en	LABPROC	blood biochemical test	728-750
25823273_en	DISO	hypertension	845-857
25823273_en	CHEM	sulfur dioxide	903-917
25823273_en	CHEM	sulfur	903-909
25823273_en	ANATOMY	heart	1002-1007
25823273_en	ANATOMY	coronary	993-1001
25823273_en	DISO	coronary heart disease	993-1015
25823273_en	DISO	CHD	1017-1020
25823273_en	CHEM	nitrogen	1055-1063
25823273_en	CHEM	nitrogen dioxide	1055-1071
25823273_en	DISO	hypertension	1219-1231
25823273_en	DISO	CHD	1236-1239
25823273_en	CHEM	copper	938-944
25823273_en	CHEM	zinc	968-972
25823273_en	LABPROC	biochemical test	734-750
25823273_en	CHEM	zinc	1095-1099
25823275_en	CHEM	arbidol	22-29
25823275_en	CHEM	umifenovir	31-41
25823275_en	DISO	respiratory tract infection	513-540
25823275_en	DISO	influenza	61-70
25823275_en	CHEM	Arbidol	223-230
25823275_en	CHEM	umifenovir	232-242
25823275_en	PHYS	adult	247-252
25823275_en	DISO	influenza	267-276
25823275_en	PHYS	respiratory	513-524
25823275_en	DISO	influenza	494-503
25823275_en	ANATOMY	respiratory tract	513-530
25823275_en	DISO	infection	531-540
25823275_en	DISO	acute respiratory tract infection	507-540
25823275_en	FINDING	durations of virus shedding	849-876
25823275_en	CHEM	umifenovir	663-673
25823275_en	FINDING	efficacy	755-763
25823275_en	FINDING	clinical and epidemiological data	1091-1124
25823275_en	FINDING	reater compared to placebo group	1374-1406
25823275_en	FINDING	time to resolution of all symptoms	779-813
25823275_en	FINDING	severity of symptoms and illness	815-847
25823275_en	FINDING	time to resolution of all symptoms	1159-1193
25823275_en	FINDING	reduced with umifenovir compared to placebo	1488-1531
25823275_en	FINDING	All symptoms were resolved	1196-1222
25823275_en	FINDING	reduction of time to resolution of all symptoms of the disease	2041-2103
25823275_en	FINDING	reducing the severity of symptoms of the disease and durations of virus shedding	2105-2185
25823275_en	FINDING	durations of virus shedding	2158-2185
25823275_en	CHEM	umifenovir	903-913
25823275_en	FINDING	efficacy and safety of Arbidol	200-230
25823275_en	FINDING	ignificantly reduced in the umifenovir group compared to placebo	1772-1836
25823275_en	DISO	influenza	970-979
25823275_en	FINDING	efficacy of umifenovir	891-913
25823275_en	FINDING	laboratory-confirmed influenza	998-1028
25823275_en	DISO	influenza	1019-1028
25823275_en	FINDING	the severity of symptoms of the disease	2114-2153
25823275_en	DISO	influenza	1063-1072
25823275_en	CHEM	Umifenovir	1127-1137
25823275_en	FINDING	most pronounced in the acute stage of the disease	1972-2021
25823275_en	FINDING	Severity of illness	1427-1446
25823275_en	FINDING	Clinical efficacy of arbidol	1-29
25823275_en	FINDING	laboratory-confirmed influenza	1297-1327
25823275_en	DISO	influenza	1318-1327
25823275_en	CHEM	umifenovir	1335-1345
25823275_en	DISO	catarrhal symptoms	1448-1466
25823275_en	CHEM	umifenovir	1501-1511
25823275_en	CHEM	Umifenovir	1643-1653
25823275_en	DISO	influenza	1742-1751
25823275_en	FINDING	shedding influenza virus	1733-1757
25823275_en	FINDING	viral shedding	1682-1696
25823275_en	CHEM	umifenovir	1800-1810
25823275_en	CHEM	umifenovir	1918-1928
25823275_en	DISO	influenza	1949-1958
25823275_en	CHEM	placebo	1524-1531
25823275_en	CHEM	placebo	1393-1400
25823275_en	CHEM	placebo	384-391
25823275_en	CHEM	placebo	145-152
25823275_en	CHEM	placebo	1829-1836
25823275_en	DISO	intoxication	1471-1483
25823275_en	CHEM	placebo	712-719
25842921_en	DISO	ischemic cardiomyopathy	26-49
25842921_en	DISO	ischemic cardiomyopathy	75-98
25842921_en	DISO	chronic heart disease	151-172
25842921_en	LABPROC	histological	628-640
25842921_en	DISO	CHD	283-286
25842921_en	LABPROC	cardiac biopsies	315-331
25842921_en	DISO	CHD	395-398
25842921_en	ANATOMY	myocardia	403-412
25842921_en	PHYS	adaptive responses	1404-1422
25842921_en	DISO	atherosclerosis	466-481
25842921_en	PHYS	triglyceride levels	852-871
25842921_en	CHEM	vasopressin	565-576
25842921_en	DISO	damage to the vascular bed	1454-1480
25842921_en	LABPROC	histochemical	642-655
25842921_en	LABPROC	immunohistological procedures	661-690
25842921_en	LABPROC	electron microscopic	692-712
25842921_en	LABPROC	electron histochemical studies	717-747
25842921_en	LABPROC	morphometry	753-764
25842921_en	PHYS	morphological changes	1927-1948
25842921_en	CHEM	cholesterol	836-847
25842921_en	DISO	chronic heart failure	198-219
25842921_en	LABPROC	biochemical monitoring	804-826
25842921_en	LABPROC	ECG	876-879
25842921_en	LABPROC	ECG monitoring	876-890
25842921_en	DISO	insufficiency	545-558
25842921_en	CHEM	vasopressin	931-942
25842921_en	DISO	damage to the myocardial tissue	1454-1502
25842921_en	ANATOMY	microvessels	1285-1297
25842921_en	ANATOMY	cardiomyocytes	1299-1313
25842921_en	ANATOMY	stroma	1315-1321
25842921_en	ANATOMY	lymph capillaries	1323-1340
25842921_en	ANATOMY	nerve endings	1346-1359
25842921_en	PHYS	secretion	1375-1384
25842921_en	ANATOMY	vascular bed	1468-1480
25842921_en	ANATOMY	myocardial tissue	1485-1502
25842921_en	DISO	occurring lesions	1534-1551
25842921_en	DISO	lesions	1544-1551
25842921_en	PHYS	lymphocirculatory	1608-1625
25842921_en	PHYS	innervation	1627-1638
25842921_en	DISO	conduction disturbances	1644-1667
25842921_en	ANATOMY	cardiomyocyte	1683-1696
25842921_en	PHYS	levels	865-871
25842921_en	FINDING	progression of chronic CHD	2078-2104
25842921_en	FINDING	myocardial changes	1738-1756
25842921_en	DISO	coronary atherosclerosis	1836-1860
25842921_en	ANATOMY	myocardium	1893-1903
25842921_en	DISO	hypoxia	1966-1973
25842921_en	DISO	CHD	2070-2073
25842921_en	FINDING	changes in secretion	1364-1384
25842921_en	DISO	CHD	2101-2104
25842921_en	FINDING	symptoms of damage to the vascular bed and myocardial tissue	1442-1502
25842921_en	DISO	damage to microvessels	1275-1297
25842921_en	DISO	damage to cardiomyocytes	1275-1313
25842921_en	DISO	CHD	2257-2260
25842921_en	DISO	damage to stroma	1275-1321
25842921_en	DISO	damage to lymph capillaries	1275-1340
25842921_en	DISO	ischemic	26-34
25842921_en	DISO	cardiomyopathy	35-49
25842921_en	DISO	ICM	100-103
25842921_en	DISO	ischemic	75-83
25842921_en	DISO	cardiomyopathy	84-98
25842921_en	ANATOMY	heart	159-164
25842921_en	DISO	heart disease	159-172
25842921_en	DISO	damage to nerve endings	1275-1359
25842921_en	DISO	CHD	174-177
25842921_en	ANATOMY	heart	206-211
25842921_en	DISO	heart failure	206-219
25842921_en	DISO	irregular diffuse cardiosclerosis	1562-1595
25842921_en	DISO	innervation disturbances	1627-1667
25842921_en	LABPROC	biopsies	323-331
25842921_en	ANATOMY	aortocoronary	362-375
25842921_en	DISO	lymphocirculatory disturbances	1608-1667
25842921_en	DISO	micro disturbances	1597-1667
25842921_en	ANATOMY	coronary	536-544
25842921_en	DISO	coronary insufficiency	536-558
25842921_en	DISO	cardiomyocyte damage	1683-1703
25842921_en	FINDING	coronary atherosclerosis progresses	1836-1871
25842921_en	PHYS	microhemocirculatory	1053-1073
25842921_en	FINDING	Functional morphology of ischemic cardiomyopathy	1-49
25842921_en	CHEM	trophic	1028-1035
25842921_en	ANATOMY	blood	830-835
25842921_en	PHYS	Compensatory responses	1387-1422
25842921_en	DISO	chronic CHD	2093-2104
25842921_en	DISO	CHD	985-988
25842921_en	ANATOMY	endothelial	1001-1012
25842921_en	CHEM	triglyceride	852-864
25842921_en	ANATOMY	blood	1112-1117
25842921_en	PHYS	blood flow	1112-1122
25842921_en	DISO	impaired blood flow	1103-1122
25842921_en	DISO	hypoxia	1130-1137
25842921_en	ANATOMY	myocardial	1158-1168
25842921_en	ANATOMY	capillaries	1329-1340
25842921_en	ANATOMY	lymph	1323-1328
25842921_en	ANATOMY	nerve	1346-1351
25842921_en	DISO	chronic heart failure	2175-2196
25842921_en	FINDING	pathogenesis and morphogenesis of CHD	2223-2260
25842921_en	ANATOMY	myocardial	1485-1495
25842921_en	ANATOMY	tissue	1496-1502
25842921_en	DISO	cardiosclerosis	1580-1595
25842921_en	DISO	diffuse cardiosclerosis	1572-1595
25842921_en	ANATOMY	myocardial	1738-1748
25842921_en	DISO	ICM	1783-1786
25842921_en	FINDING	endothelial changes	1001-1020
25842921_en	ANATOMY	coronary	1836-1844
25842921_en	DISO	atherosclerosis	1845-1860
25842921_en	LABPROC	histochemical studies	726-747
25842921_en	DISO	ICM	2145-2148
25842921_en	ANATOMY	heart	2183-2188
25842921_en	DISO	heart failure	2183-2196
25842921_en	ANATOMY	cardiac	315-322
25842921_en	ANATOMY	microhemocirculatory bed	1053-1077
25842921_en	ANATOMY	fascicules	1201-1211
25842921_en	PHYS	conduction	1644-1654
25842921_en	DISO	damaged myocardium	1885-1903
25842921_en	CHEM	trophic component	1028-1045
25842923_en	DISO	damage to the stem cell niches	118-148
25842923_en	ANATOMY	lung biopsies	629-642
25842923_en	DISO	IPF	683-686
25842923_en	DISO	NSIP	702-706
25842923_en	DISO	DIP	722-725
25842923_en	DISO	COP	740-743
25842923_en	DISO	BO	746-748
25842923_en	CHEM	hematoxylin	798-809
25842923_en	CHEM	eosin	814-819
25842923_en	LABPROC	immunohistochemical reactions	854-883
25842923_en	CHEM	MMP-1	911-916
25842923_en	CHEM	MMP-2	918-923
25842923_en	CHEM	MMP-7	925-930
25842923_en	CHEM	Apo-Cas	932-939
25842923_en	CHEM	vimentin	963-971
25842923_en	CHEM	SMA	1004-1007
25842923_en	CHEM	TGF-β	1030-1035
25842923_en	CHEM	TNF-α	1037-1042
25842923_en	CHEM	CD34	1044-1048
25842923_en	CHEM	Ost-4	1050-1055
25842923_en	PHYS	regeneration of lung tissue	1591-1618
25842923_en	CHEM	LSAB	1188-1192
25842923_en	CHEM	PEROXIDASE	1200-1210
25842923_en	ANATOMY	SCN areas	2030-2039
25842923_en	ANATOMY	respiratory acini	162-179
25842923_en	ANATOMY	acinus	1451-1457
25842923_en	DISO	IIPs	1365-1369
25842923_en	ANATOMY	respiratory acinus	1439-1457
25842923_en	FINDING	spread of a lesion to different SCN areas	1533-1574
25842923_en	DISO	inflammatory infiltrate	1501-1524
25842923_en	ANATOMY	cells	1810-1815
25842923_en	CHEM	MMP	911-914
25842923_en	ANATOMY	lung tissue	1607-1618
25842923_en	ANATOMY	mesenchymal cell	1624-1640
25842923_en	ANATOMY	myofibroblast	1646-1659
25842923_en	DISO	interstitial pneumonias	282-305
25842923_en	ANATOMY	mesenchymal stem cell	1713-1734
25842923_en	CHEM	Oct-4	1752-1757
25842923_en	CHEM	Vimentin	1759-1767
25842923_en	CHEM	SMA	1769-1772
25842923_en	CHEM	CD117	1774-1779
25842923_en	CHEM	CD34	1785-1789
25842923_en	ANATOMY	biopsies	634-642
25842923_en	ANATOMY	SCN	1863-1866
25842923_en	PHYS	marker cell	1843-1854
25842923_en	ANATOMY	SCN	2030-2033
25842923_en	ANATOMY	respiratory acinus	2047-2065
25842923_en	ANATOMY	mesenchymal	1713-1724
25842923_en	FINDING	morphological and molecular biological features	67-114
25842923_en	PHYS	respiratory	162-173
25842923_en	PHYS	morphological changes	1942-1963
25842923_en	ANATOMY	stem cell	132-141
25842923_en	ANATOMY	cell	137-141
25842923_en	DISO	chronic idiopathic interstitial pneumonias	263-305
25842923_en	FINDING	clinical course	1912-1927
25842923_en	ANATOMY	lung	187-191
25842923_en	DISO	cryptogenic organizing pneumonia (COP) with bronchiolitis obliterans	403-471
25842923_en	CHEM	MMP	918-921
25842923_en	DISO	pneumonias	295-305
25842923_en	PHYS	respiratory	2047-2058
25842923_en	CHEM	antibodies	1169-1179
25842923_en	DISO	idiopathic interstitial pneumonias	271-305
25842923_en	DISO	IIP	307-310
25842923_en	DISO	idiopathic pulmonary fibrosis	323-352
25842923_en	DISO	pulmonary fibrosis	334-352
25842923_en	DISO	fibrosis	344-352
25842923_en	ANATOMY	pulmonary	334-343
25842923_en	DISO	IPF	354-357
25842923_en	DISO	pneumonia	386-395
25842923_en	DISO	desquamative interstitial pneumonia	360-395
25842923_en	DISO	interstitial pneumonia	373-395
25842923_en	DISO	DIP	397-400
25842923_en	DISO	pneumonia	426-435
25842923_en	DISO	COP	437-440
25842923_en	DISO	cryptogenic organizing pneumonia	403-435
25842923_en	DISO	organizing pneumonia	415-435
25842923_en	DISO	bronchiolitis obliterans	447-471
25842923_en	DISO	bronchiolitis	447-460
25842923_en	DISO	BO	473-475
25842923_en	DISO	pneumonia	507-516
25842923_en	DISO	interstitial pneumonia	494-516
25842923_en	DISO	nonspecific interstitial pneumonia	482-516
25842923_en	DISO	NSIP	518-522
25842923_en	CHEM	antibodies	1235-1245
25842923_en	FINDING	differ in the site and degree of initial and secondary respiratory acinus damages	1384-1465
25842923_en	CHEM	paraffin	762-770
25842923_en	LABPROC	van Gieson's picrofuchsin	824-849
25842923_en	DISO	infiltrate	1514-1524
25842923_en	DISO	respiratory acinus damages	1439-1465
25842923_en	CHEM	Vimentin	973-981
25842923_en	ANATOMY	stem cell niches	132-148
25842923_en	ANATOMY	SCN	150-153
25842923_en	CHEM	CD117	1061-1066
25842923_en	ANATOMY	lung	1607-1611
25842923_en	CHEM	CD68	1083-1087
25842923_en	CHEM	EMA	1093-1096
25842923_en	ANATOMY	tissue	1612-1618
25842923_en	ANATOMY	cell	1636-1640
25842923_en	ANATOMY	mesenchymal	1624-1635
25842923_en	DISO	lesion	1545-1551
25842923_en	ANATOMY	cell	1730-1734
25842923_en	ANATOMY	stem cell	1725-1734
25842923_en	PHYS	myofibroblast differentiation	1646-1675
25842923_en	DISO	SCN damage	1863-1873
25842923_en	CHEM	MMP	925-928
25842923_en	FINDING	degree of morphological changes	1932-1963
25842923_en	FINDING	severity and depth of damage to the SCN areas of the respiratory acinus	1994-2065
25842923_en	DISO	damage to the SCN areas	2016-2039
25842923_en	ANATOMY	acinus	2059-2065
25842923_en	DISO	IPP	1967-1970
25842923_en	ANATOMY	lung	629-633
25842923_en	ANATOMY	acini	174-179
25842923_en	CHEM	immunoglobulin	1154-1168
25842923_en	LABPROC	Biotinylated	1114-1126
25842923_en	CHEM	immunoglobulin antibodies	1154-1179
25842923_en	LABPROC	stained	785-792
25842923_en	ANATOMY	SCN	1565-1568
25842923_en	PHYS	expression	1790-1800
25842923_en	ANATOMY	cell	1850-1854
25842923_en	DISO	COP + BO	740-748
25842923_en	DISO	inflammatory	1501-1513
25842923_en	ANATOMY	sections	771-779
25842923_en	FINDING	aggressiveness of an inflammatory infiltrate	1480-1524
25842923_en	PHYS	regeneration	1591-1603
25842923_en	FINDING	changes in the pathogenesis	232-259
25872388_en	CHEM	Diflucan	577-585
25872388_en	CHEM	asketin cefuroxime	623-641
25872388_en	CHEM	amikacin	653-661
25872388_en	CHEM	gentamicin	672-682
25872388_en	CHEM	amphotericin B	693-707
25872388_en	CHEM	BSS	718-721
25872388_en	ANATOMY	eye	751-754
25872388_en	INJURY_POISONING	toxic	1787-1792
25872388_en	CHEM	antifungal drugs generic	109-93
25872388_en	LABPROC	diluted	920-927
25872388_en	CHEM	Diflucan	967-975
25872388_en	CHEM	asketin cefuroxime	986-1004
25872388_en	CHEM	gentamicin	1014-1024
25872388_en	CHEM	amikacin	1036-1044
25872388_en	CHEM	amphotericin B	1056-1070
25872388_en	FINDING	no toxic effects	1101-1117
25872388_en	CHEM	BSS	1135-1138
25872388_en	CHEM	Moxifloxacin	1143-1155
25872388_en	ANATOMY	anterior chamber	1186-1202
25872388_en	ANATOMY	corneal endothelium	1310-1329
25872388_en	ANATOMY	cytoplasmic	1356-1367
25872388_en	DISO	swelling	1368-1376
25872388_en	ANATOMY	endothelial cells	1384-1401
25872388_en	DISO	desquamation	1420-1432
25872388_en	ANATOMY	posterior chamber	1470-1487
25872388_en	INJURY_POISONING	toxic	1534-1539
25872388_en	DISO	allergic	1541-1549
25872388_en	FINDING	neither of injected drugs caused toxic, allergic, or inflammatory reactions	1501-1576
25872388_en	FINDING	toxic reaction	1787-1801
25872388_en	CHEM	Moxifloxacin	1834-1846
25872388_en	ANATOMY	eye	29-32
25872388_en	CHEM	brand name antibiotic	71-104
25872388_en	ANATOMY	anterior eye segment	20-40
25872388_en	FINDING	toxicity	41-49
25872388_en	CHEM	generic antibiotic	86-104
25872388_en	CHEM	antibiotic	1242-1252
25872388_en	CHEM	antifungal drugs	1257-1273
25872388_en	CHEM	antibiotic	94-104
25872388_en	CHEM	antifungal drugs	109-125
25872388_en	CHEM	Moxifloxacin	169-181
25872388_en	CHEM	cefuroxime	191-201
25872388_en	CHEM	asketin cefuroxime	183-201
25872388_en	CHEM	amikacin	203-211
25872388_en	CHEM	gentamicin	213-223
25872388_en	CHEM	Diflucan	225-233
25872388_en	CHEM	amphotericin B	239-253
25872388_en	ANATOMY	anterior chamber	289-305
25872388_en	LABPROC	high concentrations	1213-1232
25872388_en	CHEM	antifungal drugs brand name	109-81
25872388_en	CHEM	asketin	183-190
25872388_en	CHEM	Moxifloxacin	553-565
25872388_en	CHEM	cefuroxime	631-641
25872388_en	ANATOMY	fellow eye	744-754
25872388_en	CHEM	antibiotics	466-477
25872388_en	CHEM	antifungals	482-493
25872388_en	LABPROC	highly diluted	913-927
25872388_en	LABPROC	diluted	63-70
25872388_en	CHEM	cefuroxime	994-1004
25872388_en	FINDING	toxic effects	1104-1117
25872388_en	LABPROC	concentrations	1218-1232
25872388_en	CHEM	highly diluted medications	1709-1735
25872388_en	CHEM	asketin	623-630
25872388_en	CHEM	asketin	986-993
25872388_en	DISO	exudation	1453-1462
25872388_en	CHEM	antibiotics	845-856
25872388_en	CHEM	antifungals	861-872
25872388_en	CHEM	Moxifloxacin	929-941
25872388_en	ANATOMY	corneal	1310-1317
25872388_en	ANATOMY	endothelium	1318-1329
25872388_en	ANATOMY	endothelial	1384-1395
25872388_en	ANATOMY	cells	1396-1401
25872388_en	LABPROC	highly diluted	1709-1723
25872388_en	DISO	inflammatory	1554-1566
25872388_en	LABPROC	histopathological examination	1590-1619
25872388_en	CHEM	generics	159-167
25872388_en	LABPROC	diluted	1716-1723
25872388_en	FINDING	absence of toxic reaction	1776-1801
25872388_en	DISO	cytoplasmic swelling	1356-1376
25872388_en	DISO	fibrin exudation	1446-1462
25872388_en	CHEM	generics	613-621
25872388_en	PHYS	changes in the corneal endothelium	1295-1329
25909792_en	LABPROC	EEG	1-4
25909792_en	DISO	paranoid schizophrenia: effects	56-87
25909792_en	DISO	productive disorders	571-604
25909792_en	LABPROC	EEG	152-155
25909792_en	DISO	schizophrenic	167-180
25909792_en	DISO	paranoid syndrome	1700-1717
25909792_en	DISO	paranoid	56-64
25909792_en	FINDING	diffuse increase of spectral power of gamma and delta ranges	1056-1116
25909792_en	LABPROC	EEG	327-330
25909792_en	PHYS	healthy	936-943
25909792_en	PHYS	delta range	1296-1307
25909792_en	DISO	symptomatology positive	113-99
25909792_en	DISO	positive disorders	659-686
25909792_en	DISO	negative symptomatology	104-127
25909792_en	DISO	Deficient states	1118-1134
25909792_en	LABPROC	EEG	533-536
25909792_en	FINDING	main index of negative symptomatology	992-1029
25909792_en	DISO	negative disorders	586-604
25909792_en	DISO	negative disorders	668-686
25909792_en	LABPROC	EEG	798-801
25909792_en	DISO	paranoid schizophrenia	869-891
25909792_en	FINDING	evidence of concrete clinical indices	691-728
25909792_en	DISO	negative symptomatology	1006-1029
25909792_en	DISO	volitional disorders	1160-1180
25909792_en	ANATOMY	left hemisphere	1272-1287
25909792_en	ANATOMY	hemisphere	1277-1287
25909792_en	ANATOMY	hemisphere	1676-1686
25909792_en	FINDING	EEG changes	1404-1415
25909792_en	ANATOMY	hemisphere	1335-1345
25909792_en	DISO	delusion disturbances	1589-1610
25909792_en	DISO	Positive symptomatology	1347-1370
25909792_en	LABPROC	EEG	1404-1407
25909792_en	DISO	negative	1421-1429
25909792_en	FINDING	less reflected in EEG changes	1386-1415
25909792_en	PHYS	delta ranges	1104-1116
25909792_en	LABPROC	EEG	1549-1552
25909792_en	DISO	delusion	1589-1597
25909792_en	ANATOMY	hemisphere	1788-1798
25909792_en	ANATOMY	frontal	1313-1320
25909792_en	ANATOMY	left hemisphere	1671-1686
25909792_en	DISO	paranoid syndrome with primary interpretative delusion	1700-1754
25909792_en	DISO	delusion	1746-1754
25909792_en	FINDING	frequency and regional EEG	510-536
25909792_en	ANATOMY	right hemisphere	1782-1798
25909792_en	DISO	schizophrenia: effects	65-87
25909792_en	PHYS	gamma ranges	1094-1116
25909792_en	FINDING	EEG frequency and regional properties	1-38
25909792_en	LABPROC	EEG spectral analysis	327-348
25909792_en	CHEM	psychoactive medication	902-925
25909792_en	DISO	psychopathological symptom complexes	1462-1498
25909792_en	DISO	Deficient states with the predominance of volitional disorders	1118-1180
25909792_en	DISO	schizophrenia	878-891
25909792_en	DISO	paranoid	869-877
25909792_en	FINDING	summary prevalence of positive/negative disorders	637-686
25909792_en	ANATOMY	cortical	1760-1768
25909792_en	ANATOMY	cortical areas	1760-1774
25909792_en	ANATOMY	frontal areas	1650-1663
25909792_en	ANATOMY	frontal areas	1313-1326
25909792_en	FINDING	lateralized increase of spectral power	1205-1243
25909792_en	FINDING	spatially structured EEG patterns	1528-1561
25909792_en	FINDING	spatially structured EEG patterns in the beta range	1528-1579
25909792_en	PHYS	beta-gamma ranges	1247-1264
25909792_en	FINDING	clinical heterogeneity of the disease	238-275
25909792_en	PHYS	state of patients	285-302
25909792_en	PHYS	beta range	1569-1579
25909792_en	FINDING	EEG changes	152-163
25909792_en	FINDING	Spectral characteristics of background EEG	759-801
25909792_en	LABPROC	background EEG	787-801
25909792_en	PHYS	neurophysiological mechanisms	416-445
25909792_en	DISO	primary interpretative delusion	1723-1754
26036068_en	INJURY_POISONING	neck trauma	1777-1788
26036068_en	INJURY_POISONING	neck trauma	175-186
26036068_en	INJURY_POISONING	injuries	49-57
26036068_en	INJURY_POISONING	trauma	180-186
26036068_en	ANATOMY	bone	76-80
26036068_en	ANATOMY	larynx	82-88
26036068_en	ANATOMY	trachea	94-101
26036068_en	ANATOMY	neck	175-179
26036068_en	INJURY_POISONING	complete fractures	1000-1018
26036068_en	INJURY_POISONING	breaks of the connections	1051-1076
26036068_en	ANATOMY	cervical portion of the trachea	1650-1681
26036068_en	INJURY_POISONING	injuries	302-310
26036068_en	INJURY_POISONING	neck injuries	390-403
26036068_en	FINDING	harm to human health	334-354
26036068_en	PHYS	death	492-497
26036068_en	ANATOMY	neck	609-613
26036068_en	INJURY_POISONING	neck trauma	609-620
26036068_en	INJURY_POISONING	fractures	748-757
26036068_en	ANATOMY	sublingual bone	765-780
26036068_en	ANATOMY	laryngeal	782-791
26036068_en	ANATOMY	tracheal cartilages	796-815
26036068_en	INJURY_POISONING	injuries to the greater horns of the hyoid bone	835-882
26036068_en	INJURY_POISONING	breaks	1051-1057
26036068_en	ANATOMY	hyoid bone	872-882
26036068_en	ANATOMY	hyoid	872-877
26036068_en	ANATOMY	thyroid cartilage	913-930
26036068_en	INJURY_POISONING	injuries	1145-1153
26036068_en	ANATOMY	arch of the cricoid cartilage	948-977
26036068_en	PHYS	health	348-354
26036068_en	ANATOMY	tracheal cartilages	1026-1045
26036068_en	ANATOMY	bone	1095-1099
26036068_en	ANATOMY	hyoid bone	1089-1099
26036068_en	ANATOMY	body	1100-1104
26036068_en	ANATOMY	greater horns	1113-1126
26036068_en	ANATOMY	tracheal	796-804
26036068_en	ANATOMY	neck region	1161-1172
26036068_en	ANATOMY	neck	1269-1273
26036068_en	INJURY_POISONING	neck trauma	1269-1280
26036068_en	INJURY_POISONING	fractures	1009-1018
26036068_en	INJURY_POISONING	cracks	989-995
26036068_en	PHYS	death	1527-1532
26036068_en	ANATOMY	neck	1596-1600
26036068_en	INJURY_POISONING	injuries	395-403
26036068_en	ANATOMY	organs	1601-1607
26036068_en	ANATOMY	cervical	1650-1658
26036068_en	ANATOMY	larynx	1635-1641
26036068_en	ANATOMY	trachea	1674-1681
26036068_en	FINDING	scope of the injuries in the neck region is large	1132-1181
26036068_en	FINDING	severity higher	1193-1208
26036068_en	ANATOMY	neck	1777-1781
26036068_en	FINDING	absence of previous external injurious impacts	1337-1383
26036068_en	ANATOMY	corpses	1456-1463
26036068_en	INJURY_POISONING	fractures	1887-1896
26036068_en	ANATOMY	hyoid-laryngeal-tracheal complex	1924-1956
26036068_en	INJURY_POISONING	injuries	1715-1723
26036068_en	ANATOMY	sublungual bone	65-80
26036068_en	INJURY_POISONING	blunt neck trauma	169-186
26036068_en	INJURY_POISONING	trauma	1782-1788
26036068_en	INJURY_POISONING	trauma	614-620
26036068_en	ANATOMY	neck	390-394
26036068_en	INJURY_POISONING	injuries	835-843
26036068_en	ANATOMY	tracheal	463-471
26036068_en	PHYS	death	379-384
26036068_en	INJURY_POISONING	blunt neck trauma	603-620
26036068_en	ANATOMY	tracheal	675-683
26036068_en	ANATOMY	bone	776-780
26036068_en	ANATOMY	cartilages	805-815
26036068_en	ANATOMY	greater horns	851-864
26036068_en	ANATOMY	cricoid cartilage	960-977
26036068_en	INJURY_POISONING	trauma	1274-1280
26036068_en	ANATOMY	bone	878-882
26036068_en	ANATOMY	greater horns of the hyoid bone	851-882
26036068_en	ANATOMY	inferior horns	891-905
26036068_en	ANATOMY	thyroid	913-920
26036068_en	ANATOMY	cartilage	921-930
26036068_en	ANATOMY	inferior horns of the thyroid cartilage	891-930
26036068_en	ANATOMY	cartilage	968-977
26036068_en	INJURY_POISONING	fissures	932-940
26036068_en	ANATOMY	tracheal	1026-1034
26036068_en	ANATOMY	cartilages	1035-1045
26036068_en	ANATOMY	hyoid bone body	1089-1104
26036068_en	FINDING	external injurious impacts	1357-1383
26036068_en	ANATOMY	neck	1161-1165
26036068_en	INJURY_POISONING	injuries in the neck region	1145-1172
26036068_en	INJURY_POISONING	blunt neck trauma	1263-1280
26036068_en	ANATOMY	tracheal	1498-1506
26036068_en	ANATOMY	entire complex of the neck organs	1574-1607
26036068_en	ANATOMY	tracheal	1737-1745
26036068_en	INJURY_POISONING	blunt neck trauma	1771-1788
26036068_en	INJURY_POISONING	external defects	1862-1878
26036068_en	ANATOMY	hyoid	1924-1929
26036068_en	ANATOMY	laryngeal	1930-1939
26036068_en	ANATOMY	tracheal	1940-1948
26036068_en	ANATOMY	constituents of the hyoid-laryngeal-tracheal complex	1904-1956
26036068_en	ANATOMY	neck organs	1596-1607
26081319_en	DISO	pain	15-19
26081319_en	FINDING	level of disability before and after surgical treatment.	287-343
26081319_en	DISO	lumbar vertebral canal stenosis	82-113
26081319_en	ANATOMY	low back	586-594
26081319_en	DISO	depression	681-691
26081319_en	DISO	lumbar vertebral canal stenosis	176-207
26081319_en	ANATOMY	central canal	1246-1259
26081319_en	FINDING	significant reduction of pain syndrome and the level of depression	1430-1496
26081319_en	ANATOMY	lumbar vertebral canal	409-431
26081319_en	FINDING	efficacy of surgical treatment	142-172
26081319_en	ANATOMY	lumbar vertebral canal	82-104
26081319_en	DISO	lumbar vertebral canal stenosis	409-440
26081319_en	ANATOMY	lumbar vertebral canal	176-198
26081319_en	DISO	Affective disorders	636-655
26081319_en	ANATOMY	Blood serum	700-711
26081319_en	CHEM	thrombocytic serotonin	716-738
26081319_en	LABPROC	ELISA	760-765
26081319_en	ANATOMY	lumbar vertebral canal	1346-1368
26081319_en	DISO	low back pain	586-599
26081319_en	FINDING	improvement of quality of life	1512-1542
26081319_en	PHYS	quality of life	1171-1186
26081319_en	DISO	pain syndrome	975-988
26081319_en	DISO	disability	296-306
26081319_en	DISO	pain	1142-1146
26081319_en	DISO	neurological disorders	1043-1065
26081319_en	DISO	stenosis	1260-1268
26081319_en	DISO	Neuropathic pain	1130-1146
26081319_en	DISO	depression	1151-1161
26081319_en	PHYS	quality of life	1527-1542
26081319_en	DISO	central canal stenosis	1246-1268
26081319_en	DISO	lateral stenosis	1295-1311
26081319_en	ANATOMY	back	590-594
26081319_en	DISO	lumbar vertebral canal stenosis	1346-1377
26081319_en	DISO	pain	1455-1459
26081319_en	PHYS	decompression of nervous structures	1391-1426
26081319_en	ANATOMY	nervous structures	1408-1426
26081319_en	DISO	pain syndrome	1455-1468
26081319_en	DISO	depression	1486-1496
26081319_en	PHYS	quality of life	1094-1109
26081319_en	PHYS	quality of life	267-282
26081319_en	DISO	disability	600-610
26081319_en	ANATOMY	vertebral	89-98
26081319_en	ANATOMY	lumbar vertebral	82-98
26081319_en	CHEM	serotonin	729-738
26081319_en	DISO	stenosis	105-113
26081319_en	PHYS	quality of life	23-38
26081319_en	PHYS	life	278-282
26081319_en	ANATOMY	vertebral	183-192
26081319_en	DISO	stenosis	199-207
26081319_en	ANATOMY	lumbar vertebral	176-192
26081319_en	DISO	pain	240-244
26081319_en	PHYS	life	34-38
26081319_en	PHYS	life	1105-1109
26081319_en	ANATOMY	vertebral	416-425
26081319_en	ANATOMY	lumbar vertebral	409-425
26081319_en	DISO	stenosis	432-440
26081319_en	PHYS	life	1182-1186
26081319_en	DISO	Pain	550-554
26081319_en	PHYS	life	1538-1542
26081319_en	FINDING	significantly affected quality of life and work capacity	1071-1127
26081319_en	DISO	pain	595-599
26081319_en	DISO	back pain	590-599
26081319_en	DISO	chronic pain syndrome	967-988
26081319_en	DISO	low back pain disability	586-610
26081319_en	ANATOMY	thrombocytic	716-728
26081319_en	ANATOMY	Blood	700-705
26081319_en	ANATOMY	serum	706-711
26081319_en	ANATOMY	nervous	1408-1415
26081319_en	DISO	pain	975-979
26081319_en	PHYS	work capacity	1114-1127
26081319_en	DISO	chronic pain syndrome of mixed etiology	967-1006
26081319_en	DISO	stenosis	1303-1311
26081319_en	DISO	nociceptive	1008-1019
26081319_en	DISO	neurotic type	1024-1037
26081319_en	PHYS	decompression	1391-1404
26081319_en	FINDING	reduced quality of life and daily activities	1163-1207
26081319_en	DISO	stenosis	1369-1377
26081319_en	ANATOMY	vertebral	1353-1362
26081319_en	ANATOMY	lumbar vertebral	1346-1362
26146046_en	LABPROC	angiography	242-253
26146046_en	LABPROC	SCT	258-261
26146046_en	LABPROC	angiography	262-273
26146046_en	DISO	cerebral aneurysms	295-313
26146046_en	LABPROC	angiographic examination	207-231
26146046_en	FINDING	mean duration	457-470
26146046_en	LABPROC	angiographic examination	541-565
26146046_en	DISO	aneurysms	586-595
26146046_en	DISO	aneurysms	652-661
26146046_en	DISO	aneurysms	704-713
26146046_en	DISO	aneurysms	727-736
26146046_en	DISO	aneurysm	151-159
26146046_en	ANATOMY	circle of Willis	830-846
26146046_en	DISO	aneurysms	856-865
26146046_en	FINDING	Neither lethal nor unfavorable outcomes were recorded	1046-1099
26146046_en	DISO	de novo aneurysm	909-925
26146046_en	DISO	aneurysm	917-925
26146046_en	FINDING	de novo aneurysms were formed	578-607
26146046_en	ANATOMY	middle cerebral artery	1006-1028
26146046_en	FINDING	outcomes	1077-1085
26146046_en	LABPROC	Dynamic angiographic follow-up	1438-1468
26146046_en	FINDING	lethal	1054-1060
26146046_en	DISO	aneurysm	1162-1170
26146046_en	FINDING	de novo aneurysm formation	143-169
26146046_en	DISO	hypertension	1219-1231
26146046_en	ANATOMY	main artery	1358-1369
26146046_en	LABPROC	angiography	1474-1485
26146046_en	LABPROC	magnetic resonance angiography	1489-1519
26146046_en	LABPROC	angiographic	61-73
26146046_en	FINDING	reasonability and duration of angiographic follow-up	31-83
26146046_en	ANATOMY	cerebral	112-120
26146046_en	DISO	aneurysms	121-130
26146046_en	DISO	cerebral aneurysms	112-130
26146046_en	DISO	de novo aneurysm	143-159
26146046_en	ANATOMY	cerebral	233-241
26146046_en	LABPROC	cerebral angiography	233-253
26146046_en	LABPROC	SCT angiography	258-273
26146046_en	ANATOMY	cerebral	295-303
26146046_en	DISO	aneurysms	304-313
26146046_en	DEVICE	spirals	944-951
26146046_en	DISO	de novo aneurysms	578-595
26146046_en	DISO	de novo aneurysms	644-661
26146046_en	ANATOMY	anterior part of the circle of Willis	809-846
26146046_en	DISO	De novo aneurysms	848-865
26146046_en	DISO	aneurysm	990-998
26146046_en	ANATOMY	cerebral	1013-1021
26146046_en	ANATOMY	artery	1022-1028
26146046_en	ANATOMY	cerebral artery	1013-1028
26146046_en	FINDING	high risk of de novo aneurysm formation	1141-1180
26146046_en	DISO	de novo aneurysm	1154-1170
26146046_en	PHYS	young	1200-1205
26146046_en	PHYS	young	1300-1305
26146046_en	FINDING	unfavorable outcomes	1065-1085
26146046_en	FINDING	follow-up duration	397-415
26146046_en	ANATOMY	artery	1363-1369
26146046_en	LABPROC	angiographic	1446-1458
26146046_en	LABPROC	SCT	1470-1473
26146046_en	LABPROC	SCT angiography	1470-1485
26146046_en	LABPROC	angiography	1508-1519
26226776_en	ANATOMY	colorectal	167-177
26226776_en	ANATOMY	liver	90-95
26226776_en	DISO	colorectal cancer	72-89
26226776_en	FINDING	enhances tumor cell proliferation	1810-1843
26226776_en	DISO	metastatic CRC	352-366
26226776_en	CHEM	E-cadherin	128-138
26226776_en	CHEM	β-catenin	143-152
26226776_en	DISO	cancer	178-184
26226776_en	DISO	colorectal cancer	167-184
26226776_en	DISO	liver metastases	191-207
26226776_en	CHEM	vascular endothelial growth factor	488-522
26226776_en	ANATOMY	cells	309-314
26226776_en	CHEM	VEGF	482-486
26226776_en	CHEM	catenin	972-979
26226776_en	ANATOMY	samples	367-374
26226776_en	CHEM	E-cadherin	588-598
26226776_en	CHEM	β-catenin	603-612
26226776_en	ANATOMY	metastatic CRC samples	352-374
26226776_en	CHEM	β-catenin	970-979
26226776_en	CHEM	anti-VEGF agent	1067-1082
26226776_en	DISO	metastases	96-106
26226776_en	DISO	tumor	1307-1312
26226776_en	CHEM	E-cadherin	1266-1276
26226776_en	CHEM	β-catenin	1281-1290
26226776_en	ANATOMY	cells	1313-1318
26226776_en	CHEM	E-cadherin	1355-1365
26226776_en	ANATOMY	membrane	1366-1374
26226776_en	CHEM	β-catenin	1392-1401
26226776_en	CHEM	cadherin	1357-1365
26226776_en	ANATOMY	membrane	1402-1410
26226776_en	CHEM	VEGF	1594-1598
26226776_en	PHYS	intercellular contacts	1719-1741
26226776_en	CHEM	anti-VEGF agent	1589-1604
26226776_en	CHEM	anti-VEGF	477-486
26226776_en	DISO	CRC	1639-1642
26226776_en	FINDING	positive impact on the cadherin-catenin complex	1649-1696
26226776_en	CHEM	catenin	1759-1766
26226776_en	CHEM	cadherin-catenin complex	1672-1696
26226776_en	PHYS	proliferation	1830-1843
26226776_en	CHEM	β-catenin	1757-1766
26226776_en	DISO	tumor	1819-1824
26226776_en	CHEM	cadherin	130-138
26226776_en	ANATOMY	colorectal	72-82
26226776_en	CHEM	catenin	145-152
26226776_en	DISO	cancer	83-89
26226776_en	DISO	liver metastases	90-106
26226776_en	DISO	CRC	186-189
26226776_en	ANATOMY	liver	191-196
26226776_en	CHEM	adhesion molecule	40-57
26226776_en	PHYS	expression	58-68
26226776_en	DISO	tumor	303-308
26226776_en	DISO	metastases	197-207
26226776_en	PHYS	expression	153-163
26226776_en	DISO	CRC	363-366
26226776_en	PHYS	adhesive properties	280-299
26226776_en	CHEM	cytotoxic	419-428
26226776_en	ANATOMY	vascular	488-496
26226776_en	ANATOMY	endothelial	497-508
26226776_en	CHEM	cytotoxic	454-463
26226776_en	LABPROC	immunohistochemically examined	537-567
26226776_en	CHEM	cadherin	590-598
26226776_en	CHEM	antibodies	574-584
26226776_en	CHEM	catenin	605-612
26226776_en	CHEM	cytotoxic	722-731
26226776_en	CHEM	VEGF	741-745
26226776_en	ANATOMY	membrane	832-840
26226776_en	CHEM	E-cadherin	857-867
26226776_en	PHYS	membrane localization	832-853
26226776_en	FINDING	significant increase in the number of cases of normal membrane localization of E-cadherin	778-867
26226776_en	CHEM	cytotoxic	911-920
26226776_en	CHEM	anti-VEGF	1067-1076
26226776_en	CHEM	anti-VEGF agents	736-752
26226776_en	DISO	metastatic	352-362
26226776_en	PHYS	β-catenin levels	970-986
26226776_en	FINDING	no significant differences	1020-1046
26226776_en	PHYS	nuclear localization of the protein	1139-1174
26226776_en	ANATOMY	cytoplasmic	1411-1422
26226776_en	CHEM	protein	1167-1174
26226776_en	FINDING	decrease in the number of cases of abnormal nuclear localization of the protein	1095-1174
26226776_en	DISO	metastatic	1628-1638
26226776_en	CHEM	catenin	1283-1290
26226776_en	PHYS	E-cadherin and β-catenin localization	1266-1303
26226776_en	DISO	metastatic CRC	1628-1642
26226776_en	CHEM	cadherin	1672-1680
26226776_en	CHEM	catenin	1681-1688
26226776_en	PHYS	membrane localization	1366-1387
26226776_en	ANATOMY	cell	1825-1829
26226776_en	PHYS	membrane-cytoplasmic expression	1402-1433
26226776_en	CHEM	growth factor	509-522
26226776_en	CHEM	cytotoxic	1514-1523
26226776_en	FINDING	increased intercellular contacts	1709-1741
26226776_en	FINDING	suppressed β-catenin functioning as a transcription factor	1746-1804
26226776_en	FINDING	not received drug therapy	664-689
26226776_en	CHEM	cadherin	859-867
26226776_en	CHEM	catenin	1394-1401
26226776_en	CHEM	a transcription facto	1782-1803
26226776_en	CHEM	cytotoxic	1221-1230
26226776_en	ANATOMY	nuclear	1139-1146
26226776_en	FINDING	abnormal nuclear localization of the protein	1130-1174
26226776_en	CHEM	cadherin	1268-1276
26226776_en	PHYS	transcription	1784-1797
26226776_en	FINDING	combination of normal E-cadherin membrane localization and β-catenin membrane-cytoplasmic expression prevailed	1333-1443
26245096_en	ANATOMY	vagus nerve	18-29
26245096_en	ANATOMY	vagus nerve system	18-36
26245096_en	DISO	sympathetic imbalance	66-87
26245096_en	PHYS	sudden cardiac death	103-123
26245096_en	ANATOMY	soft tissues	680-692
26245096_en	ANATOMY	vagus nerve system	173-191
26245096_en	ANATOMY	atrioventricular ganglion	193-218
26245096_en	ANATOMY	cardiomyocytes	235-249
26245096_en	PHYS	death	118-123
26245096_en	INJURY_POISONING	craniovertebral injury	331-353
26245096_en	DISO	acute coronary insufficiency	382-410
26245096_en	INJURY_POISONING	injuries	609-617
26245096_en	DISO	insufficiency	850-863
26245096_en	ANATOMY	vagus nerve system	483-501
26245096_en	ANATOMY	pial soft tissues	913-930
26245096_en	DISO	lesions	522-529
26245096_en	ANATOMY	jugular ganglia	537-552
26245096_en	INJURY_POISONING	craniovertebral injuries	593-617
26245096_en	ANATOMY	ganglion	210-218
26245096_en	ANATOMY	ganglia	653-660
26245096_en	ANATOMY	nerve trunks	662-674
26245096_en	ANATOMY	jugular foramina	700-716
26245096_en	DISO	atrophic changes	736-752
26245096_en	ANATOMY	ganglia	771-778
26245096_en	ANATOMY	vagus nerve system	786-804
26245096_en	INJURY_POISONING	injury	347-353
26245096_en	DISO	acute coronary insufficiency	835-863
26245096_en	DISO	hemosiderosis	892-905
26245096_en	ANATOMY	soft tissues	918-930
26245096_en	ANATOMY	medulla oblongata	938-955
26245096_en	ANATOMY	nerve	24-29
26245096_en	PHYS	changes in cardiomyocytes	224-249
26245096_en	PHYS	morphological marker	42-62
26245096_en	FINDING	fatal outcome	269-282
26245096_en	ANATOMY	cardiac	110-117
26245096_en	ANATOMY	vagus nerve	173-184
26245096_en	DISO	insufficiency	397-410
26245096_en	ANATOMY	nerve	179-184
26245096_en	ANATOMY	pial	913-917
26245096_en	ANATOMY	atrioventricular	193-209
26245096_en	DISO	hemorrhage	633-643
26245096_en	ANATOMY	craniovertebral	331-346
26245096_en	ANATOMY	coronary	388-396
26245096_en	DISO	coronary insufficiency	388-410
26245096_en	ANATOMY	vagus nerve	483-494
26245096_en	ANATOMY	nerve	489-494
26245096_en	ANATOMY	jugular	537-544
26245096_en	ANATOMY	ganglia	545-552
26245096_en	ANATOMY	craniovertebral	593-608
26245096_en	PHYS	died	825-829
26245096_en	ANATOMY	nerve	662-667
26245096_en	ANATOMY	tissues	685-692
26245096_en	ANATOMY	jugular	700-707
26245096_en	ANATOMY	foramina	708-716
26245096_en	ANATOMY	vagus nerve	786-797
26245096_en	ANATOMY	nerve	792-797
26245096_en	ANATOMY	coronary	841-849
26245096_en	DISO	coronary insufficiency	841-863
26245096_en	ANATOMY	tissues	923-930
26245096_en	PHYS	cardiac death	110-123
26245096_en	DISO	Pathology of the vagus nerve system	1-36
26271422_en	ANATOMY	abdominal	44-53
26271422_en	ANATOMY	abdominal wall	44-58
26271422_en	DISO	hernias	294-301
26271422_en	ANATOMY	umbilical	75-84
26271422_en	PHYS	health	958-964
26271422_en	ANATOMY	abdominal	187-196
26271422_en	ANATOMY	abdominal wall	187-201
26271422_en	ANATOMY	umbilical	252-261
26271422_en	ANATOMY	ventral	286-293
26271422_en	ANATOMY	ventral	103-110
26271422_en	DISO	hernias	111-118
26271422_en	DISO	ventral hernias	103-118
26271422_en	DISO	ventral hernias	286-301
26271422_en	DISO	large ventral hernias	280-301
26271422_en	ANATOMY	abdomen	316-323
26271422_en	DISO	ptosis	324-330
26271422_en	DISO	abdomen ptosis	316-330
26271422_en	DISO	hernias umbilical	111-84
26271422_en	ANATOMY	abdominal	441-450
26271422_en	ANATOMY	abdominal wall	441-455
26271422_en	DISO	umbilical hernias	252-301
26271422_en	DISO	abdominal wall defect	441-462
26271422_en	CHEM	polypropylene	478-491
26271422_en	ANATOMY	tissues	584-591
26271422_en	ANATOMY	musculoaponeurotic tissues	565-591
26271422_en	ANATOMY	hypogastric area	603-619
26271422_en	CHEM	polypropylenepolyvinylidenefluoride	653-688
26271422_en	FINDING	increased physical health	939-964
26271422_en	CHEM	Polypropylene	720-733
26271422_en	DEVICE	Polypropylene endoprosthesis	720-748
26271422_en	PHYS	physical health	949-964
26271422_en	DISO	postoperative ventral hernias	89-118
26271422_en	FINDING	amount of satisfactory outcomes reduced	1087-1126
26271422_en	FINDING	amount of satisfactory outcomes	1087-1118
26271422_en	DISO	postoperative large ventral hernias	266-301
26271422_en	DEVICE	prosthesis	492-502
26271422_en	DEVICE	polypropylene prosthesis	478-502
26271422_en	DEVICE	standard polypropylene prosthesis	469-502
26271422_en	DEVICE	prosthesis	689-699
26271422_en	DEVICE	polypropylenepolyvinylidenefluoride prosthesis	653-699
26271422_en	DEVICE	super lightweight polypropylenepolyvinylidenefluoride prosthesis	635-699
26271422_en	FINDING	increased psychic	939-996
26271422_en	FINDING	number of excellent results	1036-1063
26271422_en	LABPROC	ultrasonic investigation	159-183
26271422_en	FINDING	number of excellent results increased	1036-1073
26271422_en	DEVICE	Endoprosthetic	1-15
26271422_en	DEVICE	Endoprosthetic	411-425
26271422_en	DEVICE	endoprosthetic	533-547
26271558_en	DISO	upper esophageal sphincter achalasia	14-50
26271558_en	PHYS	elderly age	665-676
26271558_en	DISO	upper esophageal sphincter achalasia	162-198
26271558_en	DISO	achalasia	215-224
26271558_en	DISO	stroke in brain stem	244-264
26271558_en	ANATOMY	pharyngoesophageal junction	401-428
26271558_en	PHYS	innervation	547-558
26271558_en	ANATOMY	pharyngeal	607-617
26271558_en	FINDING	Severe condition of patients	632-660
26271558_en	ANATOMY	muscles	562-569
26271558_en	FINDING	preservation of innervation	531-558
26271558_en	ANATOMY	epiglottis	592-602
26271558_en	ANATOMY	pharyngeal constrictors	607-630
26271558_en	PHYS	age	673-676
26271558_en	DISO	achalasia	41-50
26271558_en	ANATOMY	sphincter	31-40
26271558_en	ANATOMY	esophageal sphincter	20-40
26271558_en	ANATOMY	upper esophageal sphincter	14-40
26271558_en	DISO	achalasia	189-198
26271558_en	ANATOMY	sphincter	179-188
26271558_en	ANATOMY	esophageal sphincter	168-188
26271558_en	ANATOMY	upper esophageal sphincter	162-188
26271558_en	ANATOMY	brain	254-259
26271558_en	ANATOMY	brain stem	254-264
26271558_en	DISO	stroke	244-250
26271558_en	DISO	Zakharchenko-Wallenberg syndrome	266-298
26271558_en	ANATOMY	esophageal	20-30
26271558_en	ANATOMY	esophageal	168-178
26271558_en	ANATOMY	pharyngoesophageal	401-419
26271558_en	FINDING	Plastic myotomy gives excellent and good results	452-500
26271558_en	ANATOMY	constrictors	618-630
26310014_en	DISO	Vogt-Koyanagi-Harada syndrome	1-30
26310014_en	DISO	Vogt-Koyanagi-Harada (VKH) syndrome	92-127
26310014_en	DISO	VKH	114-117
26310014_en	DISO	bilateral panuveitis	183-203
26310014_en	DISO	keratomalacia	219-232
26310014_en	ANATOMY	left eye	234-242
26310014_en	CHEM	Methylprednisolone	293-311
26310014_en	CHEM	azathioprine	327-339
26310014_en	DISO	uveitis	408-415
26310014_en	ANATOMY	eye	514-517
26310014_en	DISO	retinal detachment	458-476
26310014_en	DISO	cataract	492-500
26310014_en	ANATOMY	right eye	508-517
26310014_en	ANATOMY	neuroepithelium	577-592
26310014_en	FINDING	reattachment	604-616
26310014_en	ANATOMY	eyes	625-629
26310014_en	CHEM	Metypred	648-656
26310014_en	CHEM	prednisolone	681-693
26310014_en	CHEM	azathioprine	698-710
26310014_en	DISO	panuveitis	722-732
26310014_en	DISO	pupil occlusion	738-753
26310014_en	CHEM	prednisolone	796-808
26310014_en	ANATOMY	pupil	738-743
26310014_en	CHEM	methylprednisolone	930-948
26310014_en	CHEM	azathioprine	953-965
26310014_en	DISO	uveitis	1131-1138
26310014_en	CHEM	Metypred	1030-1038
26310014_en	DISO	side effects	1238-1250
26310014_en	DISO	VKH syndrome	1075-1087
26310014_en	FINDING	regression of uveitis	394-415
26310014_en	DISO	autoimmune uveitis	1120-1138
26310014_en	CHEM	azathioprine	1157-1169
26310014_en	FINDING	cessation of prednisolone	783-808
26310014_en	CHEM	prednisolone	1217-1229
26310014_en	DISO	VKH	1274-1277
26310014_en	ANATOMY	retinal	458-465
26310014_en	DISO	occlusion	744-753
26310014_en	DISO	panuveitis	193-203
26310014_en	DISO	unilateral keratomalacia	208-232
26310014_en	ANATOMY	eye	239-242
26310014_en	CHEM	Metypred	313-321
26310014_en	FINDING	rapid resolution of acute condition	975-1010
26310014_en	DISO	bilateral detachment of neuroepithelium	553-592
26310014_en	DISO	Bilateral panuveitis	712-732
26310014_en	FINDING	slows progression of the disease	1170-1202
26310014_en	FINDING	minimizes prednisolone-induced side effects	1207-1250
26310014_en	DISO	detachment of neuroepithelium	563-592
26355937_en	CHEM	polymethylmethacrylate	7-29
26355937_en	ANATOMY	bone	80-84
26355937_en	PHYS	age	205-208
26355937_en	DISO	bone lesions	80-92
26355937_en	DISO	Arteriovenous dysplasia	95-118
26355937_en	DISO	arteriovenous shunt	406-425
26355937_en	PHYS	young age	199-208
26355937_en	ANATOMY	osseous	229-236
26355937_en	PHYS	female	539-545
26355937_en	FINDING	failing however to achieve complete liquidation of the arteriovenous reflux	710-785
26355937_en	ANATOMY	limb	349-353
26355937_en	ANATOMY	osseous apparatus	229-246
26355937_en	DISO	angiodysplasia	573-587
26355937_en	FINDING	liquidation of the arteriovenous reflux	746-785
26355937_en	ANATOMY	limb	601-605
26355937_en	FINDING	removing arteriovenous shunt and trophic impairments	397-449
26355937_en	DISO	trophic impairments	430-449
26355937_en	ANATOMY	extremity	381-390
26355937_en	ANATOMY	lower limb	595-605
26355937_en	ANATOMY	tibial bone	615-626
26355937_en	ANATOMY	arteriovenous	765-778
26355937_en	FINDING	salvage of the extremity	366-390
26355937_en	DISO	arteriovenous reflux	765-785
26355937_en	ANATOMY	tissues	836-843
26355937_en	DISO	angiomatous tissues	824-843
26355937_en	DISO	complications	177-190
26355937_en	ANATOMY	bone	905-909
26355937_en	ANATOMY	tibial bone	949-960
26355937_en	ANATOMY	intramedullary canal	965-985
26355937_en	CHEM	polymethylmethacrylate	1016-1038
26355937_en	ANATOMY	arteries	1176-1184
26355937_en	ANATOMY	tissues	1212-1219
26355937_en	DISO	angiomatous tissues	1200-1219
26355937_en	FINDING	salvage of the supporting function of limbs	1292-1335
26355937_en	PHYS	supporting function of limbs	1307-1335
26355937_en	ANATOMY	limbs	1330-1335
26355937_en	ANATOMY	axis of the tibial bone	937-960
26355937_en	DISO	angiodysplasia	60-74
26355937_en	DISO	arteriovenous angiodysplasia	46-74
26355937_en	DISO	dysplasia	109-118
26355937_en	ANATOMY	bone	622-626
26355937_en	FINDING	increase radical nature of interventions	1246-1286
26355937_en	DISO	arteriovenous angiodysplasia	559-587
26355937_en	ANATOMY	arteriovenous	46-59
26355937_en	ANATOMY	Arteriovenous	95-108
26355937_en	ANATOMY	affected limb	340-353
26355937_en	ANATOMY	bone	956-960
26355937_en	CHEM	PMMA	1040-1044
26355937_en	ANATOMY	afferent arteries	1167-1184
26355937_en	ANATOMY	arteriovenous	406-419
26355937_en	ANATOMY	arteriovenous	559-572
26356060_en	CHEM	actovegin	305-314
26356060_en	DISO	critical ischemia	331-348
26356060_en	DISO	atherosclerosis	486-501
26356060_en	DISO	atherosclerosis obliterans	486-512
26356060_en	FINDING	improvement of transcutaneous oxygen tension has not been received	1451-1517
26356060_en	ANATOMY	toes	585-589
26356060_en	CHEM	pentoxifylline	673-687
26356060_en	CHEM	rheopolyglukin	697-711
26356060_en	CHEM	low molecular weight heparins	792-821
26356060_en	CHEM	heparins	813-821
26356060_en	CHEM	actovegin	879-888
26356060_en	PHYS	microcirculation	1089-1105
26356060_en	LABPROC	polarography	1112-1124
26356060_en	LABPROC	laser Doppler imaging	1129-1150
26356060_en	PHYS	index of regional tissue perfusion	1366-1400
26356060_en	LABPROC	histological studies	1198-1218
26356060_en	FINDING	double control of therapy's effectiveness	1236-1277
26356060_en	PHYS	microcirculation	1313-1329
26356060_en	ANATOMY	tissue	1384-1390
26356060_en	PHYS	perfusion	1391-1400
26356060_en	PHYS	transcutaneous oxygen tension	1466-1495
26356060_en	CHEM	actovegin	1571-1580
26356060_en	ANATOMY	skin	1590-1594
26356060_en	PHYS	skin perfusion	1590-1604
26356060_en	ANATOMY	tissue	1684-1690
26356060_en	PHYS	microcirculation	1639-1655
26356060_en	PHYS	tissue oxygenation	1684-1702
26356060_en	FINDING	Positive effect of actovegin	1716-1744
26356060_en	CHEM	actovegin	1735-1744
26356060_en	PHYS	collateral blood flow	1767-1788
26356060_en	ANATOMY	lower limbs	1830-1841
26356060_en	ANATOMY	extremities	358-369
26356060_en	ANATOMY	lower limbs	51-62
26356060_en	ANATOMY	limbs	57-62
26356060_en	DISO	distal occlusion	27-43
26356060_en	ANATOMY	lower extremities	352-369
26356060_en	DISO	critical ischemia of lower extremities	331-369
26356060_en	ANATOMY	limb	523-527
26356060_en	DISO	necrotic processes	555-573
26356060_en	DISO	critical limb ischemia	514-536
26356060_en	LABPROC	Cytological	1182-1193
26356060_en	PHYS	regional tissue perfusion	1375-1400
26356060_en	CHEM	oxygen	1481-1487
26356060_en	PHYS	oxygen tension	1481-1495
26356060_en	PHYS	perfusion	1595-1604
26356060_en	FINDING	activated microcirculation	1629-1655
26356060_en	FINDING	increased tissue oxygenation	1674-1702
26356060_en	FINDING	improved skin perfusion	1581-1604
26356060_en	PHYS	blood flow	1778-1788
26356060_en	ANATOMY	blood	1778-1783
26356060_en	DISO	occlusion	1813-1822
26356060_en	ANATOMY	limbs	1836-1841
26356060_en	DISO	distal occlusion	1806-1822
26356060_en	DISO	ischemia	340-348
26356060_en	DISO	ischemia of lower extremities	340-369
26356060_en	DISO	critical limb ischemia stage III-IV	514-549
26356060_en	FINDING	effectiveness of actovegin	288-314
26356060_en	CHEM	antiplatelet agents	724-743
26356060_en	CHEM	statins	845-852
26356060_en	FINDING	therapy's effectiveness	1254-1277
26356060_en	FINDING	pain-free walking distance	1058-1084
26356060_en	DISO	occlusion	34-43
26356060_en	DISO	pain	1058-1062
26356060_en	DISO	ischemia	528-536
26356060_en	DISO	limb ischemia	523-536
26356162_en	CHEM	BDNF	41-45
26356162_en	CHEM	cerebrolysin	18-30
26356162_en	PHYS	BDNF level	41-51
26356162_en	DISO	aphasia	81-88
26356162_en	PHYS	carbohydrate metabolism	102-125
26356162_en	DISO	carbohydrate metabolism disorders	102-135
26356162_en	DISO	stroke	305-311
26356162_en	FINDING	speech recovery	232-247
26356162_en	CHEM	BDNF	252-256
26356162_en	DISO	left-hemisphere stroke	289-311
26356162_en	DISO	carbohydrate metabolism disorders	316-349
26356162_en	DISO	diabetes mellitus type2	351-374
26356162_en	DISO	prediabetes	378-389
26356162_en	CHEM	cerebrolysin	404-416
26356162_en	CHEM	BDNF	750-754
26356162_en	DISO	aphasia	641-648
26356162_en	ANATOMY	serum	755-760
26356162_en	DISO	speech impairment	731-748
26356162_en	PHYS	BDNF serum concentrations	750-775
26356162_en	CHEM	cerebrolysin	821-833
26356162_en	CHEM	physiological solution	876-898
26356162_en	DISO	aphasia	1018-1025
26356162_en	DISO	speech impairment	1141-1158
26356162_en	DISO	carbohydrate metabolism disorders	1329-1362
26356162_en	CHEM	BDNF	1390-1394
26356162_en	CHEM	cerebrolysin	1480-1492
26356162_en	DISO	stroke	1540-1546
26356162_en	DISO	aphasia	1547-1554
26356162_en	ANATOMY	hemisphere	294-304
26356162_en	DISO	stroke	74-80
26356162_en	DISO	post stroke aphasia	69-88
26356162_en	CHEM	carbohydrate	102-114
26356162_en	CHEM	carbohydrate	316-328
26356162_en	PHYS	carbohydrate metabolism	316-339
26356162_en	DISO	diabetes mellitus	351-368
26356162_en	DISO	diabetes	351-359
26356162_en	CHEM	solution	890-898
26356162_en	DISO	stroke	1011-1017
26356162_en	DISO	post stroke aphasia	1006-1025
26356162_en	CHEM	carbohydrate	1329-1341
26356162_en	PHYS	carbohydrate metabolism	1329-1352
26356162_en	FINDING	increase in BDNF concentrations	1378-1409
26356162_en	PHYS	metabolism	115-125
26356162_en	DISO	post stroke aphasia	1535-1554
26356162_en	FINDING	improves the prognosis of their rehabilitation	1577-1623
26356162_en	FINDING	improvement of speech	1202-1223
26356162_en	DISO	Speech Pathology	488-504
26356162_en	PHYS	metabolism	329-339
26356162_en	ANATOMY	left-hemisphere	289-304
26356162_en	FINDING	severity of speech impairment	719-748
26356162_en	PHYS	metabolism	1342-1352
26356162_en	FINDING	cerebrolysin effect	18-37
26356162_en	FINDING	Clinical efficacy of cerebrolysin	800-833
26356162_en	PHYS	BDNF concentrations	252-271
26356162_en	FINDING	changes in the rate of speech recovery and BDNF concentrations	209-271
26356162_en	PHYS	BDNF concentrations	1390-1409
26356515_en	CHEM	anxiolytics	68-79
26356515_en	CHEM	hypnotics	84-93
26356515_en	DISO	drug dependence	119-134
26356515_en	FINDING	risk was higher	1307-1322
26356515_en	DISO	psychiatric	210-221
26356515_en	PHYS	aged	205-209
26356515_en	CHEM	anxiolytic	252-262
26356515_en	CHEM	hypnotic	267-275
26356515_en	CHEM	benzodiazepines	276-291
26356515_en	CHEM	benzodiazepines	472-487
26356515_en	DISO	psychopathological	666-684
26356515_en	CHEM	benzodiazepine	769-783
26356515_en	DISO	pathological dependence	897-920
26356515_en	DISO	drug dependence	836-851
26356515_en	DISO	pathological dependence of benzodiazepine	897-938
26356515_en	CHEM	benzodiazepine	924-938
26356515_en	CHEM	benzodiazepine	940-954
26356515_en	PHYS	tolerability	1058-1070
26356515_en	FINDING	exacerbation of dependence	1018-1044
26356515_en	FINDING	increase in tolerability to benzodiazepine	1046-1088
26356515_en	CHEM	benzodiazepine	1074-1088
26356515_en	CHEM	anxiolytics	1089-1100
26356515_en	CHEM	hypnotics	1105-1114
26356515_en	DISO	benzodiazepine dependence	769-794
26356515_en	FINDING	higher risk in patients aged ≤ 60 years	1231-1270
26356515_en	CHEM	diazepam	1293-1301
26356515_en	CHEM	phenazepam	1349-1359
26356515_en	DISO	psychopathological	167-185
26356515_en	CHEM	hypnotic benzodiazepines	267-291
26356515_en	DISO	psychiatric disorder	412-432
26356515_en	DISO	somatic/autonomic symptoms	987-1013
26356515_en	DISO	benzodiazepine withdrawal syndrome	940-974
26356515_en	FINDING	clinical/psychopathological characteristics	158-201
26356615_en	DISO	brain infarction	115-131
26356615_en	ANATOMY	brain	115-120
26356615_en	DISO	infarction	121-131
26356615_en	DISO	stroke	253-259
26356615_en	DISO	ischemic	244-252
26356615_en	DISO	ischemic stroke	244-259
26356615_en	ANATOMY	carotid territory	535-552
26356615_en	FINDING	significant 1,5-1,7- fold decrease	1062-1096
26356615_en	CHEM	acid	706-710
26356615_en	CHEM	ascorbic acid	697-710
26356615_en	CHEM	cytoflavin	727-737
26356615_en	CHEM	cytoflavin	781-791
26356615_en	DISO	ischemic lesion	1268-1283
26356615_en	CHEM	ascorbic acid	1338-1351
26356615_en	CHEM	cytoflavin	1370-1380
26356615_en	CHEM	cytoflavin	1535-1545
26356615_en	PHYS	neurologic	1606-1616
26356615_en	CHEM	cytoflavin	1669-1679
26356615_en	CHEM	cytoflavin	1822-1832
26356615_en	DISO	stroke	521-527
26356615_en	DISO	ischemic	512-520
26356615_en	PHYS	Patient's condition	872-891
26356615_en	LABPROC	CT	1028-1030
26356615_en	DISO	cerebral ischemic lesion	1104-1128
26356615_en	DISO	lesion	1122-1128
26356615_en	ANATOMY	cerebral	1104-1112
26356615_en	CHEM	cytoflavin	1157-1167
26356615_en	CHEM	ascorbic acid	1215-1228
26356615_en	DISO	ischemic lesion	1113-1128
26356615_en	DISO	lesion	1277-1283
26356615_en	PHYS	functional	1618-1628
26356615_en	ANATOMY	vascular	425-433
26356615_en	FINDING	2-fold higher	1317-1330
26356615_en	FINDING	percentage of patients with ischemic lesion, increased	1240-1294
26356615_en	FINDING	no significant morphologic changes	1173-1207
26356615_en	FINDING	No differences in clinical variables	1691-1727
26356615_en	DISO	ischemic stroke	512-527
26356615_en	DISO	ischemic	1113-1121
26356615_en	DISO	ischemic	1268-1276
26356615_en	FINDING	more prominent improvement	1576-1602
26356615_en	CHEM	acid	1224-1228
26356615_en	CHEM	acid	1347-1351
26356615_en	FINDING	clinical and morphological results	193-227
26356615_en	FINDING	Clinical and morphologic efficacy	1-34
26356616_en	CHEM	escitalopram	34-46
26356616_en	DISO	dementia	68-76
26356616_en	DISO	depression	94-104
26356616_en	DISO	moderate cognitive dysfunction	109-139
26356616_en	DISO	chronic brain ischemia	156-178
26356616_en	CHEM	cipralex	236-244
26356616_en	CHEM	escitalopram	222-234
26356616_en	DISO	cognitive dysfunction	118-139
26356616_en	DISO	dementia	267-275
26356616_en	DISO	depression	293-303
26356616_en	DISO	moderate cognitive dysfunction	308-338
26356616_en	DISO	chronic brain ischemia	355-377
26356616_en	DISO	chronic brain ischemia	448-470
26356616_en	DISO	mild or moderate depression	475-502
26356616_en	DISO	cognitive dysfunction	517-538
26356616_en	CHEM	escitalopram:	576-589
26356616_en	CHEM	escitalopram	857-869
26356616_en	DISO	depression	916-926
26356616_en	DISO	cognitive dysfunction	943-964
26356616_en	DISO	chronic brain ischemia	982-1004
26356616_en	DISO	dementia	1037-1045
26356616_en	DISO	dysfunction	128-139
26356616_en	DISO	ischemia	170-178
26356616_en	DISO	cognitive dysfunction	317-338
26356616_en	ANATOMY	brain	164-169
26356616_en	DISO	dysfunction	527-538
26356616_en	DISO	dysfunction	953-964
26356616_en	DISO	ischemia	369-377
26356616_en	ANATOMY	brain	363-368
26356616_en	DISO	brain ischemia	456-470
26356616_en	DISO	ischemia	462-470
26356616_en	ANATOMY	brain	456-461
26356616_en	DISO	brain ischemia	990-1004
26356616_en	DISO	ischemia	996-1004
26356616_en	ANATOMY	brain	990-995
26356616_en	FINDING	decrease of the risk of dementia	1013-1045
26356616_en	FINDING	efficacy of escitalopram	845-869
26356616_en	DISO	brain ischemia	164-178
26356616_en	DISO	brain ischemia	363-377
26356616_en	DISO	dysfunction	327-338
26356616_en	DISO	depression	492-502
26390722_en	DISO	acute myeloid leukemias	49-72
26390722_en	DISO	leukemias	200-209
26390722_en	DISO	acute myeloid leukemias	186-209
26390722_en	PHYS	CR	493-495
26390722_en	DISO	AML	361-364
26390722_en	FINDING	survival	560-568
26390722_en	FINDING	RFS	570-573
26390722_en	PHYS	complete remissions	472-491
26390722_en	DISO	recurrences	498-509
26390722_en	PHYS	deaths	511-517
26390722_en	FINDING	4-year overall survival	523-568
26390722_en	FINDING	relapse-free survival	547-568
26390722_en	DISO	AML	720-723
26390722_en	DISO	non-M3 types	725-737
26390722_en	FINDING	notified incidence rate	844-867
26390722_en	CHEM	cytarabine	1037-1047
26390722_en	CHEM	hypomethylating agents	1076-1098
26390722_en	FINDING	mortality	1327-1336
26390722_en	PHYS	deaths	1357-1363
26390722_en	DISO	primary refractory disease	1388-1414
26390722_en	PHYS	deaths	1427-1433
26390722_en	PHYS	CR	1436-1438
26390722_en	CHEM	LDC	1503-1506
26390722_en	CHEM	HA	1523-1525
26390722_en	DISO	Recurrences	1527-1538
26390722_en	PHYS	CR	1596-1598
26390722_en	CHEM	LDC	1756-1759
26390722_en	CHEM	LDC	1860-1863
26390722_en	FINDING	mortality	1889-1898
26390722_en	DISO	AML	2087-2090
26390722_en	DISO	relapse	547-554
26390722_en	DISO	leukemias	63-72
26390722_en	ANATOMY	myeloid	55-62
26390722_en	DISO	myeloid leukemias	55-72
26390722_en	FINDING	efficiency of their treatment	253-282
26390722_en	FINDING	efficiency of their treatment	410-439
26390722_en	DISO	myeloid leukemias	192-209
26390722_en	DISO	AML	211-214
26390722_en	ANATOMY	myeloid	192-199
26390722_en	FINDING	Clinical and epidemiological characteristics	1-45
26390722_en	PHYS	remissions	481-491
26390722_en	FINDING	rates of complete remissions	463-491
26390722_en	CHEM	low-dose cytarabine	1028-1047
26390722_en	CHEM	LDC	1049-1052
26390722_en	CHEM	HA	1100-1102
26390722_en	ANATOMY	stem cell	1230-1239
26390722_en	ANATOMY	cell	1235-1239
26390722_en	ANATOMY	hematopoietic stem cell	1216-1239
26390722_en	ANATOMY	allogeneic hematopoietic stem cell	1205-1239
26390722_en	FINDING	limited resources of accompanying therapy	1947-1988
26390722_en	PHYS	hematopoietic	1216-1229
26390722_en	FINDING	poor sanitary conditions	1990-2014
26390722_en	FINDING	OS	1647-1649
26390722_en	FINDING	Four-year OS	1637-1649
26390722_en	FINDING	OS	539-541
26390722_en	FINDING	RFS	1778-1781
26390722_en	FINDING	4-year RFS	1771-1781
26390722_en	FINDING	none of the patients underwent	1174-1204
26390722_en	FINDING	High mortality rates in the induction	1884-1921
26390722_en	FINDING	no own opportunities to perform allo-HSCT	2020-2061
26390722_en	FINDING	median follow-up	1604-1620
26390722_en	DISO	M3 types	729-737
26485778_en	ANATOMY	skin	13-17
26485778_en	ANATOMY	nerve	1214-1219
26485778_en	CHEM	neuropeptides	32-45
26485778_en	CHEM	neurotrophins	47-60
26485778_en	DISO	dermatoses	104-114
26485778_en	FINDING	appearance of positively stained epidermal nerve fibers	1125-1180
26485778_en	ANATOMY	skin	989-993
26485778_en	CHEM	neurotransmitters	149-166
26485778_en	DISO	dermatitis	307-317
26485778_en	DISO	itch	209-213
26485778_en	ANATOMY	skin	242-246
26485778_en	DISO	inflammatory response	247-268
26485778_en	DISO	psoriasis	286-295
26485778_en	DISO	atopic dermatitis	300-317
26485778_en	ANATOMY	Skin biopsy specimens	341-362
26485778_en	DISO	psoriasis	385-394
26485778_en	DISO	atopic dermatitis	416-433
26485778_en	LABPROC	immunoperoxidase	469-485
26485778_en	LABPROC	indirect immunofluorescence assays	491-525
26485778_en	CHEM	PGP9.5	601-607
26485778_en	LABPROC	histological	455-467
26485778_en	CHEM	protein gene product 9.5	575-599
26485778_en	CHEM	amphiregulin	610-622
26485778_en	CHEM	CGRP-R	696-702
26485778_en	CHEM	nerve growth factor	705-724
26485778_en	CHEM	TrkA	748-752
26485778_en	CHEM	substance P	758-769
26485778_en	CHEM	SP-R	792-796
26485778_en	LABPROC	indirect immunofluorescence assay	802-835
26485778_en	DEVICE	Statistica 10	922-935
26485778_en	DISO	dermatitis	1037-1047
26485778_en	LABPROC	Immunoperoxidase examination	953-981
26485778_en	ANATOMY	epidermal	1158-1167
26485778_en	ANATOMY	skin biopsy specimens	989-1010
26485778_en	DISO	atopic dermatitis	1030-1047
26485778_en	DISO	psoriasis	1052-1061
26485778_en	ANATOMY	nerve	1168-1173
26485778_en	CHEM	amphiregulin	1094-1106
26485778_en	CHEM	NGF	1108-1111
26485778_en	CHEM	PGP9.5	1117-1123
26485778_en	ANATOMY	nerve fibers	1168-1180
26485778_en	ANATOMY	epidermal nerve fibers	1158-1180
26485778_en	CHEM	nerve reduction factor	1214-1236
26485778_en	CHEM	semaphorin 3A	1237-1250
26485778_en	DISO	atopic dermatitis	1284-1301
26485778_en	DISO	psoriasis	1306-1315
26485778_en	LABPROC	Immunoperoxidase	953-969
26485778_en	CHEM	CGRP	1347-1351
26485778_en	CHEM	CGRP-R	1356-1362
26485778_en	CHEM	SP	1364-1366
26485778_en	CHEM	SP-R	1368-1372
26485778_en	CHEM	TrkA	1378-1382
26485778_en	DISO	inflammatory response	1397-1418
26485778_en	CHEM	neuropeptides	1715-1728
26485778_en	CHEM	neurotrophins	1733-1746
26485778_en	ANATOMY	skin	1790-1794
26485778_en	DISO	inflammatory response	1795-1816
26485778_en	PHYS	body's sensitization	1903-1923
26485778_en	ANATOMY	body's	1903-1909
26485778_en	PHYS	sensitization	1910-1923
26485778_en	LABPROC	biopsy	346-352
26485778_en	CHEM	reduction factor	1220-1236
26485778_en	ANATOMY	Skin	341-345
26485778_en	DISO	dermatitis	423-433
26485778_en	LABPROC	immunofluorescence assays	500-525
26485778_en	PHYS	number of epidermal nerve fibers	1574-1606
26485778_en	CHEM	semaphorin	624-634
26485778_en	CHEM	semaphorin 3A	624-637
26485778_en	CHEM	calcitonin gene-related peptide	639-670
26485778_en	CHEM	CGRP	672-676
26485778_en	CHEM	calcitonin	639-649
26485778_en	CHEM	NGF	726-729
26485778_en	CHEM	SP	771-773
26485778_en	FINDING	closely related to the development of a skin inflammatory response	1750-1816
26485778_en	LABPROC	immunofluorescence assay	811-835
26485778_en	DISO	dermatitis	1291-1301
26485778_en	PHYS	production of neuropeptides and neurotrophins	1701-1746
26485778_en	DISO	atopic dermatitis	1512-1529
26485778_en	DISO	dermatitis	1519-1529
26485778_en	DISO	psoriasis	1534-1543
26485778_en	FINDING	larger number of epidermal nerve fibers	1567-1606
26485778_en	ANATOMY	epidermal nerve fibers	1584-1606
26485778_en	ANATOMY	epidermal	1584-1593
26485778_en	ANATOMY	nerve	1594-1599
26485778_en	ANATOMY	nerve fibers	1594-1606
26485778_en	DISO	itch	1681-1685
26485778_en	FINDING	favor the body's sensitization and the chronic pattern the course of diseases	1893-1970
26485778_en	DISO	pathogenesis	88-100
26485778_en	ANATOMY	biopsy specimens	346-362
26485778_en	ANATOMY	biopsy specimens	994-1010
26485778_en	ANATOMY	nerve	705-710
26485778_en	CHEM	CGRP	1356-1360
26485778_en	CHEM	SP	792-794
26485778_en	CHEM	SP	1368-1370
26485778_en	CHEM	semaphorin	1237-1247
26485778_en	CHEM	receptors	71-80
26485778_en	CHEM	receptors	177-186
26485778_en	CHEM	protein	575-582
26485778_en	LABPROC	biopsy	994-1000
26485778_en	PHYS	expression	1196-1206
26485778_en	PHYS	expression	1080-1090
26485778_en	FINDING	enhanced expression	1071-1090
26485778_en	FINDING	decreased expression of the nerve reduction factor	1186-1236
26485778_en	PHYS	expression	1333-1343
26485778_en	FINDING	increased expression	1323-1343
26485778_en	FINDING	disease severity	1659-1675
26485778_en	FINDING	direct correlation	1616-1634
26485778_en	FINDING	itch intensity	1681-1695
26525622_en	DISO	cognitive impairment	29-49
26525622_en	DISO	epilepsy	81-89
26525622_en	DISO	cognitive impairment	111-131
26525622_en	CHEM	hopantenic acid	152-167
26525622_en	CHEM	pantogam	169-177
26525622_en	DISO	epilepsy	221-229
26525622_en	DISO	cognitive impairment	234-254
26525622_en	DISO	epilepsy	314-322
26525622_en	CHEM	pantogam	336-344
26525622_en	DISO	epilepsy	383-391
26525622_en	CHEM	pantogam	412-420
26525622_en	DISO	symptomatic epilepsy	503-523
26525622_en	DISO	cryptogenic epilepsy	478-498
26525622_en	DISO	epilepsy	515-523
26525622_en	LABPROC	video-EEG monitoring	607-627
26525622_en	LABPROC	EEG	602-605
26525622_en	FINDING	did not receive pantogam	396-420
26525622_en	LABPROC	EEG	613-616
26525622_en	LABPROC	brain MRI	632-641
26525622_en	DISO	cognitive impairment	658-678
26525622_en	CHEM	pantogam	769-777
26525622_en	DISO	cognitive impairment	984-1004
26525622_en	FINDING	improvement of EEG	1101-1119
26525622_en	LABPROC	EEG	1116-1119
26525622_en	FINDING	no increase in the frequency of seizures	1210-1250
26525622_en	DISO	seizures	1242-1250
26525622_en	PHYS	preschool age	53-66
26525622_en	DISO	epilepsy	490-498
26525622_en	LABPROC	MRI	638-641
26525622_en	ANATOMY	brain	632-637
26525622_en	FINDING	decrease in cognitive impairment	972-1004
26525622_en	CHEM	acid	163-167
26525622_en	FINDING	good tolerability	1176-1193
26525622_en	FINDING	age normalization	1079-1096
26525622_en	PHYS	age	63-66
26525622_en	PHYS	age	1079-1082
26525622_en	FINDING	efficacy of hopantenic acid	140-167
26525625_en	CHEM	cytoflavin	17-27
26525625_en	DISO	burnout syndrome	48-64
26525625_en	CHEM	cytoflavin	105-115
26525625_en	FINDING	efficacy of cytoflavin	5-27
26525625_en	DISO	burnout syndrome	150-166
26525625_en	LABPROC	neurophysiological examinations	236-267
26525625_en	FINDING	stability of the resulting effect	536-569
26525625_en	CHEM	cytoflavin	343-353
26525625_en	CHEM	ethylmethylhydroxypyridine succinate	371-407
26525625_en	CHEM	cytoflavin	617-627
26525625_en	CHEM	ethylmethylhydroxypyridine	673-699
26525625_en	CHEM	ethylmethylhydroxypyridine succinate	673-709
26525625_en	CHEM	cytoflavin	762-772
26525625_en	FINDING	improvement	629-640
26525625_en	CHEM	succinate	700-709
26525625_en	CHEM	succinate	398-407
26525625_en	CHEM	ethylmethylhydroxypyridine	371-397
26525625_en	FINDING	efficacy of cytoflavin	93-115
26525625_en	FINDING	efficacy of cytoflavin	605-627
26525625_en	FINDING	higher efficacy of cytoflavin	598-627
26525625_en	FINDING	improvement	711-722
26525625_en	FINDING	improvement was more persisten	788-818
26525625_en	FINDING	clinical results	827-843
26525628_en	DISO	syringomyelia	29-42
26525628_en	FINDING	slowly progressive course was most frequent	662-705
26525628_en	DISO	syringomyelia	125-138
26525628_en	PHYS	motor	500-505
26525628_en	DISO	sensory disorders	488-515
26525628_en	DISO	trophic changes	517-532
26525628_en	ANATOMY	bone	556-560
26525628_en	ANATOMY	spine	652-657
26525628_en	ANATOMY	cervical	620-628
26525628_en	PHYS	sensory	488-495
26525628_en	DISO	motor disorders	500-515
26525628_en	ANATOMY	thoracic	629-637
26525628_en	ANATOMY	skin	540-544
26525628_en	ANATOMY	joint	546-551
26525628_en	DISO	bone deformations	556-573
26525628_en	DISO	lesion	593-599
26525628_en	ANATOMY	cervical-thoracic region	620-644
26525628_en	FINDING	Disease duration	308-324
26525628_en	DISO	Clinical characteristics	1-25
26525628_en	DISO	clinical characteristics	97-121
26528618_en	DISO	destruction	423-434
26528618_en	ANATOMY	odontoid process	49-65
26528618_en	DISO	invaginated	37-48
26528618_en	ANATOMY	C2 vertebra	73-84
26528618_en	ANATOMY	junction	734-742
26528618_en	ANATOMY	craniovertebral region	129-151
26528618_en	ANATOMY	clivus	153-159
26528618_en	ANATOMY	junction	312-320
26528618_en	ANATOMY	C2 vertebra	212-223
26528618_en	ANATOMY	C2	236-238
26528618_en	ANATOMY	craniovertebral	296-311
26528618_en	ANATOMY	craniovertebral junction	296-320
26528618_en	DISO	craniovertebral junction instability	296-332
26528618_en	DISO	lesion	374-380
26528618_en	ANATOMY	C2	387-389
26528618_en	ANATOMY	vertebrae	470-479
26528618_en	ANATOMY	C2	467-469
26528618_en	ANATOMY	clivus structures	442-459
26528618_en	ANATOMY	C1-C2 vertebrae	464-479
26528618_en	ANATOMY	spinal cord	503-514
26528618_en	DISO	compression of the spinal cord	484-514
26528618_en	DISO	chordoma	552-560
26528618_en	DISO	giant cell tumor	562-578
26528618_en	DISO	osteoblastoma	580-593
26528618_en	DISO	rheumatoid lesion	595-612
26528618_en	DISO	metastases	614-624
26528618_en	DISO	platybasia	626-636
26528618_en	DISO	basilar impression	642-660
26528618_en	ANATOMY	craniovertebral	718-733
26528618_en	DISO	instability of the craniovertebral junction	699-742
26528618_en	ANATOMY	craniovertebral junction	718-742
26528618_en	DISO	neurological disorders	771-793
26528618_en	ANATOMY	odontoid process	954-970
26528618_en	DISO	invagination	934-946
26528618_en	FINDING	complete decompression	1771-1793
26528618_en	ANATOMY	C2 vertebra	978-989
26528618_en	ANATOMY	odontoid process	1120-1136
26528618_en	ANATOMY	C2	1117-1119
26528618_en	PHYS	motions	1291-1298
26528618_en	ANATOMY	distal legs	1315-1326
26528618_en	DISO	neurological symptoms	1201-1222
26528618_en	PHYS	strength and range of motions	1269-1298
26528618_en	ANATOMY	arms	1306-1310
26528618_en	ANATOMY	legs	1322-1326
26528618_en	DISO	spasticity	1338-1348
26528618_en	ANATOMY	arms	1356-1360
26528618_en	DISO	spasticity	1387-1397
26528618_en	ANATOMY	legs	1405-1409
26528618_en	PHYS	sensitivity	1457-1468
26528618_en	ANATOMY	arms	1476-1480
26528618_en	ANATOMY	legs	1482-1486
26528618_en	ANATOMY	torso	1492-1497
26528618_en	DISO	liquorrhea	1514-1524
26528618_en	DISO	stenosis	1886-1894
26528618_en	DISO	fistula	1589-1596
26528618_en	FINDING	no signs of liquorrhea	1619-1641
26528618_en	DISO	liquorrhea	1631-1641
26528618_en	LABPROC	MRI	1677-1680
26528618_en	LABPROC	spiral CT	1685-1694
26528618_en	DISO	bone defect	1720-1731
26528618_en	ANATOMY	odontoid process	1742-1758
26528618_en	ANATOMY	medulla oblongata	1801-1818
26528618_en	ANATOMY	upper cervical spine segments	1823-1852
26528618_en	DISO	spinal canal stenosis	1873-1894
26528618_en	ANATOMY	soft palate	2085-2096
26528618_en	ANATOMY	oropharynx	2117-2127
26528618_en	ANATOMY	sutures	2288-2295
26528618_en	DISO	failure of sutures in the oral cavity	2277-2314
26528618_en	ANATOMY	oropharynx	2348-2358
26528618_en	INJURY_POISONING	wound surface	2327-2340
26528618_en	ANATOMY	oral cavity	2303-2314
26528618_en	FINDING	increase in the strength and range of motions	1253-1298
26528618_en	ANATOMY	oropharynx area	2348-2363
26528618_en	ANATOMY	stomach	2450-2457
26528618_en	DEVICE	stomach tube	2450-2462
26528618_en	DISO	inflammatory complications	2486-2512
26528618_en	ANATOMY	oral cavity	2520-2531
26528618_en	ANATOMY	C2	2613-2615
26528618_en	ANATOMY	C1-C2 segment	2610-2623
26528618_en	FINDING	complicates the diagnosis and surgical treatment	801-849
26528618_en	ANATOMY	vertebra	76-84
26528618_en	ANATOMY	C1 anterior arch	161-177
26528618_en	ANATOMY	odontoid process	179-195
26528618_en	FINDING	no evidence of spinal canal stenosis	1858-1894
26528618_en	ANATOMY	vertebra	215-223
26528618_en	ANATOMY	body of the C2 vertebra	200-223
26528618_en	ANATOMY	C1	233-235
26528618_en	ANATOMY	C0	230-232
26528618_en	ANATOMY	C0-C1-C2 segments	230-247
26528618_en	DISO	lesion of C1-C2 segments	374-398
26528618_en	ANATOMY	C1-C2 segments	384-398
26528618_en	FINDING	hospitalization and rehabilitation duration is reduced	2158-2212
26528618_en	DISO	destruction of the clivus structures	423-459
26528618_en	ANATOMY	cell	568-572
26528618_en	DISO	tumor	573-578
26528618_en	ANATOMY	giant cell	562-572
26528618_en	DISO	lesion	606-612
26528618_en	FINDING	significant advantages	2050-2072
26528618_en	FINDING	regressed spasticity	1328-1348
26528618_en	FINDING	reduced spasticity	1379-1397
26528618_en	DISO	complications	2499-2512
26528618_en	DISO	Postoperative liquorrhea	1500-1524
26528618_en	LABPROC	CT	1692-1694
26528618_en	ANATOMY	bone	1720-1724
26528618_en	ANATOMY	C2	1739-1741
26528618_en	FINDING	no problems and complications	2230-2259
26528618_en	DISO	postoperative bone defect	1706-1731
26528618_en	ANATOMY	clivus	1763-1769
26528618_en	ANATOMY	cervical	1829-1837
26528618_en	ANATOMY	spine	1838-1843
26528618_en	DISO	complications	2246-2259
26528618_en	ANATOMY	spinal canal	1873-1885
26528618_en	ANATOMY	palate	2090-2096
26528618_en	FINDING	soft palate remains intact	2085-2111
26528618_en	ANATOMY	oropharynx area	2117-2132
26528618_en	FINDING	oropharynx area is less damaged	2117-2148
26528618_en	ANATOMY	oral	2520-2524
26528618_en	ANATOMY	vertebra	981-989
26528618_en	DISO	CSF fistula	1585-1596
26528618_en	FINDING	partial regression of the neurological symptoms	1175-1222
26528618_en	ANATOMY	oral	2303-2307
26528618_en	ANATOMY	C1	161-163
26528618_en	ANATOMY	C1	384-386
26528618_en	ANATOMY	C1	464-466
26528618_en	ANATOMY	C1	2610-2612
26528618_en	ANATOMY	C2	73-75
26528618_en	ANATOMY	C2	212-214
26528618_en	ANATOMY	C2	978-980
26528618_en	ANATOMY	spinal	503-509
26528618_en	ANATOMY	spinal	1873-1879
26528618_en	DISO	inflammatory	2486-2498
26528618_en	FINDING	improvement in all kinds of sensitivity	1429-1468
26591552_en	CHEM	pioglitazone	27-39
26591552_en	DISO	heart disease	118-131
26591552_en	DISO	asthma	86-92
26591552_en	DISO	coronary heart disease	109-131
26591552_en	CHEM	pioglitazone	184-196
26591552_en	DISO	heart disease	275-288
26591552_en	ANATOMY	heart	275-280
26591552_en	DISO	asthma	243-249
26591552_en	DISO	coronary heart disease	266-288
26591552_en	DISO	inflammation	2275-2287
26591552_en	DISO	asthma	355-361
26591552_en	DISO	CHD	378-381
26591552_en	PHYS	ERF	429-432
26591552_en	PHYS	External respiratory function	398-427
26591552_en	LABPROC	electrocardiograms	435-453
26591552_en	PHYS	blood pressure	455-469
26591552_en	PHYS	BP	471-473
26591552_en	CHEM	hs-CRP	618-624
26591552_en	ANATOMY	Blood	543-548
26591552_en	ANATOMY	urine	553-558
26591552_en	FINDING	improved EDVD	1717-1730
26591552_en	CHEM	high-sensitivity C-reactive protein	581-616
26591552_en	ANATOMY	endothelial	657-668
26591552_en	PHYS	endothelial function	657-677
26591552_en	ANATOMY	endothelium	703-714
26591552_en	PHYS	endothelium-independent vasodilation	729-765
26591552_en	PHYS	EIVD	776-780
26591552_en	FINDING	not statistically significantly differ in basic clinical and anamnestic data	1052-1128
26591552_en	CHEM	pioglitazone	893-905
26591552_en	LABPROC	measuring endothelium-dependent and endothelium-independent vasodilation	693-765
26591552_en	CHEM	pioglitazone	995-1007
26591552_en	FINDING	Clinical effectiveness of pioglitazone	1-39
26591552_en	DISO	inflammation	1961-1973
26591552_en	FINDING	clinical effectiveness of pioglitazone	158-196
26591552_en	FINDING	stabilization of ERF and endothelial function	1172-1217
26591552_en	PHYS	ERF	1189-1192
26591552_en	ANATOMY	endothelial	1197-1208
26591552_en	PHYS	endothelial function	1197-1217
26591552_en	DISO	asthma symptoms	1282-1297
26591552_en	DISO	asthma	1282-1288
26591552_en	DISO	angina	1318-1324
26591552_en	DISO	angina attacks	1318-1332
26591552_en	PHYS	hs-CRP levels	1366-1379
26591552_en	CHEM	pioglitazone	1408-1420
26591552_en	ANATOMY	bronchial	1560-1569
26591552_en	DISO	asthma	1474-1480
26591552_en	DISO	CHD	1497-1500
26591552_en	DISO	angina	1603-1609
26591552_en	ANATOMY	brachial	1862-1870
26591552_en	DISO	bronchial obstruction	1560-1581
26591552_en	DISO	angina pain	1603-1614
26591552_en	DISO	asthma attacks	1619-1633
26591552_en	CHEM	nitroglycerin	1640-1653
26591552_en	CHEM	salbutamol	1658-1668
26591552_en	FINDING	lowered systolic and diastolic blood pressure	1670-1715
26591552_en	PHYS	diastolic blood pressure	1691-1715
26591552_en	ANATOMY	blood	1776-1781
26591552_en	PHYS	EDVD	1726-1730
26591552_en	PHYS	blood flow	1776-1786
26591552_en	PHYS	hyperemia	1813-1822
26591552_en	PHYS	reactive hyperemia	1804-1822
26591552_en	ANATOMY	brachial artery	1862-1877
26591552_en	ANATOMY	BA	1879-1881
26591552_en	CHEM	pioglitazone	2100-2112
26591552_en	DISO	asthma	2157-2163
26591552_en	DISO	CHD	2180-2183
26591552_en	PHYS	anthropometric measurements	480-507
26591552_en	DISO	systemic inflammation	1952-1973
26591552_en	PHYS	endothelial functional activity	2302-2333
26591552_en	ANATOMY	endothelial	2302-2313
26591552_en	ANATOMY	heart	118-123
26591552_en	ANATOMY	coronary	109-117
26591552_en	ANATOMY	coronary	266-274
26591552_en	DISO	CHD	290-293
26591552_en	PHYS	External respiratory	398-418
26591552_en	ANATOMY	blood	455-460
26591552_en	CHEM	C-reactive protein	598-616
26591552_en	CHEM	CRP	621-624
26591552_en	PHYS	vasodilation	753-765
26591552_en	ANATOMY	endothelium	729-740
26591552_en	PHYS	endothelium-dependent vasodilation	703-765
26591552_en	PHYS	EDVD	767-771
26591552_en	CHEM	hs-CRP	1366-1372
26591552_en	CHEM	CRP	1369-1372
26591552_en	DISO	asthma	1619-1625
26591552_en	PHYS	blood pressure	1701-1715
26591552_en	ANATOMY	blood	1701-1706
26591552_en	PHYS	systolic blood pressure	1678-1715
26591552_en	PHYS	RH	1824-1826
26591552_en	PHYS	index of reactivity	1829-1848
26591552_en	PHYS	IR	1850-1852
26591552_en	ANATOMY	artery	1871-1877
26591552_en	PHYS	EIVD	1897-1901
26591552_en	PHYS	IR	1916-1918
26591552_en	ANATOMY	BA	1926-1928
26591552_en	PHYS	BA diameter	1926-1937
26591552_en	CHEM	hs-CRP	1979-1985
26591552_en	CHEM	CRP	1982-1985
26591552_en	PHYS	hs-CRP values	1979-1992
26591552_en	DISO	hypercholesterolemia	2007-2027
26591552_en	CHEM	cholesterol	2039-2050
26591552_en	PHYS	total cholesterol levels	2033-2057
26591552_en	FINDING	reduced systemic inflammation	1944-1973
26591552_en	DISO	systemic inflammation	2266-2287
26591552_en	FINDING	reduces systemic inflammation	2258-2287
26591552_en	FINDING	improves endothelial functional activity	2293-2333
26591552_en	LABPROC	test for reactive hyperemia	1795-1822
26591552_en	FINDING	frequency of asthma symptoms	1269-1297
26591552_en	FINDING	decline in hs-CRP levels	1355-1379
26591552_en	FINDING	increases in IR and A% BA diameter	1903-1937
26591552_en	FINDING	duration of angina attacks	1306-1332
26591552_en	PHYS	linear velocity of blood flow	1757-1786
26591552_en	CHEM	protein	609-616
26591552_en	CHEM	total cholesterol	2033-2050
26591552_en	DISO	attacks	1626-1633
26591552_en	DISO	attacks	1325-1332
26591552_en	DISO	pain	1610-1614
26591552_en	FINDING	increases	1252-1261
26591552_en	FINDING	improved clinical disease control	1501-1534
26591552_en	LABPROC	Blood and urine laboratory values	543-576
26591552_en	FINDING	decreased	1536-1545
26591552_en	FINDING	frequency	1590-1599
26591552_en	FINDING	increases in the maximum linear velocity of blood flow	1732-1786
26591552_en	FINDING	improves the clinical course of the diseases	2184-2228
26591552_en	FINDING	increases their control	2233-2256
26591552_en	PHYS	respiratory	407-418
26600613_en	DISO	podoconiosis	31-43
26600613_en	DISO	Podoconiosis	46-58
26600613_en	DISO	inflammatory disease	65-85
26600613_en	CHEM	irritant minerals in soil	119-144
26600613_en	DISO	swelling of the lower limb	169-195
26600613_en	DISO	lymphoedema	197-208
26600613_en	DISO	acute pain	214-224
26600613_en	DISO	podoconiosis	378-390
26600613_en	CHEM	minerals	128-136
26600613_en	ANATOMY	foot	774-778
26600613_en	DISO	podoconiosis	543-555
26600613_en	DISO	lymphoedema	732-743
26600613_en	ANATOMY	foot	788-792
26600613_en	DEVICE	compression	811-822
26600613_en	INJURY_POISONING	wound	799-804
26600613_en	DISO	acute infections	874-890
26600613_en	DISO	podoconiosis	956-968
26600613_en	DISO	infections	880-890
26600613_en	DEVICE	shoes	1127-1132
26600613_en	DISO	pain	220-224
26600613_en	FINDING	reduce podoconiosis incidence	536-565
26600613_en	DISO	tropical diseases	1022-1039
26600613_en	ANATOMY	lower limb	185-195
26600613_en	ANATOMY	limb	191-195
26600613_en	DEVICE	footwear	611-619
26600613_en	ANATOMY	foot	629-633
26600613_en	ANATOMY	legs	852-856
26600613_en	DISO	swelling	169-177
26753198_en	PHYS	respiratory	8-19
26753198_en	PHYS	gas exchange	128-140
26753198_en	ANATOMY	lungs	351-356
26753198_en	ANATOMY	trachea	358-365
26753198_en	ANATOMY	bronchi	367-374
26753198_en	ANATOMY	mediastinal structures	379-401
26753198_en	ANATOMY	thoracic	499-507
26753198_en	PHYS	gas exchange	645-657
26753198_en	PHYS	respiratory	867-878
26753198_en	PHYS	respiratory	1082-1093
26753198_en	DISO	cardiorespiratory pathology	1234-1261
26753198_en	PHYS	gas exchange	1314-1326
26753198_en	ANATOMY	bronchi	1385-1392
26753198_en	ANATOMY	trachea	1368-1375
26753198_en	ANATOMY	main bronchi	1380-1392
26753198_en	DEVICE	"shunt-breath" system	1443-1464
26753198_en	ANATOMY	thoracic	36-44
26753198_en	ANATOMY	thoracic	198-206
26753198_en	ANATOMY	mediastinal	379-390
26753198_en	CHEM	gas	645-648
26753198_en	CHEM	gas	128-131
26753198_en	FINDING	safety and efficacy of anesthetic management	451-495
26753198_en	PHYS	respiratory	557-568
26753198_en	FINDING	maximize the efficiency of gas exchange	618-657
26753198_en	ANATOMY	thoracic	896-904
26753198_en	ANATOMY	lung	933-937
26753198_en	ANATOMY	airways	983-990
26753198_en	ANATOMY	lung	1166-1170
26753198_en	PHYS	cardiorespiratory	1234-1251
26753198_en	PHYS	respiratory	1523-1534
26753198_en	FINDING	Effectiveness of special respiratory technologies for thoracic surgery	842-912
26753198_en	CHEM	gas	1314-1317
26753198_en	PHYS	breath	1450-1456
26753198_en	DEVICE	shunt	1444-1449
26821417_en	DISO	respiratory viral infections	43-71
26821417_en	DISO	temporary disability	984-1004
26821417_en	DISO	acute respiratory viral infections	37-71
26821417_en	DISO	ARVI	284-288
26821417_en	DISO	respiratory viral infections	254-282
26821417_en	FINDING	fewer adverse reactions	1250-1273
26821417_en	CHEM	Influnet	219-227
26821417_en	DISO	acute respiratory viral infections	248-282
26821417_en	DISO	uncomplicated mild and moderate ARVI	364-400
26821417_en	CHEM	Influnet	482-490
26821417_en	CHEM	Rinza	516-521
26821417_en	FINDING	rapider alleviation of fever and other ARVI symptoms	715-767
26821417_en	DISO	ARVI symptoms	754-767
26821417_en	CHEM	Influnet	683-691
26821417_en	DISO	fever	738-743
26821417_en	DISO	ARVI	754-758
26821417_en	CHEM	Rinza	838-843
26821417_en	CHEM	Combination drugs	1-18
26821417_en	CHEM	Influnet	1167-1175
26821417_en	CHEM	monocomponent drugs	865-884
26821417_en	DISO	ARVI	1022-1026
26821417_en	FINDING	more economically sound	1049-1072
26821417_en	FINDING	more cost- effective	1343-1363
26821417_en	DISO	ARVI	1188-1192
26821417_en	PHYS	respiratory	43-54
26821417_en	DISO	infections	61-71
26821417_en	PHYS	respiratory	254-265
26821417_en	CHEM	Combination drugs	1226-1243
26821417_en	CHEM	monocomponent drugs	1296-1315
26821417_en	DISO	ARVI	1330-1334
26821417_en	FINDING	shorter temporary disability	976-1004
26821417_en	CHEM	Influnet	1028-1036
26821417_en	DISO	infections	272-282
26821417_en	DISO	viral infections	266-282
26821417_en	CHEM	combination drug	202-218
26821417_en	FINDING	clinical effectiveness of the drugs	622-657
26821417_en	DISO	disability	994-1004
26821417_en	DISO	mild and moderate ARVI	378-400
26821417_en	DISO	ARVI	396-400
26821417_en	FINDING	higher clinical and economic feasibility of Influnet therapy	1123-1183
26821419_en	DISO	pulmonary arterial hypertension	13-44
26821419_en	DISO	connective tissue diseases	62-88
26821419_en	CHEM	sildenafil	101-111
26821419_en	CHEM	sildenafil	182-192
26821419_en	DISO	PAH	436-439
26821419_en	DISO	CTD	456-459
26821419_en	DISO	PAH	569-572
26821419_en	ANATOMY	pulmonary	718-727
26821419_en	CHEM	phosphodiesterase	785-802
26821419_en	ANATOMY	right heart	702-713
26821419_en	ANATOMY	pulmonary artery	718-734
26821419_en	CHEM	sildenafil	771-781
26821419_en	CHEM	phosphodiesterase type 5 inhibitor	785-819
26821419_en	PHYS	vasodilator	830-841
26821419_en	DISO	PAH	895-898
26821419_en	PHYS	survival	1050-1058
26821419_en	PHYS	right atrial pressure	1261-1282
26821419_en	PHYS	hemodynamic parameters	1237-1259
26821419_en	PHYS	atrial pressure	1267-1282
26821419_en	PHYS	vascular resistance	1298-1317
26821419_en	PHYS	survival	1428-1436
26821419_en	CHEM	sildenafil	1394-1404
26821419_en	DISO	PAH	1454-1457
26821419_en	DISO	CTD	1474-1477
26821419_en	ANATOMY	artery	728-734
26821419_en	ANATOMY	heart	708-713
26821419_en	ANATOMY	atrial	1267-1273
26821419_en	DISO	CTD	1685-1688
26821419_en	PHYS	Survival	1-9
26821419_en	DISO	hypertension	32-44
26821419_en	ANATOMY	pulmonary	13-22
26821419_en	ANATOMY	arterial	23-31
26821419_en	ANATOMY	pulmonary arterial	13-31
26821419_en	ANATOMY	tissue	73-79
26821419_en	ANATOMY	connective tissue	62-79
26821419_en	PHYS	survival	200-208
26821419_en	DISO	pulmonary arterial hypertension	226-257
26821419_en	DISO	hypertension	245-257
26821419_en	DISO	PAH	259-262
26821419_en	DISO	connective tissue diseases	280-306
26821419_en	DISO	CTD	308-311
26821419_en	ANATOMY	pulmonary	226-235
26821419_en	ANATOMY	arterial	236-244
26821419_en	ANATOMY	pulmonary arterial	226-244
26821419_en	ANATOMY	tissue	291-297
26821419_en	ANATOMY	connective tissue	280-297
26821419_en	CHEM	potent vasodilator	823-841
26821419_en	FINDING	Survival rates	933-947
26821419_en	FINDING	Three-year survival rates	1039-1064
26821419_en	PHYS	Survival	933-941
26821419_en	FINDING	survival rates	1050-1064
26821419_en	ANATOMY	vascular	1298-1306
26821419_en	DISO	arterial hypertension	236-257
26821419_en	DISO	arterial hypertension	23-44
26821419_en	FINDING	duration of the follow-up	1207-1232
26821419_en	FINDING	time to clinical deterioration	1152-1182
26821419_en	FINDING	clinical deterioration	1160-1182
26821419_en	FINDING	improves survival	1419-1436
26953424_en	ANATOMY	odontogenic	61-72
26953424_en	DISO	sinusitis	73-82
26953424_en	DISO	Inflammatory diseases	86-107
26953424_en	ANATOMY	maxillary sinuses	115-132
26953424_en	PHYS	adult	157-162
26953424_en	DISO	inflammatory processes	232-254
26953424_en	DISO	Odontogenic maxillary sinusitis	175-206
26953424_en	ANATOMY	maxillofacial area	258-276
26953424_en	DISO	odontogenic lesions	394-413
26953424_en	DISO	sinusitis	514-523
26953424_en	DISO	odontogenic sinusitis	502-523
26953424_en	DISO	maxillary sinusitis	752-771
26953424_en	LABPROC	X-ray examinations	789-807
26953424_en	DEVICE	CT PISASSO TRIO	826-841
26953424_en	LABPROC	MSCT	868-872
26953424_en	DEVICE	Brillians 6	873-884
26953424_en	DEVICE	Brillians 64	889-901
26953424_en	ANATOMY	sinuses	1178-1185
26953424_en	DISO	foreign bodies in the maxillary sinuses	1146-1185
26953424_en	ANATOMY	maxillary sinuses	1168-1185
26953424_en	ANATOMY	roots	1218-1223
26953424_en	ANATOMY	root fragments	1227-1241
26953424_en	DEVICE	implants	1243-1251
26953424_en	DEVICE	rubber drains	1253-1266
26953424_en	DEVICE	endodontic instruments	1281-1303
26953424_en	DISO	odontogenic cysts	1333-1350
26953424_en	DISO	mycotic infection	1406-1423
26953424_en	ANATOMY	sinuses	1843-1850
26953424_en	DISO	mycotic	1406-1413
26953424_en	LABPROC	dental volumetric tomography	1586-1614
26953424_en	LABPROC	multislice CT	1618-1631
26953424_en	LABPROC	CT	1629-1631
26953424_en	CHEM	rubber	1253-1259
26953424_en	DISO	sinusitis	1747-1756
26953424_en	DISO	relapses	1782-1790
26953424_en	DISO	nflammatory processes	1804-1825
26953424_en	ANATOMY	maxillary sinuses	1833-1850
26953424_en	DISO	odontogenic sinusitis	61-82
26953424_en	ANATOMY	sinuses	125-132
26953424_en	ANATOMY	Odontogenic	175-186
26953424_en	DISO	maxillary sinusitis	187-206
26953424_en	DISO	sinusitis	197-206
26953424_en	FINDING	clinical and radiological characteristics of odontogenic sinusitis	457-523
26953424_en	DISO	lesions	406-413
26953424_en	ANATOMY	odontogenic	394-405
26953424_en	ANATOMY	odontogenic	502-513
26953424_en	ANATOMY	oral	636-640
26953424_en	ANATOMY	endodontic	1281-1291
26953424_en	DISO	sinusitis	762-771
26953424_en	DEVICE	drains	1260-1266
26953424_en	DISO	cysts	1345-1350
26953424_en	ANATOMY	odontogenic	1333-1344
26953424_en	ANATOMY	Maxillofacial	575-588
26953424_en	FINDING	reduce the incidence	1758-1778
26953424_en	DISO	chronic inflammatory processes	1795-1825
26953424_en	LABPROC	volumetric tomography	1593-1614
26953424_en	ANATOMY	maxillofacial	1515-1528
26953424_en	ANATOMY	maxillary	115-124
26953424_en	ANATOMY	maxillary	187-196
26953424_en	ANATOMY	maxillary	752-761
26953424_en	ANATOMY	maxillary	1168-1177
26953424_en	ANATOMY	maxillary	1833-1842
26953424_en	DISO	infection	1414-1423
26953424_en	FINDING	ensure the correct clinical and radiological approaches	1636-1691
26953424_en	LABPROC	tomography	1604-1614
26953424_en	LABPROC	radiological	21-33
26953424_en	LABPROC	radiological	1668-1680
26953424_en	LABPROC	radiological	470-482
26977723_en	PHYS	biomechanical properties	142-166
26977723_en	ANATOMY	corneal	15-22
26977723_en	DISO	bullous keratopathy	94-113
26977723_en	DISO	keratopathy	206-217
26977723_en	ANATOMY	cornea	174-180
26977723_en	DISO	bullous keratopathy	198-217
26977723_en	DEVICE	Ocular response analyzer	271-295
26977723_en	ANATOMY	eyes	352-356
26977723_en	DISO	bullous keratopathy	363-382
26977723_en	PHYS	Corneal hysteresis	752-770
26977723_en	PHYS	CRF	807-810
26977723_en	DISO	keratopathy	872-883
26977723_en	DISO	bullous keratopathy	864-883
26977723_en	ANATOMY	eyes	884-888
26977723_en	DISO	keratopathy	1212-1223
26977723_en	ANATOMY	corneal	1234-1241
26977723_en	PHYS	intraocular pressure	1254-1274
26977723_en	PHYS	Goldman-related IOP	1301-1320
26977723_en	ANATOMY	eyes	1194-1198
26977723_en	DISO	bullous keratopathy	1204-1223
26977723_en	PHYS	corneal-compensated intraocular pressure	1234-1274
26977723_en	PHYS	IOPcc	1276-1281
26977723_en	PHYS	IOP	1317-1320
26977723_en	PHYS	IOPcc	1394-1399
26977723_en	PHYS	IOPg	1404-1408
26977723_en	ANATOMY	eyes	1572-1576
26977723_en	PHYS	IOP	1585-1588
26977723_en	DISO	Chronic edema	1647-1660
26977723_en	ANATOMY	cornea	1668-1674
26977723_en	PHYS	CH	1752-1754
26977723_en	PHYS	CRF	1759-1762
26977723_en	ANATOMY	eye	1800-1803
26977723_en	ANATOMY	fellow healthy eyes	1557-1576
26977723_en	ANATOMY	eye	1847-1850
26977723_en	PHYS	corneal thickness	2105-2122
26977723_en	PHYS	corneal rigidity	2192-2208
26977723_en	ANATOMY	cornea	2057-2063
26977723_en	DISO	chronically swollen	2067-2086
26977723_en	ANATOMY	corneal	2105-2112
26977723_en	ANATOMY	corneal	2192-2199
26977723_en	ANATOMY	eyes	2212-2216
26977723_en	DISO	bullous keratopathy	2222-2241
26977723_en	PHYS	IOP	2308-2311
26977723_en	DISO	glaucoma	2362-2370
26977723_en	PHYS	biomechanics	23-35
26977723_en	DISO	keratopathy	102-113
26977723_en	DEVICE	ORA	297-300
26977723_en	DISO	keratopathy	371-382
26977723_en	ANATOMY	endothelial	565-576
26977723_en	DEVICE	microkeratome	615-628
26977723_en	ANATOMY	Corneal	752-759
26977723_en	PHYS	CH	772-774
26977723_en	PHYS	corneal resistance factor	780-805
26977723_en	ANATOMY	corneal	780-787
26977723_en	PHYS	IOPg	1322-1326
26977723_en	FINDING	lower than normal	1056-1073
26977723_en	ANATOMY	fellow healthy eye	1832-1850
26977723_en	DISO	keratopathy	2230-2241
26977723_en	FINDING	difference between IOPcc and IOPg	1375-1408
26977723_en	FINDING	lower than normal	1957-1974
26977723_en	DISO	edema	1655-1660
26977723_en	DISO	swollen	2079-2086
26977723_en	FINDING	exceeded the mean Goldman-related IOP	1283-1320
26977723_en	PHYS	healthy	1564-1571
26977723_en	PHYS	viscoelastic properties	1704-1727
26977723_en	FINDING	CH and CRF values decrease significantly	1752-1792
26977723_en	PHYS	biomechanical indices	2142-2163
26977723_en	FINDING	correlate with its biomechanical indices	2123-2163
26977723_en	FINDING	Postoperative reduction in corneal rigidity	2165-2208
26977723_en	FINDING	significantly decreased in non-operated bullous keratopathy eyes	824-888
26977723_en	PHYS	healthy	904-911
26977723_en	FINDING	partially recovered and stabilized	991-1025
26977723_en	FINDING	not statistically different.	1607-1635
26977723_en	FINDING	alteration of its viscoelastic properties	1686-1727
26977723_en	PHYS	healthy	1839-1846
26977723_en	FINDING	partially recover	1927-1944
26977723_en	FINDING	lead to underestimation of the true level of IOP	2263-2311
26977723_en	FINDING	delays in diagnosis of concomitant glaucoma	2327-2370
26977764_en	ANATOMY	tracheal	29-37
26977764_en	ANATOMY	tracheal bifurcation	29-49
26977764_en	DISO	bronchial cancer	72-88
26977764_en	DISO	bronchial cancer	191-207
26977764_en	DISO	Squamous cell carcinoma	406-429
26977764_en	DISO	adenocarcinoma	431-445
26977764_en	DISO	dimorphic cancer	447-463
26977764_en	DISO	carcinoid	465-474
26977764_en	DISO	small cell cancer	496-513
26977764_en	DISO	clear cell renal cancer	518-541
26977764_en	ANATOMY	bronchopulmonary segment	965-989
26977764_en	ANATOMY	right upper lobe	993-1009
26977764_en	ANATOMY	m.latiss.dorsi	1075-1089
26977764_en	ANATOMY	m.intercostalis	1091-1106
26977764_en	ANATOMY	m.serr.anterior flaps	1111-1132
26977764_en	DISO	Postoperative complications	1171-1198
26977764_en	PHYS	head adduction	1304-1318
26977764_en	DISO	broncho-pleural fistula	1327-1350
26977764_en	DISO	T3-T4N0 tumors	1406-1420
26977764_en	DISO	T3-T4N0	1406-1413
26977764_en	DISO	tumors	1414-1420
26977764_en	DISO	T3-4N1-2	1461-1469
26977764_en	DISO	tumors	1470-1476
26977764_en	ANATOMY	carina	1556-1562
26977764_en	DISO	tumors	1698-1704
26977764_en	DISO	N0-tumors	1695-1704
26977764_en	DISO	cancer	82-88
26977764_en	ANATOMY	bronchial	72-81
26977764_en	ANATOMY	carina	152-158
26977764_en	DISO	cancer	201-207
26977764_en	ANATOMY	bronchial	191-200
26977764_en	DISO	bronchial malignant tumors	263-289
26977764_en	DISO	malignant tumors	273-289
26977764_en	DISO	tumors	283-289
26977764_en	ANATOMY	bronchial	263-272
26977764_en	ANATOMY	cell	524-528
26977764_en	DISO	carcinoma	420-429
26977764_en	DISO	complications	1185-1198
26977764_en	ANATOMY	cell	415-419
26977764_en	ANATOMY	Squamous cell	406-419
26977764_en	DISO	cancer	457-463
26977764_en	DISO	adenocystic cancer	476-494
26977764_en	DISO	cancer	488-494
26977764_en	DISO	cancer	507-513
26977764_en	DISO	cancer	535-541
26977764_en	DISO	renal cancer	529-541
26977764_en	ANATOMY	renal	529-534
26977764_en	ANATOMY	clear cell	518-528
26977764_en	ANATOMY	Tracheal	722-730
26977764_en	ANATOMY	carina	731-737
26977764_en	ANATOMY	Tracheal carina	722-737
26977764_en	ANATOMY	carina	928-934
26977764_en	ANATOMY	bronchopulmonary	965-981
26977764_en	ANATOMY	upper lobe	999-1009
26977764_en	ANATOMY	head	1304-1308
26977764_en	DISO	fistula	1343-1350
26977764_en	ANATOMY	broncho	1327-1334
26977764_en	ANATOMY	pleural	1335-1342
26977764_en	ANATOMY	broncho-pleural	1327-1342
26977764_en	DISO	T3-4N1-2 tumors	1461-1476
26977764_en	FINDING	survival	1485-1493
26977764_en	FINDING	5-year survival	1478-1493
26977764_en	FINDING	In-hospital mortality	1236-1257
26977764_en	FINDING	mortality	1365-1374
26977764_en	FINDING	mortality	1248-1257
26977764_en	FINDING	Long-term results in T3-T4N0 tumors were significantly better compared with T3-4N1-2 tumors	1385-1476
26977764_en	FINDING	satisfactory long-term results	1647-1677
26977764_en	ANATOMY	small cell	496-506
26977764_en	ANATOMY	cell	502-506
26977764_en	FINDING	may be improved using primary bronhomyoplasty	1578-1623
26977764_en	FINDING	reduced broncho-pleural fistula incidence and mortality	1319-1374
26977789_en	LABPROC	diffusion kurtosis imaging	23-49
26977789_en	DISO	proliferative activity	58-80
26977789_en	DISO	glioma	90-96
26977789_en	LABPROC	DKI	194-197
26977789_en	DISO	gliomas	2211-2218
26977789_en	LABPROC	diffusion kurtosis imaging	166-192
26977789_en	DISO	brain glioma	84-96
26977789_en	DISO	proliferative activity	226-248
26977789_en	ANATOMY	CNAWM	405-410
26977789_en	FINDING	statistically significant correlation between the glioma proliferative activity index and diffusion values	1729-1835
26977789_en	ANATOMY	contralateral normal appearing white matter	360-403
26977789_en	DISO	gliomas	492-499
26977789_en	DISO	brain gliomas	486-499
26977789_en	DISO	gliomas	545-552
26977789_en	LABPROC	mean diffusivities	652-704
26977789_en	LABPROC	diffusion tensor	634-650
26977789_en	LABPROC	RA	736-738
26977789_en	LABPROC	anisotropies	740-752
26977789_en	LABPROC	diffusion kurtosis	758-776
26977789_en	LABPROC	kurtosis	817-825
26977789_en	LABPROC	kurtosis anisotropy	827-846
26977789_en	DISO	glioma	912-918
26977789_en	ANATOMY	CNAWM	1016-1021
26977789_en	ANATOMY	normal appearing white matter	2158-2187
26977789_en	LABPROC	diffusion parameters	1140-1160
26977789_en	LABPROC	FA	1237-1239
26977789_en	LABPROC	RA	1244-1246
26977789_en	LABPROC	AK	1321-1323
26977789_en	LABPROC	RK	1329-1331
26977789_en	LABPROC	anisotropy	1337-1347
26977789_en	LABPROC	RD	1404-1406
26977789_en	LABPROC	RK	1554-1556
26977789_en	LABPROC	MK	1603-1605
26977789_en	LABPROC	AK	1627-1629
26977789_en	LABPROC	RK	1652-1654
26977789_en	LABPROC	RD	1681-1683
26977789_en	FINDING	immunohistochemical changes	2020-2047
26977789_en	LABPROC	RK	1836-1838
26977789_en	LABPROC	KA	1859-1861
26977789_en	LABPROC	RD	1882-1884
26977789_en	LABPROC	FA	1904-1906
26977789_en	LABPROC	RA	1931-1933
26977789_en	ANATOMY	CNAWM	1956-1961
26977789_en	LABPROC	DKI	1984-1987
26977789_en	ANATOMY	contralateral	2144-2157
26977789_en	FINDING	microstructural changes	2113-2136
26977789_en	DISO	gliomas	2051-2058
26977789_en	LABPROC	DKI	2061-2064
26977789_en	LABPROC	kurtosis	993-1001
26977789_en	ANATOMY	contralateral normal appearing white matter	2144-2187
26977789_en	ANATOMY	white matter	2175-2187
26977789_en	DISO	brain gliomas	2205-2218
26977789_en	ANATOMY	brain	2205-2210
26977789_en	ANATOMY	brain	84-89
26977789_en	DISO	glioma	219-225
26977789_en	DISO	glioma	292-298
26977789_en	DISO	proliferative activity	299-321
26977789_en	ANATOMY	contralateral	360-373
26977789_en	ANATOMY	white matter	391-403
26977789_en	ANATOMY	normal appearing white matter	374-403
26977789_en	LABPROC	glioma proliferative activity index	292-327
26977789_en	LABPROC	diffusion parameters	332-352
26977789_en	ANATOMY	brain	486-491
26977789_en	FINDING	values increased	1361-1377
26977789_en	FINDING	glioma proliferative activity index increased	1432-1477
26977789_en	LABPROC	diffusion kurtosis	23-41
26977789_en	LABPROC	axial diffusivities	663-704
26977789_en	LABPROC	radial diffusivities	679-704
26977789_en	LABPROC	diffusivities	691-704
26977789_en	LABPROC	MD	658-660
26977789_en	LABPROC	AD	670-672
26977789_en	LABPROC	RD	687-689
26977789_en	LABPROC	fractional anisotropies	706-752
26977789_en	LABPROC	relative anisotropies	726-752
26977789_en	LABPROC	FA	718-720
26977789_en	LABPROC	mean kurtosis	778-825
26977789_en	LABPROC	MK	784-786
26977789_en	LABPROC	axial kurtosis	789-825
26977789_en	LABPROC	AK	796-798
26977789_en	LABPROC	radial kurtosis	805-825
26977789_en	LABPROC	RK	813-815
26977789_en	LABPROC	KA	848-850
26977789_en	DISO	proliferative activity	861-883
26977789_en	DISO	malignant glioma parts	902-924
26977789_en	DISO	glioma	1030-1036
26977789_en	DISO	proliferative activity	1037-1059
26977789_en	FINDING	relationship between the tensor and kurtosis parameters of CNAWM and the glioma proliferative activity index	957-1065
26977789_en	DISO	glioma	1169-1175
26977789_en	DISO	proliferative activity	1176-1198
26977789_en	FINDING	DKI demonstrated a high sensitivity	2061-2096
26977789_en	LABPROC	Kurtosis	1307-1315
26977789_en	LABPROC	MK	1317-1319
26977789_en	LABPROC	KA	1349-1351
26977789_en	LABPROC	FA	1353-1355
26977789_en	LABPROC	RA	1357-1359
26977789_en	LABPROC	AD	1400-1402
26977789_en	LABPROC	MD	1396-1398
26977789_en	LABPROC	diffusivity	1383-1394
26977789_en	DISO	glioma	1432-1438
26977789_en	DISO	proliferative activity	1439-1461
26977789_en	DISO	proliferative activity	1512-1534
26977789_en	DISO	glioma	1779-1785
26977789_en	DISO	proliferative activity	1786-1808
26977789_en	FINDING	values decreased	1408-1424
26977789_en	LABPROC	kurtosis	33-41
26977789_en	LABPROC	diffusion kurtosis	166-184
26977789_en	LABPROC	kurtosis	176-184
26977789_en	LABPROC	kurtosis	768-776
26977789_en	LABPROC	kurtosis	827-835
26977789_en	LABPROC	anisotropy	836-846
26977789_en	FINDING	correlation between all the absolute and normalized diffusion parameters and the glioma proliferative activity index	1088-1204
26977789_en	FINDING	correlation between diffusion kurtosis imaging and the proliferative activity	3-80
26977789_en	FINDING	strong correlation between the proliferative activity index	1481-1540
26977789_en	LABPROC	immunohistochemical	2020-2039
26977789_en	LABPROC	tensor	982-988
26977908_en	DISO	Alexithymia	1-12
26977908_en	DISO	left-hemispheric cerebral infarction	30-66
26977908_en	PHYS	recovery	79-87
26977908_en	DISO	alexithymia	139-150
26977908_en	ANATOMY	cerebral	413-421
26977908_en	DISO	cerebral infarction	413-432
26977908_en	ANATOMY	middle cerebral artery	452-474
26977908_en	DISO	chronic brain ischemia	545-567
26977908_en	DISO	cerebral infarction	763-782
26977908_en	DISO	alexithymia	807-818
26977908_en	DISO	Alexithymia	821-832
26977908_en	DISO	cerebral infarction	850-869
26977908_en	DISO	brain ischemia	553-567
26977908_en	ANATOMY	left-hemispheric	30-46
26977908_en	DISO	anxiety	152-159
26977908_en	DISO	depression	164-174
26977908_en	DISO	cerebral infarction	193-212
26977908_en	ANATOMY	middle cerebral artery	232-254
26977908_en	ANATOMY	cerebral artery	239-254
26977908_en	ANATOMY	artery	248-254
26977908_en	PHYS	recovery	286-294
26977908_en	ANATOMY	cerebral	193-201
26977908_en	ANATOMY	cerebral	47-55
26977908_en	ANATOMY	cerebral artery	459-474
26977908_en	ANATOMY	cerebral	239-247
26977908_en	ANATOMY	cerebral	459-467
26977908_en	ANATOMY	artery	468-474
26977908_en	DISO	ischemia	559-567
26977908_en	ANATOMY	brain	553-558
26977908_en	ANATOMY	cerebral	763-771
26977908_en	ANATOMY	cerebral	850-858
26977908_en	FINDING	complicate the rehabilitation	945-974
26977908_en	DISO	alexithymia	660-671
26977908_en	DISO	neurological deficit	692-712
26977908_en	DISO	anxiety	735-742
26977908_en	DISO	depression	747-757
26977908_en	DISO	infarction	56-66
26977908_en	DISO	infarction	202-212
26977908_en	DISO	infarction	422-432
26977908_en	DISO	infarction	772-782
26977908_en	DISO	infarction	859-869
26977908_en	PHYS	sex	714-717
26977908_en	FINDING	affects the adequate self-esteem of physical and mental condition	870-935
26977908_en	FINDING	correlation between the level of alexithymia	627-671
26977908_en	PHYS	physical	906-914
26977916_en	CHEM	Melatonin	1-10
26977916_en	DISO	chronic pain syndromes	14-36
26977916_en	CHEM	Melatonin	39-48
26977916_en	CHEM	neurohormone	52-64
26977916_en	ANATOMY	epiphysis	84-93
26977916_en	ANATOMY	extrapineal structures	98-120
26977916_en	DISO	pain	468-472
26977916_en	ANATOMY	body	374-378
26977916_en	FINDING	efficacy of melatonin	443-464
26977916_en	DISO	pain syndromes	22-36
26977916_en	CHEM	receptors	1020-1029
26977916_en	ANATOMY	cardiovascular system	263-284
26977916_en	ANATOMY	gastrointestinal tract	293-315
26977916_en	PHYS	reproductive functions	335-357
26977916_en	PHYS	metabolism	359-369
26977916_en	PHYS	metabolism and body mass regulation	359-394
26977916_en	ANATOMY	bowel	602-607
26977916_en	CHEM	melatonin	455-464
26977916_en	DISO	pain syndromes	468-482
26977916_en	DISO	chronic back pain	618-635
26977916_en	DISO	pain	631-635
26977916_en	CHEM	melatonin	542-551
26977916_en	ANATOMY	back	626-630
26977916_en	DISO	fibromyalgia	568-580
26977916_en	DISO	headache	582-590
26977916_en	DISO	irritated bowel syndrome	592-616
26977916_en	CHEM	melatonin	1010-1019
26977916_en	DISO	rheumatoid arthritis	640-660
26977916_en	FINDING	analgesic properties of melatonin	686-719
26977916_en	CHEM	melatonin	710-719
26977916_en	PHYS	sleep	776-781
26977916_en	DISO	chronic pain syndromes	893-915
26977916_en	CHEM	melatonin	826-835
26977916_en	DISO	pain	901-905
26977916_en	PHYS	circadian rhythms	851-868
26977916_en	PHYS	chronobiotic	154-166
26977916_en	FINDING	analgesic effect of melatonin	963-992
26977916_en	CHEM	melatonin	983-992
26977916_en	CHEM	melatonin receptors	1010-1029
26977916_en	CHEM	neurotransmitter systems	1042-1066
26977916_en	PHYS	body mass	374-383
26977916_en	DISO	pain	22-26
26977916_en	FINDING	improvement of sleep	761-781
26977916_en	PHYS	antioxidant	168-179
26977916_en	DISO	arthritis	651-660
26977916_en	PHYS	oncostatic	181-191
26977916_en	PHYS	immunomodulating	193-209
26977916_en	PHYS	normothymic	211-222
26977916_en	PHYS	anxiolytic	227-237
26977916_en	DISO	back pain	626-635
26977916_en	FINDING	normalizing circadian rhythms	839-868
26977916_en	DISO	pain syndromes	901-915
26977916_en	PHYS	synthesized	65-76
26977916_en	CHEM	neurotransmitter	1042-1058
26977916_en	PHYS	adaptive potential	804-822
26977916_en	FINDING	activation of own adaptive potential	786-822
26977916_en	FINDING	analgesic effect	963-979
26977916_en	FINDING	analgesic properties	686-706
26978046_en	ANATOMY	internuclear interneurons	18-43
26978046_en	ANATOMY	brain stem	57-67
26978046_en	DISO	arterial hypertension	71-92
26978046_en	ANATOMY	IN	145-147
26978046_en	ANATOMY	internuclear interneurons	118-143
26978046_en	PHYS	metabolism	165-175
26978046_en	CHEM	nitric oxide	179-191
26978046_en	CHEM	hydrogen sulfide	193-209
26978046_en	CHEM	carbon monoxide	214-229
26978046_en	ANATOMY	caudal brainstem	237-253
26978046_en	ANATOMY	brain	57-62
26978046_en	DISO	hypertension	296-308
26978046_en	ANATOMY	postmortem material	359-378
26978046_en	DISO	arterial hypertension	440-461
26978046_en	LABPROC	Immunohistochemistry	464-484
26978046_en	CHEM	nNOS	497-501
26978046_en	CHEM	HO-2	503-507
26978046_en	CHEM	CBS	509-512
26978046_en	LABPROC	histochemical	517-530
26978046_en	CHEM	NADPH-diaphorase	542-558
26978046_en	ANATOMY	nucleus	690-697
26978046_en	ANATOMY	IN	578-580
26978046_en	ANATOMY	giant cell reticular nuclei	608-645
26978046_en	ANATOMY	small cell reticular nuclei	618-645
26978046_en	ANATOMY	small cell reticular nucleus	653-681
26978046_en	ANATOMY	nucleus of the solitary tract	690-719
26978046_en	ANATOMY	lateral reticular nucleus	744-769
26978046_en	FINDING	changes are more pronounced	1455-1482
26978046_en	LABPROC	immunohistochemical reaction	906-934
26978046_en	ANATOMY	intranuclear	1646-1658
26978046_en	ANATOMY	internuclear	1663-1675
26978046_en	DISO	high blood pressure	973-992
26978046_en	PHYS	blood pressure	978-992
26978046_en	ANATOMY	blood	978-983
26978046_en	ANATOMY	cell	624-628
26978046_en	CHEM	nNOS-positive	1310-1323
26978046_en	ANATOMY	nNOS-positive neurons	1310-1331
26978046_en	ANATOMY	cell	659-663
26978046_en	ANATOMY	IN1	1419-1422
26978046_en	ANATOMY	IN	1451-1453
26978046_en	ANATOMY	IN3	1491-1494
26978046_en	ANATOMY	IN2	1499-1502
26978046_en	ANATOMY	cells	1192-1197
26978046_en	PHYS	hemodynamic	1579-1590
26978046_en	ANATOMY	interneurons	1632-1644
26978046_en	ANATOMY	IN	1716-1718
26978046_en	PHYS	blood pressure	1750-1764
26978046_en	ANATOMY	nucleus	674-681
26978046_en	PHYS	hemodynamics	1820-1832
26978046_en	ANATOMY	IN	1840-1842
26978046_en	ANATOMY	small cell	653-663
26978046_en	PHYS	Topochemistry	1-14
26978046_en	ANATOMY	interneurons	31-43
26978046_en	ANATOMY	arterial	71-79
26978046_en	DISO	hypertension	80-92
26978046_en	ANATOMY	interneurons	131-143
26978046_en	ANATOMY	brainstem	244-253
26978046_en	ANATOMY	small MN	1071-1079
26978046_en	DISO	hypertension	449-461
26978046_en	ANATOMY	arterial	440-448
26978046_en	CHEM	NADPH	542-547
26978046_en	CHEM	diaphorase	548-558
26978046_en	ANATOMY	reticular nuclei	629-645
26978046_en	ANATOMY	nucleus	762-769
26978046_en	ANATOMY	reticular nucleus	664-681
26978046_en	ANATOMY	solitary tract	705-719
26978046_en	ANATOMY	reticular nucleus	752-769
26978046_en	ANATOMY	IN1	647-650
26978046_en	ANATOMY	IN2	721-724
26978046_en	ANATOMY	IN3	771-774
26978046_en	ANATOMY	IN	785-787
26978046_en	ANATOMY	blood	1750-1755
26978046_en	FINDING	increases in blood pressure	1737-1764
26978046_en	FINDING	stable, obviously, integrating function	1898-1937
26978046_en	ANATOMY	cell	1008-1012
26978046_en	ANATOMY	internuclear	18-30
26978046_en	ANATOMY	internuclear	118-130
26978046_en	CHEM	nNOS	1310-1314
26978046_en	ANATOMY	cells	1538-1543
26978046_en	ANATOMY	large IN	1710-1718
26978046_en	CHEM	oxide	186-191
26978046_en	CHEM	nitric	179-185
26978046_en	CHEM	hydrogen	193-201
26978046_en	CHEM	sulfide	202-209
26978046_en	CHEM	carbon	214-220
26978046_en	CHEM	monoxide	221-229
26978046_en	PHYS	healthy	257-264
26978046_en	PHYS	lifetime	287-295
26978046_en	PHYS	healthy	384-391
26978046_en	PHYS	lifetime	431-439
26978046_en	ANATOMY	small cell	618-628
26978046_en	ANATOMY	nuclei	639-645
26978046_en	PHYS	size	798-802
26978046_en	PHYS	shape	804-809
26978046_en	ANATOMY	sprouts	835-842
26978046_en	PHYS	length and structure of sprouts	811-842
26978046_en	FINDING	intensity of immunohistochemical reaction	893-934
26978046_en	PHYS	cell size	1008-1017
26978046_en	ANATOMY	MN	1077-1079
26978046_en	ANATOMY	MN	954-956
26978046_en	FINDING	intensity of MN response	941-965
26978046_en	ANATOMY	MN	1117-1119
26978046_en	ANATOMY	major MN	1111-1119
26978046_en	PHYS	concentration	1199-1212
26978046_en	PHYS	reaction rate	1217-1230
26978046_en	ANATOMY	neurons	1324-1331
26978046_en	PHYS	quantitative indicators	1270-1293
26978046_en	FINDING	significant reduction in the proportion of these cells, concentration and reaction rate	1143-1230
26978046_en	FINDING	More significant changes in quantitative indicators	1242-1293
26978046_en	PHYS	quantitative indicators	1354-1377
26978046_en	FINDING	reduction in the quantitative indicators	1337-1377
26978046_en	ANATOMY	cells	1409-1414
26978046_en	PHYS	localization of cells	1393-1414
26978046_en	ANATOMY	arge IN	1446-1453
26978046_en	PHYS	hemodynamic control	1579-1598
26978046_en	PHYS	responsive	1723-1733
26978046_en	PHYS	regulation of hemodynamics	1806-1832
26978046_en	ANATOMY	Small IN	1834-1842
26978172_en	CHEM	Leptin	1-7
26978172_en	PHYS	metabolic	36-45
26978172_en	DISO	diabetes	78-86
26978172_en	DISO	type 2 diabetes	71-86
26978172_en	DISO	asthma	126-132
26978172_en	CHEM	resistin	180-188
26978172_en	DISO	T2DM	393-397
26978172_en	DISO	T2DM	419-423
26978172_en	DISO	asthma	440-446
26978172_en	CHEM	adiponectin	190-201
26978172_en	CHEM	carbohydrate	564-576
26978172_en	CHEM	lipid	581-586
26978172_en	CHEM	leptin	613-619
26978172_en	CHEM	adiponectin	631-642
26978172_en	CHEM	IL	657-659
26978172_en	CHEM	IL-10	667-672
26978172_en	DISO	lower adiponectin concentrations	742-774
26978172_en	DISO	Hyperleptinemia	702-717
26978172_en	DISO	hyperresistinemia	719-736
26978172_en	DISO	IR	989-991
26978172_en	CHEM	adiponectin	748-759
26978172_en	DISO	T2DM	807-811
26978172_en	DISO	asthma	851-857
26978172_en	DISO	subclinical inflammation	935-959
26978172_en	DISO	insulin resistance	969-987
26978172_en	DISO	compensatory hyperinsulinemia	1008-1037
26978172_en	DISO	dyslipidemia	1101-1113
26978172_en	DISO	atherogenic dyslipidemia	1089-1113
26978172_en	CHEM	total cholesterol	1153-1170
26978172_en	CHEM	triglycerides	1176-1189
26978172_en	CHEM	C	1215-1216
26978172_en	CHEM	high-density lipoprotein	1270-1294
26978172_en	FINDING	decreasing adiponectin values	1808-1837
26978172_en	CHEM	resistin	1391-1399
26978172_en	CHEM	insulin	1405-1412
26978172_en	DISO	T2DM	1462-1466
26978172_en	DISO	asthma	1503-1509
26978172_en	DISO	IR	1528-1530
26978172_en	DISO	compensatory hyperinsulinemia	1546-1575
26978172_en	DISO	Hyperresistinemia	1577-1594
26978172_en	DISO	IR	1630-1632
26978172_en	DISO	inflammation	1869-1881
26978172_en	DISO	T2DM	1689-1693
26978172_en	DISO	asthma	1730-1736
26978172_en	DISO	hyperleptinemia	1756-1771
26978172_en	DISO	hyperresistinemia	1773-1790
26978172_en	DISO	inflammation	947-959
26978172_en	CHEM	adiponectin	1819-1830
26978172_en	DISO	subclinical inflammation	1857-1881
26978172_en	CHEM	resistin	9-17
26978172_en	CHEM	leptin	203-209
26978172_en	DISO	type 2 diabetes mellitus	266-290
26978172_en	DISO	diabetes	273-281
26978172_en	DISO	diabetes mellitus	273-290
26978172_en	DISO	T2DM	292-296
26978172_en	DISO	asthma	337-343
26978172_en	PHYS	Anthropometric measurements	535-562
26978172_en	CHEM	resistin	621-629
26978172_en	CHEM	interleukin	644-655
26978172_en	CHEM	interleukin (IL)-6	644-662
26978172_en	CHEM	C	1295-1296
26978172_en	CHEM	cholesterol	1159-1170
26978172_en	CHEM	lipoprotein	1203-1214
26978172_en	CHEM	low-density lipoprotein C	1191-1216
26978172_en	DISO	atherogenic	1222-1233
26978172_en	CHEM	lipoprotein	1283-1294
26978172_en	CHEM	high-density lipoprotein C	1270-1296
26978172_en	PHYS	adiponectin values	1819-1837
26978172_en	CHEM	insulin	969-976
26978172_en	CHEM	IL	667-669
26978172_en	PHYS	apparently healthy	489-507
26978172_en	PHYS	metabolic	228-237
26978172_en	PHYS	metabolic parameters	587-607
26978172_en	CHEM	hormonal	23-31
26978172_en	PHYS	hormonal and metabolic parameters	23-56
26978172_en	FINDING	increases in the levels of total cholesterol (C), triglycerides, low-density lipoprotein C, and atherogenic index	1126-1239
26978172_en	CHEM	hormonal	215-223
26978172_en	PHYS	hormonal and metabolic parameters	215-248
26978172_en	FINDING	decrease in those of high-density lipoprotein C	1249-1296
26978172_en	PHYS	level of resistin	1382-1399
26978172_en	DISO	hyperinsulinemia	1559-1575
26978172_en	FINDING	positive correlation of the level of resistin with insulin	1354-1412
26978172_en	PHYS	metabolic	587-596
26978172_en	PHYS	levels	673-679
26978172_en	DISO	hyperinsulinemia	1021-1037
26978172_en	PHYS	levels of total cholesterol	1143-1170
26978172_en	PHYS	levels	1143-1149
26978172_en	CHEM	C	1172-1173
26978172_en	CHEM	low-density lipoprotein	1191-1214
26978176_en	PHYS	excretion	9-18
26978176_en	DISO	podocyte injury	34-49
26978176_en	ANATOMY	podocyte	34-42
26978176_en	DISO	diabetes	67-75
26978176_en	DISO	diabetes mellitus	67-84
26978176_en	DISO	diabetic	399-407
26978176_en	PHYS	normal albuminuria	582-600
26978176_en	DISO	microalbuminuria	639-655
26978176_en	DISO	proteinuria	697-708
26978176_en	ANATOMY	podocyte	802-810
26978176_en	ANATOMY	glomerular	1524-1534
26978176_en	CHEM	nephrin	831-838
26978176_en	CHEM	podocin	843-850
26978176_en	LABPROC	enzyme immunoassay	870-888
26978176_en	DISO	Nephrinuria	898-909
26978176_en	PHYS	NAU	968-971
26978176_en	DISO	MAU	973-976
26978176_en	DISO	PU	982-984
26978176_en	DISO	Podocinuria	1000-1011
26978176_en	DISO	NU	1093-1095
26978176_en	DISO	DN	1099-1101
26978176_en	DISO	PU	1107-1109
26978176_en	DISO	DM	1148-1150
26978176_en	PHYS	NAU	1156-1159
26978176_en	CHEM	podocin	1196-1203
26978176_en	PHYS	excretion	1204-1213
26978176_en	DISO	DM	1273-1275
26978176_en	DISO	albuminuria	1319-1330
26978176_en	DISO	MAU	1358-1361
26978176_en	DISO	DM	1393-1395
26978176_en	DISO	albuminuria	1420-1431
26978176_en	DISO	NU	1447-1449
26978176_en	PHYS	creatinine levels	1487-1504
26978176_en	PHYS	glomerular filtration rate	1524-1550
26978176_en	DISO	NU	1552-1554
26978176_en	PHYS	glycated hemoglobin levels	1580-1606
26978176_en	PHYS	systolic blood pressure	1716-1739
26978176_en	DISO	NU	1745-1747
26978176_en	PHYS	urinary nephrin and podocin levels	1811-1845
26978176_en	CHEM	nephrin	1819-1826
26978176_en	CHEM	podocin	1831-1838
26978176_en	ANATOMY	Urinary	1-8
26978176_en	DISO	DN	1897-1899
26978176_en	PHYS	Urinary excretion	1-18
26978176_en	ANATOMY	glomerular apparatus	1926-1946
26978176_en	DISO	DM	1950-1952
26978176_en	ANATOMY	urinary	108-115
26978176_en	PHYS	excretion	116-125
26978176_en	PHYS	urinary excretion	108-125
26978176_en	ANATOMY	podocyte	141-149
26978176_en	DISO	podocyte injury	141-156
26978176_en	DISO	diabetic nephropathy	208-228
26978176_en	DISO	DN	230-232
26978176_en	DISO	nephropathy	217-228
26978176_en	DISO	diabetes mellitus	294-311
26978176_en	DISO	diabetes	294-302
26978176_en	DISO	DM	313-315
26978176_en	DISO	albuminuria	341-352
26978176_en	DISO	proteinuria	353-364
26978176_en	DISO	DM	433-435
26978176_en	DISO	DM	455-457
26978176_en	LABPROC	urinary concentration in one urinary portion	516-560
26978176_en	PHYS	albuminuria	589-600
26978176_en	PHYS	NAU	602-605
26978176_en	DISO	MAU	657-660
26978176_en	DISO	PU	710-712
26978176_en	FINDING	significantly higher	1114-1134
26978176_en	DISO	NU	911-913
26978176_en	DISO	PDU	1013-1016
26978176_en	PHYS	NAU	1061-1064
26978176_en	DISO	MAU	1066-1069
26978176_en	DISO	PU	1075-1077
26978176_en	PHYS	NAU	1168-1171
26978176_en	DISO	MAU	1173-1176
26978176_en	DISO	PU	1182-1184
26978176_en	PHYS	podocin excretion	1196-1213
26978176_en	DISO	NU	1311-1313
26978176_en	DISO	PDU	1454-1457
26978176_en	ANATOMY	serum	1481-1486
26978176_en	PHYS	glycated	1580-1588
26978176_en	CHEM	hemoglobin	1589-1599
26978176_en	DISO	DM	1642-1644
26978176_en	FINDING	may be used for the early preclinical diagnosis of DN	1846-1899
26978176_en	ANATOMY	blood	1725-1730
26978176_en	PHYS	blood pressure	1725-1739
26978176_en	DISO	DM	1779-1781
26978176_en	CHEM	creatinine	1487-1497
26978176_en	ANATOMY	urinary	516-523
26978176_en	ANATOMY	urinary	545-552
26978176_en	ANATOMY	urinary	780-787
26978176_en	ANATOMY	urinary	1811-1818
26978176_en	CHEM	podocyte structural proteins	802-830
26978176_en	DISO	diabetic	208-216
26978176_en	PHYS	glomerular filtration	1524-1545
26978176_en	PHYS	urinary levels of the podocyte structural proteins	780-830
26978176_en	FINDING	direct significant correlation of systolic blood pressure	1682-1739
26978176_en	FINDING	direct correlation of NU with albuminuria	1289-1330
26978176_en	DISO	type 1 DM	426-435
26978176_en	DISO	type 2 DM	448-457
26978176_en	FINDING	equally higher and did not differ between the types of DM	1218-1275
26978176_en	FINDING	correlated directly	1458-1477
26978176_en	FINDING	correlated inversely	1458-1518
26978176_en	FINDING	directly correlated with glycated hemoglobin levels	1555-1606
26978176_en	DISO	types 1 DM	1628-1644
26978176_en	DISO	types 2 DM	1628-1644
26978176_en	DISO	type 2 DM	1772-1781
26978176_en	PHYS	markers for podocyte injury	22-49
26978176_en	PHYS	markers for podocyte injury	129-156
26978176_en	PHYS	urinary concentration	516-537
26978176_en	PHYS	healthy	755-762
26978176_en	CHEM	enzyme	870-876
26978176_en	CHEM	structural proteins	811-830
26978176_en	CHEM	proteins	822-830
26978232_en	ANATOMY	Ileal	170-175
26978232_en	ANATOMY	Ileal biopsy specimens	170-192
26978232_en	DISO	Crohn's disease	258-273
26978232_en	DISO	colitis	302-309
26978232_en	DISO	IBD	313-316
26978232_en	ANATOMY	ileal	364-369
26978232_en	ANATOMY	ileal mucosa	364-376
26978232_en	LABPROC	Immunohistochemical examination	399-430
26978232_en	CHEM	anti-somatostatin receptor type 2	451-484
26978232_en	ANATOMY	membranous	1439-1449
26978232_en	ANATOMY	epitheliocytes	575-589
26978232_en	PHYS	cytoplasmic expression	1001-1023
26978232_en	ANATOMY	cytoplasmic	669-680
26978232_en	DISO	Crohn's disease	819-834
26978232_en	DISO	IBDU	884-888
26978232_en	ANATOMY	cytoplasmic	1001-1012
26978232_en	CHEM	SSTR-2	1121-1127
26978232_en	DISO	Crohn's disease	1192-1207
26978232_en	ANATOMY	mucosa	1246-1252
26978232_en	DISO	indeterminate (unclassified) colitis	1271-1307
26978232_en	CHEM	SSTR2	1327-1332
26978232_en	PHYS	SSTR2 staining types	1327-1347
26978232_en	ANATOMY	membranous	1363-1373
26978232_en	ANATOMY	cytoplasmic	1375-1386
26978232_en	PHYS	membranous staining	1439-1458
26978232_en	ANATOMY	biopsy specimens	176-192
26978232_en	ANATOMY	intraepithelial	1529-1544
26978232_en	ANATOMY	neuroendocrine	1474-1488
26978232_en	ANATOMY	cytoplasmic	1501-1512
26978232_en	ANATOMY	lymphocytes	1547-1558
26978232_en	ANATOMY	T lymphocytes	1545-1558
26978232_en	ANATOMY	membranous	1575-1585
26978232_en	ANATOMY	neuroendocrine	1619-1633
26978232_en	ANATOMY	epithelial	1638-1648
26978232_en	CHEM	somatostatin	45-57
26978232_en	CHEM	somatostatin receptor	45-66
26978232_en	ANATOMY	mucosa	91-97
26978232_en	ANATOMY	ileal	85-90
26978232_en	ANATOMY	ileal mucosa	85-97
26978232_en	DISO	inflammatory bowel disease	115-141
26978232_en	DISO	bowel disease	128-141
26978232_en	DISO	IBD	143-146
26978232_en	ANATOMY	bowel	128-133
26978232_en	ANATOMY	cells	548-553
26978232_en	DISO	CD	275-277
26978232_en	DISO	indeterminate colitis	288-309
26978232_en	DISO	IBD unclassified	313-329
26978232_en	DISO	IBDU	331-335
26978232_en	DISO	indeterminate colitis of IBD unclassified	288-329
26978232_en	ANATOMY	mucosa	370-376
26978232_en	CHEM	somatostatin receptor type 2	456-484
26978232_en	CHEM	SSTR-2	486-492
26978232_en	CHEM	somatostatin receptor	456-477
26978232_en	CHEM	SSTR	486-490
26978232_en	CHEM	SSTR2	523-528
26978232_en	PHYS	expressing	1128-1138
26978232_en	ANATOMY	membranous	657-667
26978232_en	ANATOMY	membranous	1068-1078
26978232_en	ANATOMY	cytoplasmic	1079-1090
26978232_en	CHEM	SSTR	1121-1125
26978232_en	ANATOMY	membranous	1399-1409
26978232_en	ANATOMY	cytoplasmic	1410-1421
26978232_en	PHYS	expression	1513-1523
26978232_en	ANATOMY	membranous	693-703
26978232_en	ANATOMY	cytoplasmic	704-715
26978232_en	ANATOMY	cells	733-738
26978232_en	ANATOMY	intraepithelial T lymphocytes	1529-1558
26978232_en	ANATOMY	cytoplasmic	1586-1597
26978232_en	PHYS	expression	1598-1608
26978232_en	LABPROC	biopsy	176-182
26978232_en	PHYS	SSTR-2-expressing	1121-1138
26978232_en	ANATOMY	cells	1139-1144
26978232_en	ANATOMY	cells	1428-1433
26978232_en	ANATOMY	membranous	744-754
26978232_en	CHEM	antibodies	494-504
26978232_en	DISO	inflammatory	115-127
26978232_en	PHYS	somatostatin receptor expression	45-77
26978232_en	PHYS	membranous expression	744-765
26978232_en	PHYS	receptor expression	616-635
26978232_en	FINDING	number of SSTR-2-expressing cells was significantly smaller	1111-1170
26978232_en	PHYS	cytoplasmic expression	1501-1523
26978232_en	PHYS	membranous-cytoplasmic expression	1575-1608
26978232_en	CHEM	receptor	58-66
26978232_en	LABPROC	SSTR2-positively stained cells were counted	523-566
26978232_en	CHEM	receptor	469-477
26978232_en	CHEM	receptor	616-624
26978232_en	DISO	colitis	1300-1307
26978233_en	ANATOMY	liver	90-95
26978233_en	PHYS	apoptosis	58-67
26978233_en	DISO	liver metastases	90-106
26978233_en	DISO	colorectal liver metastases	79-106
26978233_en	CHEM	survivin	214-222
26978233_en	CHEM	p53 protein	143-154
26978233_en	CHEM	effector caspases-3	156-175
26978233_en	CHEM	effector caspases -7	156-182
26978233_en	ANATOMY	colorectal	79-89
26978233_en	CHEM	antiapoptotic protein	192-213
26978233_en	DISO	colorectal adenocarcinoma	226-251
26978233_en	DISO	colorectal adenocarcinoma metastases to the liver	226-275
26978233_en	ANATOMY	liver	270-275
26978233_en	CHEM	VEGF	368-372
26978233_en	DISO	colorectal carcinoma	452-472
26978233_en	ANATOMY	colorectal	452-462
26978233_en	ANATOMY	liver	491-496
26978233_en	LABPROC	immunohistologically examined	502-531
26978233_en	CHEM	VEGF	669-673
26978233_en	CHEM	anti-tumor drug	755-770
26978233_en	CHEM	Caspase 3	804-813
26978233_en	CHEM	survivin	833-841
26978233_en	CHEM	VEGF	947-951
26978233_en	ANATOMY	colorectal	1391-1401
26978233_en	DISO	adenocarcinoma	1402-1416
26978233_en	CHEM	survivin	1160-1168
26978233_en	DISO	colorectal adenocarcinoma metastases to the liver	1391-1440
26978233_en	DISO	tumor	1473-1478
26978233_en	ANATOMY	cells	1479-1484
26978233_en	CHEM	caspase-7	1227-1236
26978233_en	CHEM	p53	1241-1244
26978233_en	CHEM	bevacizumab	1333-1344
26978233_en	CHEM	effector caspases	156-173
26978233_en	DISO	colorectal adenocarcinoma	1391-1416
26978233_en	CHEM	Caspase	804-811
26978233_en	ANATOMY	liver	1435-1440
26978233_en	PHYS	apoptosis	1460-1469
26978233_en	ANATOMY	tumor cells	1473-1484
26978233_en	CHEM	effector caspase 3	1517-1535
26978233_en	CHEM	p53	143-146
26978233_en	CHEM	protein	206-213
26978233_en	PHYS	apoptosis	1627-1636
26978233_en	CHEM	protein	1688-1695
26978233_en	CHEM	protein	147-154
26978233_en	CHEM	antiapoptotic protein	1674-1695
26978233_en	CHEM	survivin	1696-1704
26978233_en	ANATOMY	colorectal	226-236
26978233_en	DISO	adenocarcinoma	237-251
26978233_en	ANATOMY	Intraoperative samples	406-428
26978233_en	DISO	carcinoma	463-472
26978233_en	DISO	colorectal carcinoma metastases to the liver	452-496
26978233_en	DISO	tumor	760-765
26978233_en	CHEM	caspase	1227-1234
26978233_en	CHEM	effector caspase	1517-1533
26978233_en	CHEM	caspase	1526-1533
26978233_en	DISO	metastases	96-106
26978233_en	CHEM	cytotoxic drugs	615-630
26978233_en	DISO	metastases	252-262
26978233_en	DISO	metastases	473-483
26978233_en	DISO	metastases	1417-1427
26978233_en	FINDING	activated apoptosis	1450-1469
26978233_en	PHYS	expression	129-139
26978233_en	CHEM	caspases	165-173
26978233_en	PHYS	Expression	790-800
26978233_en	PHYS	expression	1213-1223
26978233_en	PHYS	expression	1503-1513
26978233_en	FINDING	enhancing the expression of effector caspase 3	1489-1535
26978233_en	PHYS	expression	1656-1666
26978233_en	FINDING	decreasing the expression of the antiapoptotic protein survivi	1641-1703
26978233_en	FINDING	activated apoptosis	1617-1636
26978233_en	PHYS	apoptosis markers	58-75
26978233_en	PHYS	expression	44-54
26978233_en	CHEM	cytotoxic agents	1004-1020
26978233_en	FINDING	significantly more frequently detected	847-885
26978233_en	PHYS	survivin expression	1160-1179
26978233_en	FINDING	no survivin expression	1157-1179
26978233_en	FINDING	no statistically significant differences	1254-1294
26978418_en	CHEM	ARTRA MSM FORTE	8-23
26978418_en	DISO	knee osteoarthritis	41-60
26978418_en	CHEM	chondroitin	260-271
26978418_en	CHEM	MSM	242-245
26978418_en	CHEM	ARTRA MSM FORTE	236-251
26978418_en	CHEM	chondroitin sulfate	260-279
26978418_en	CHEM	glucosamine hydrochloride	288-313
26978418_en	CHEM	methylsulfonylmethane	322-343
26978418_en	CHEM	sodium hyaluronate	361-379
26978418_en	DISO	osteoarthritis	448-462
26978418_en	CHEM	hyaluronic acid	409-424
26978418_en	DISO	knee osteoarthritis	443-462
26978418_en	DISO	knee OA	556-563
26978418_en	DISO	pain syndrome	577-590
26978418_en	CHEM	ARTRA MSM	985-994
26978418_en	CHEM	MSM	991-994
26978418_en	CHEM	ARTRA	1065-1070
26978418_en	FINDING	significant decrease in pain	1277-1305
26978418_en	DISO	pain	1337-1341
26978418_en	DISO	pain	1301-1305
26978418_en	FINDING	pain intensity	1337-1351
26978418_en	FINDING	diminished stiffness	1462-1482
26978418_en	ANATOMY	joint	1530-1535
26978418_en	DISO	stiffness	1473-1482
26978418_en	FINDING	alleviated joint function	1519-1544
26978418_en	PHYS	joint function	1530-1544
26978418_en	CHEM	ARTRA MSM	1754-1763
26978418_en	CHEM	ARTRA	1754-1759
26978418_en	CHEM	MSM	1760-1763
26978418_en	CHEM	ARTRA	1797-1802
26978418_en	CHEM	ARTRA MSM	1837-1846
26978418_en	FINDING	positive effect occurred more rapidl	1987-2023
26978418_en	CHEM	ARTRA	2032-2037
26978418_en	CHEM	MSM	2038-2041
26978418_en	CHEM	ARTRA MSM	2032-2041
26978418_en	FINDING	positive results	2097-2113
26978418_en	CHEM	ARTRA MSM	2326-2335
26978418_en	FINDING	Get-Up and Go test results	2391-2417
26978418_en	FINDING	improvement in Get-Up and Go test results	2376-2417
26978418_en	CHEM	ARTRA	2533-2538
26978418_en	CHEM	MSM	2539-2542
26978418_en	CHEM	ARTRA	2326-2331
26978418_en	CHEM	MSM	2332-2335
26978418_en	DISO	pain	2598-2602
26978418_en	CHEM	ARTRA MSM	2533-2542
26978418_en	CHEM	ARTRA	2643-2648
26978418_en	FINDING	prompter pain relief	2589-2609
26978418_en	CHEM	ARTRA	2619-2624
26978418_en	CHEM	ARTRA MSM	2643-2652
26978418_en	DISO	OA	2693-2695
26978418_en	DISO	osteoarthritis	46-60
26978418_en	ANATOMY	knee	41-45
26978418_en	FINDING	efficacy and tolerability of the drug	122-159
26978418_en	CHEM	MSM	14-17
26978418_en	CHEM	MSM	345-348
26978418_en	ANATOMY	knee	443-447
26978418_en	DISO	OA	464-466
26978418_en	DISO	OA	561-563
26978418_en	ANATOMY	knee	556-560
26978418_en	DISO	pain	577-581
26978418_en	DISO	pain	592-596
26978418_en	FINDING	pain intensity scores	592-613
26978418_en	FINDING	WOMAC index scores	737-755
26978418_en	FINDING	efficiency of therapy in the opinion of a physician and a patient	789-854
26978418_en	FINDING	Reduced pain intensity	1329-1351
26978418_en	CHEM	ARTRA	236-241
26978418_en	CHEM	ARTRA	985-990
26978418_en	FINDING	reduced total WOMAC scores	1549-1575
26978418_en	CHEM	ARTRA	1837-1842
26978418_en	CHEM	MSM	1843-1846
26978418_en	FINDING	may be recommended for the treatment of OA	2653-2695
26978418_en	CHEM	MSM	2649-2652
26978418_en	CHEM	ARTRA	8-13
26978418_en	CHEM	ARTRA MSM	8-17
26978418_en	CHEM	ARTRA MSM	236-245
26978418_en	CHEM	hyaluronate	368-379
26978418_en	FINDING	significant improvement	2127-2150
26978418_en	CHEM	acid	420-424
26978418_en	FINDING	no adverse reactions	2263-2283
26978418_en	PHYS	quality of life	860-875
26978418_en	PHYS	life	871-875
26978418_en	CHEM	sulfate	272-279
26978418_en	CHEM	hydrochloride	300-313
26978418_en	CHEM	glucosamine	288-299
26978418_en	CHEM	sodium	361-367
26978418_en	FINDING	clinical efficacy and safety of the combined medication	180-235
26978418_en	FINDING	significantly less spent time	1637-1666
26978418_en	FINDING	differences reached the statistical significance	1698-1746
26978418_en	FINDING	effect ARTRA MSM occurred more rapidly	1830-1868
26978418_en	FINDING	evaluations of the efficiency of treatment	1918-1960
26978418_en	FINDING	evaluations of the efficiency of treatment	2444-2486
26978418_en	FINDING	well tolerated	2237-2251
26978418_en	FINDING	decrease in pain	1289-1305
26978418_en	FINDING	rapider in its effect	2339-2360
26978491_en	DISO	chronic kidney disease	47-69
26978491_en	DISO	CKD, stages I-II	356-372
26978491_en	DISO	CKD, stage III	382-396
26978491_en	DISO	CI	477-479
26978491_en	PHYS	pulse-wave	781-791
26978491_en	PHYS	frontal lobe functions	595-617
26978491_en	PHYS	mental status	549-562
26978491_en	ANATOMY	frontal lobe	595-607
26978491_en	PHYS	memory	587-593
26978491_en	LABPROC	echocardiographic study	654-677
26978491_en	PHYS	arterial blood pressure	683-706
26978491_en	ANATOMY	carotid	751-758
26978491_en	PHYS	thickness of carotid intima-media	738-771
26978491_en	FINDING	pulse-wave velocity	781-800
26978491_en	LABPROC	brain MRI	825-834
26978491_en	ANATOMY	brain	825-830
26978491_en	DISO	CKD, stages I-II	919-935
26978491_en	DISO	CKD, stage IV	952-965
26978491_en	DISO	CI	983-985
26978491_en	DISO	CKD, stages III-IV	1014-1032
26978491_en	DISO	CKD	1080-1083
26978491_en	DISO	CI	1131-1133
26978491_en	LABPROC	MRI	1154-1157
26978491_en	ANATOMY	white matter	1192-1204
26978491_en	DISO	leukoaraiosis	1225-1238
26978491_en	DISO	lateral ventricular dilatation	1249-1279
26978491_en	DISO	dilatation in the sulci of brain hemispheres	1298-1342
26978491_en	ANATOMY	sulci of brain hemispheres	1316-1342
26978491_en	PHYS	male sex	1391-1399
26978491_en	DISO	hyperhomocysteinemia	1401-1421
26978491_en	DISO	anemia	1423-1429
26978491_en	DISO	abdominal obesity	1431-1448
26978491_en	DISO	left ventricular myocardial hypertrophy	1450-1489
26978491_en	PHYS	age	1494-1497
26978491_en	DISO	CI	1529-1531
26978491_en	DISO	atherosclerotic	1565-1580
26978491_en	DISO	lesions	1581-1588
26978491_en	ANATOMY	common carotid arteries	1592-1615
26978491_en	PHYS	arterial rigidity	1631-1648
26978491_en	DISO	CKD	1684-1687
26978491_en	DISO	CI	1725-1727
26978491_en	ANATOMY	frontal lobes	1749-1762
26978491_en	DISO	CI	1802-1804
26978491_en	DISO	CKD, stages III-IV	1822-1840
26978491_en	DISO	CKD, stages III-IV	1842-1860
26978491_en	DISO	CI	1893-1895
26978491_en	DISO	kidney disease	55-69
26978491_en	ANATOMY	kidney	55-61
26978491_en	DISO	Cognitive impairment	1-21
26978491_en	DISO	cognitive impairment	128-148
26978491_en	DISO	CI	150-152
26978491_en	ANATOMY	vascular-wall	194-207
26978491_en	ANATOMY	vascular	194-202
26978491_en	DISO	vascular-wall remodeling	194-218
26978491_en	DISO	chronic kidney disease	236-258
26978491_en	DISO	kidney disease	244-258
26978491_en	ANATOMY	kidney	244-250
26978491_en	DISO	CKD	260-263
26978491_en	DISO	CKD, stage IV	410-423
26978491_en	LABPROC	24h arterial blood pressure monitoring	679-717
26978491_en	ANATOMY	arterial	683-691
26978491_en	PHYS	blood pressure	692-706
26978491_en	ANATOMY	blood	692-697
26978491_en	LABPROC	MRI	831-834
26978491_en	DISO	CI	867-869
26978491_en	ANATOMY	myocardial	1467-1477
26978491_en	ANATOMY	ventricular	1257-1268
26978491_en	DISO	CI	1113-1115
26978491_en	ANATOMY	sulci	1316-1321
26978491_en	FINDING	frequency and severity of CI	1503-1531
26978491_en	DISO	focal lesions	1171-1184
26978491_en	ANATOMY	lateral ventricular	1249-1268
26978491_en	ANATOMY	brain hemispheres	1325-1342
26978491_en	ANATOMY	brain	1325-1330
26978491_en	DISO	CI	1384-1386
26978491_en	PHYS	sex	1396-1399
26978491_en	ANATOMY	abdominal	1431-1440
26978491_en	DISO	hypertrophy	1478-1489
26978491_en	ANATOMY	left ventricular	1450-1466
26978491_en	ANATOMY	ventricular	1455-1466
26978491_en	DISO	atherosclerotic lesions	1565-1588
26978491_en	ANATOMY	arteries	1607-1615
26978491_en	ANATOMY	carotid arteries	1599-1615
26978491_en	ANATOMY	arterial	1631-1639
26978491_en	DISO	dysfunction of frontal lobes	1734-1762
26978491_en	DISO	dysfunction	1734-1745
26978491_en	DISO	obesity	1441-1448
26978491_en	DISO	chronic kidney disease (CKD), stages I-IV	236-277
26978491_en	DISO	CKD	356-359
26978491_en	DISO	CKD	382-385
26978491_en	DISO	CKD	410-413
26978491_en	DISO	CKD	919-922
26978491_en	DISO	CKD	952-955
26978491_en	DISO	CKD stages I-II	1014-1068
26978491_en	DISO	CKD	1014-1017
26978491_en	DISO	CKD	1822-1825
26978491_en	DISO	CKD	1842-1845
26978491_en	FINDING	independent predictor of CI	1868-1895
26978491_en	ANATOMY	lobe	603-607
26978491_en	DISO	predialysis stages of chronic kidney disease	25-69
26978491_en	FINDING	development and progression of cognitive impairment	97-148
26978491_en	FINDING	risk factors	159-171
26978491_en	FINDING	Frequency, severity and character of CI	440-479
26978491_en	PHYS	short-term memory	564-593
26978491_en	PHYS	delayed memory	579-593
26978491_en	LABPROC	Standard laboratory examinations	620-652
26978491_en	FINDING	severity of CI was higher	971-996
26978491_en	FINDING	predicted the development of CI	1084-1115
26978491_en	FINDING	increased the CKD severity	1670-1696
26978491_en	FINDING	higher the severity of CI	1702-1727
26978491_en	FINDING	development of CI	1787-1804
26978491_en	DISO	predialysis stages	1909-1927
26978498_en	ANATOMY	brain	104-109
26978498_en	CHEM	agomelatine	35-46
26978498_en	DISO	brain ischemia	104-118
26978498_en	DISO	depression	81-91
26978498_en	DISO	chronic brain ischemia	96-118
26978498_en	DISO	brain ischemia	261-275
26978498_en	CHEM	agomelatine	174-185
26978498_en	CHEM	valdoxan	187-195
26978498_en	DISO	ischemia	267-275
26978498_en	DISO	chronic brain ischemia	253-275
26978498_en	DISO	CBI	277-280
26978498_en	DISO	depressive episode	489-507
26978498_en	DISO	affective impairment	540-574
26978498_en	DISO	cognitive impairment	554-574
26978498_en	CHEM	Agomelatine	1121-1132
26978498_en	CHEM	valdoxan	1134-1142
26978498_en	CHEM	Agomelatine	1237-1248
26978498_en	PHYS	sleep	1258-1263
26978498_en	DISO	anxiety symptoms	1307-1323
26978498_en	DISO	anxiety	1307-1314
26978498_en	FINDING	reduced anxiety symptoms	1299-1323
26978498_en	DISO	depressive symptoms	1344-1363
26978498_en	DISO	depressive states	1558-1575
26978498_en	FINDING	No side-effects	1441-1456
26978498_en	FINDING	antidepressive activity	1501-1524
26978498_en	FINDING	balanced spectrum of effects on anxiety, depression, insomnia	1621-1682
26978498_en	DISO	mild depressive states	213-235
26978498_en	DISO	chronic brain ischemia	1593-1615
26978498_en	DISO	anxiety	1653-1660
26978498_en	DISO	depression	1662-1672
26978498_en	DISO	insomnia	1674-1682
26978498_en	FINDING	recommend agomelatine in treatment of patients	1742-1788
26978498_en	CHEM	agomelatine	1752-1763
26978498_en	DISO	CBI	1794-1797
26978498_en	DISO	ischemia	110-118
26978498_en	ANATOMY	brain	261-266
26978498_en	DISO	depressive states	218-235
26978498_en	DISO	CBI stage I	414-426
26978498_en	DISO	depressive	218-228
26978498_en	DISO	CBI stage II	448-461
26978498_en	DISO	depressive	489-499
26978498_en	DISO	depressive episode of mild severity	489-524
26978498_en	DISO	Depression	651-661
26978498_en	DISO	Anxiety	699-706
26978498_en	DISO	Depression	711-721
26978498_en	PHYS	night sleep	740-751
26978498_en	FINDING	improved sleep	1249-1263
26978498_en	FINDING	improvement of cognitive functions	1387-1421
26978498_en	FINDING	high antidepressive activity	1496-1524
26978498_en	DISO	brain ischemia	1601-1615
26978498_en	DISO	ischemia	1607-1615
26978498_en	FINDING	positive effect on cognitive functions	1688-1726
26978498_en	ANATOMY	brain	1601-1606
26978498_en	DISO	depressive	1344-1354
26978498_en	DISO	mild depressive states	1553-1575
26978498_en	PHYS	sleep	746-751
26978498_en	DISO	CBI	414-417
26978498_en	DISO	CBI	448-451
26978498_en	FINDING	efficacy and tolerability of agomelatine	145-185
26978499_en	CHEM	teraligen	28-37
26978499_en	DISO	brain ischemia	55-69
26978499_en	DISO	psychoautonomic syndrome	92-116
26978499_en	ANATOMY	brain	230-235
26978499_en	DISO	ischemia	236-244
26978499_en	CHEM	teraligen	166-175
26978499_en	DISO	psychoautonomic syndrome	193-217
26978499_en	DISO	brain ischemia	230-244
26978499_en	CHEM	teraligen	471-480
26978499_en	PHYS	Neurological status	626-645
26978499_en	PHYS	autonomic changes	647-664
26978499_en	LABPROC	Neurophysiological examination	740-770
26978499_en	LABPROC	P300 event-related potential	780-808
26978499_en	DISO	brain ischemia, stages I and II	55-86
26978499_en	LABPROC	EEG	772-775
26978499_en	DISO	disorders	1136-1145
26978499_en	DISO	psychoautonomic symptoms	929-953
26978499_en	FINDING	no side-effects	1078-1093
26978499_en	DISO	vascular disorders	1127-1145
26978499_en	DISO	ischemia	1351-1359
26978499_en	LABPROC	neurophysiological examinations	1216-1247
26978499_en	DISO	brain ischemia, stages I and II	350-381
26978499_en	DISO	psychoautonomic syndrome	1295-1319
26978499_en	PHYS	elderly	1323-1330
26978499_en	DISO	brain ischemia	1345-1359
26978499_en	DISO	ischemia	61-69
26978499_en	ANATOMY	brain	55-60
26978499_en	DISO	brain ischemia	350-364
26978499_en	DISO	ischemia	356-364
26978499_en	ANATOMY	brain	350-355
26978499_en	DISO	psychoautonomic syndrome	401-425
26978499_en	FINDING	positive dynamics of the decrease of psychoautonomic symptoms	892-953
26978499_en	FINDING	decrease of psychoautonomic symptoms, cephalgic syndrome	917-973
26978499_en	DISO	cephalgic syndrome	955-973
26978499_en	PHYS	sleep	975-980
26978499_en	FINDING	sleep normalization	975-994
26978499_en	FINDING	improvement of cognitive function	1010-1043
26978499_en	FINDING	Good tolerability	1056-1073
26978499_en	ANATOMY	vascular	1127-1135
26978499_en	ANATOMY	brain	1345-1350
26978499_en	DISO	brain ischemia, stages I and II	1345-1376
26978499_en	LABPROC	event-related potential	785-808
26978499_en	FINDING	recommended for treatment of psychoautonomic syndrome	1266-1319
26978499_en	FINDING	efficacy and safety of teraligen	5-37
26978499_en	FINDING	efficacy and safety of teraligen	143-175
26978504_en	DISO	low-back pain	86-99
26978504_en	CHEM	xefocam	206-213
26978504_en	CHEM	mydocalm-richter	218-234
26978504_en	DISO	spinal osteochondrosis	396-418
26978504_en	DISO	root syndrome	424-437
26978504_en	DISO	radiculopathia	442-456
26978504_en	ANATOMY	lumbar/sacral spine	464-483
26978504_en	DISO	pain syndrome	489-502
26978504_en	DISO	pain	582-586
26978504_en	DISO	pain syndrome	582-595
26978504_en	DEVICE	Farma T.E.B. Trans Epidermal Barrier Physio	902-945
26978504_en	CHEM	xefocam	997-1004
26978504_en	CHEM	mydocalm-richter	1060-1076
26978504_en	ANATOMY	lumbar/sacral spine	1137-1156
26978504_en	CHEM	xefocam	1242-1249
26978504_en	CHEM	mydocalm-richter	1254-1270
26978504_en	DISO	pain	1341-1345
26978504_en	FINDING	reduction of pain syndrome	1328-1354
26978504_en	DISO	pain syndrome	1341-1354
26978504_en	FINDING	pain reduction	1515-1529
26978504_en	PHYS	life	718-722
26978504_en	FINDING	Positive treatment effect	1645-1670
26978504_en	FINDING	good tolerability	1702-1719
26978504_en	DISO	pain	95-99
26978504_en	ANATOMY	low-back	86-94
26978504_en	ANATOMY	back	90-94
26978504_en	DISO	low-back pain	259-272
26978504_en	ANATOMY	root	424-428
26978504_en	DISO	pain	268-272
26978504_en	ANATOMY	low-back	259-267
26978504_en	ANATOMY	back	263-267
26978504_en	DISO	osteochondrosis	403-418
26978504_en	ANATOMY	spinal	396-402
26978504_en	ANATOMY	lumbar	464-470
26978504_en	ANATOMY	sacral	471-477
26978504_en	ANATOMY	spine	478-483
26978504_en	DISO	pain	489-493
26978504_en	FINDING	clinical efficacy of electrode pharmaphoresis	1190-1235
26978504_en	DISO	Pain	687-691
26978504_en	PHYS	Quality-of-life	707-722
26978504_en	ANATOMY	lumbar	1137-1143
26978504_en	ANATOMY	sacral	1144-1150
26978504_en	ANATOMY	spine	1151-1156
26978504_en	DISO	pain	1515-1519
26978504_en	DISO	Pain	1372-1376
26978504_en	FINDING	Clinical outcome	807-823
26978504_en	CHEM	solution	1006-1014
26978504_en	FINDING	high clinical efficacy of electrode pharmaphoresis	1185-1235
26978504_en	FINDING	Treatment efficacy	531-549
26978504_en	FINDING	clinical efficacy of electrode pharmaphoresis	3-48
26978504_en	FINDING	clinical efficacy and tolerability of electrode pharmaphoresis	124-186
26978504_en	CHEM	solution for injections	1006-1029
26978504_en	FINDING	reduced to mild grade	1390-1411
26978504_en	FINDING	increased significantly	1599-1622
26978504_en	FINDING	quality of self-service	1556-1579
26978504_en	CHEM	solution	1078-1086
26978504_en	CHEM	solution for injections	1078-1101
26978504_en	CHEM	mydocalm	1254-1262
26978504_en	CHEM	mydocalm	1060-1068
26978639_en	PHYS	lipid profile	5-18
26978639_en	DISO	psychosomatic illnesses	65-88
26978639_en	DISO	chronic cerebral ischemia	93-118
26978639_en	PHYS	plasma cholesterol and triglyceride levels	168-210
26978639_en	CHEM	triglyceride	191-203
26978639_en	DISO	psychosomatic illnesses	257-280
26978639_en	DISO	chronic cerebral ischemia	285-310
26978639_en	DISO	CCI	439-442
26978639_en	CHEM	triglyceride	494-506
26978639_en	CHEM	cholesterol	478-489
26978639_en	LABPROC	cholesterol and triglyceride tests	478-512
26978639_en	DISO	psychosomatic	838-851
26978639_en	DISO	neurotization	578-591
26978639_en	FINDING	not differ from those of patients with peptic ulcer disease	732-791
26978639_en	CHEM	Cholesterol	607-618
26978639_en	PHYS	Cholesterol levels	607-625
26978639_en	DISO	post-infarct cardiosclerosis	655-683
26978639_en	DISO	ulcer disease	778-791
26978639_en	DISO	peptic ulcer disease	771-791
26978639_en	CHEM	Triglyceride	800-812
26978639_en	FINDING	Triglyceride levels were high	800-829
26978639_en	DISO	PICS	900-904
26978639_en	FINDING	higher levels in the patients with PICS	865-904
26978639_en	DISO	PUD	935-938
26978639_en	ANATOMY	Plasma	940-946
26978639_en	CHEM	cholesterol	947-958
26978639_en	CHEM	triglyceride	963-975
26978639_en	DISO	Cognitive impairment	1085-1105
26978639_en	DISO	neurotization	1126-1139
26978639_en	DISO	psychosomatic illnesses	1177-1200
26978639_en	FINDING	not correlated with assessments of cognitive functions	988-1042
26978639_en	PHYS	plasma cholesterol and triglyceride levels	1245-1287
26978639_en	DISO	cognitive impairment	1319-1339
26978639_en	DISO	cerebral ischemia	101-118
26978639_en	DISO	ischemia	110-118
26978639_en	ANATOMY	cerebral	101-109
26978639_en	ANATOMY	plasma	168-174
26978639_en	CHEM	cholesterol	175-186
26978639_en	DISO	CCI	312-315
26978639_en	DISO	cerebral ischemia	293-310
26978639_en	DISO	ischemia	302-310
26978639_en	ANATOMY	cerebral	293-301
26978639_en	FINDING	prognostic factor for cognitive impairment	1297-1339
26978639_en	DISO	cardiosclerosis	668-683
26978639_en	DISO	PICS	685-689
26978639_en	DISO	infarct	660-667
26978639_en	DISO	PUD	793-796
26978639_en	PHYS	Triglyceride levels	800-819
26978639_en	PHYS	cholesterol and triglyceride levels	947-982
26978639_en	CHEM	cholesterol	1252-1263
26978639_en	ANATOMY	plasma	1245-1251
26978639_en	CHEM	triglyceride	1268-1280
26978639_en	CHEM	lipid	5-10
26978639_en	FINDING	correlations between plasma cholesterol and triglyceride levels	147-210
26978639_en	FINDING	Cholesterol levels were higher	607-637
26978639_en	FINDING	higher level of neurotization	1110-1139
27022660_en	DISO	Wegener's granulomatosis	67-91
27022660_en	DISO	inflammation	329-341
27022660_en	DISO	polyangiitis	53-65
27022660_en	FINDING	reduce quality of life	427-449
27022660_en	DISO	Granulomatosis with polyangiitis	96-128
27022660_en	DISO	GPA	130-133
27022660_en	DISO	Wegener's granulomatosis	162-186
27022660_en	DISO	necrotizing vasculitis	206-228
27022660_en	ANATOMY	vessels	255-262
27022660_en	FINDING	fatal outcome	507-520
27022660_en	DISO	granulomatous inflammation	315-341
27022660_en	DISO	inflammation	567-579
27022660_en	DISO	GPA	371-374
27022660_en	ANATOMY	organ of vision	382-397
27022660_en	ANATOMY	ocular	587-593
27022660_en	DISO	Granulomatosis	96-110
27022660_en	DISO	blindness bilateral	696-726
27022660_en	DISO	blindness	696-705
27022660_en	ANATOMY	ocular superficial structures	587-616
27022660_en	ANATOMY	orbital	646-653
27022660_en	ANATOMY	ocular	658-664
27022660_en	DISO	complete blindness	687-705
27022660_en	ANATOMY	organ of vision	767-782
27022660_en	ANATOMY	fibrous tunic	1024-1037
27022660_en	DISO	lesions	955-962
27022660_en	ANATOMY	orbit	970-975
27022660_en	ANATOMY	appendages	980-990
27022660_en	ANATOMY	conjunctiva	1008-1019
27022660_en	ANATOMY	eyeball:	1045-1053
27022660_en	ANATOMY	retina	1070-1076
27022660_en	ANATOMY	optic nerve	1094-1105
27022660_en	ANATOMY	Orbital	1107-1114
27022660_en	DISO	granulomas	1164-1174
27022660_en	DISO	dacryoadenitis	1176-1190
27022660_en	DISO	inflammatory infiltration	1203-1228
27022660_en	ANATOMY	muscles	1278-1285
27022660_en	ANATOMY	surrounding tissues	1236-1255
27022660_en	ANATOMY	tissues	1248-1255
27022660_en	ANATOMY	oculomotor muscles	1267-1285
27022660_en	DISO	destruction of orbital bony walls	1291-1324
27022660_en	ANATOMY	orbital bony walls	1306-1324
27022660_en	DISO	conjunctivitis	1338-1352
27022660_en	DISO	episcleritis	1357-1369
27022660_en	DISO	scleritis	1493-1502
27022660_en	ANATOMY	fibrous tunic	1413-1426
27022660_en	DISO	keratitis	1537-1546
27022660_en	DISO	necrotizing scleritis	1481-1502
27022660_en	DISO	peripheral ulcerative keratitis	1504-1546
27022660_en	DISO	stromal keratitis	1529-1546
27022660_en	ANATOMY	retina	1552-1558
27022660_en	ANATOMY	nerve	1646-1651
27022660_en	ANATOMY	optic nerve	1640-1651
27022660_en	DISO	compression of the orbit	1688-1712
27022660_en	ANATOMY	orbit	1707-1712
27022660_en	ANATOMY	tissue	1725-1731
27022660_en	DISO	complications	485-498
27022660_en	DISO	ischemic	1765-1773
27022660_en	DISO	granulomatosis with polyangiitis	33-65
27022660_en	DISO	vasculitis	218-228
27022660_en	ANATOMY	small and medium-sized vessels	232-262
27022660_en	DISO	GPA	733-736
27022660_en	ANATOMY	nerve	1100-1105
27022660_en	PHYS	oculomotor	1267-1277
27022660_en	ANATOMY	orbital	1306-1313
27022660_en	ANATOMY	bony walls	1314-1324
27022660_en	ANATOMY	eyeball	1434-1441
27022660_en	ANATOMY	stromal	1529-1536
27022660_en	PHYS	quality of life	434-449
27022660_en	PHYS	fatal	507-512
27022660_en	PHYS	life	445-449
27022660_en	DISO	inflamed	1716-1724
27022660_en	DISO	granulomatosis	33-47
27022660_en	DISO	Orbital affection	1107-1124
27022660_en	FINDING	lead to the severest complications	464-498
27022660_en	DISO	lesions of the orbit and appendages	955-990
27022660_en	ANATOMY	tunic	1421-1426
27022660_en	DISO	polyangiitis	116-128
27022660_en	DISO	necrotizing	1481-1492
27022660_en	DISO	inflammatory	1203-1215
27022660_en	DISO	Affection of the fibrous tunic	1396-1426
27022660_en	DISO	granulomatosis	77-91
27022660_en	PHYS	vision	391-397
27022660_en	DISO	granulomatosis	172-186
27022660_en	PHYS	vision	776-782
27029445_en	CHEM	actovegin	150-159
27029445_en	ANATOMY	carotid	163-170
27029445_en	ANATOMY	carotid arteries	343-359
27029445_en	CHEM	actovegin	562-571
27029445_en	CHEM	actovegin	462-471
27029445_en	DISO	asymptotic post-surgery ischemic strokes	854-894
27029445_en	DISO	ischemic strokes	878-894
27029445_en	DISO	post-surgery ischemic strokes	865-894
27029445_en	ANATOMY	brain areas	908-919
27029445_en	ANATOMY	carotid artery	1023-1037
27029445_en	CHEM	actovegin	988-997
27029445_en	ANATOMY	carotid	1023-1030
27029445_en	DISO	carotid artery stenosis	1023-1046
27029445_en	ANATOMY	carotid	52-59
27029445_en	DISO	lesions of carotid arteries	332-359
27029445_en	ANATOMY	carotid	343-350
27029445_en	ANATOMY	cerebral	586-594
27029445_en	DISO	ischemic	878-886
27029445_en	PHYS	cerebral perfusion	586-604
27029445_en	FINDING	increased the cerebral perfusion	572-604
27029445_en	LABPROC	computed tomography	641-660
27029445_en	LABPROC	one-photon emission computed tomography	621-660
27029445_en	DISO	strokes	887-894
27029445_en	ANATOMY	brain	908-913
27029445_en	ANATOMY	artery	1031-1037
27029445_en	DISO	stenosis	1038-1046
27029445_en	LABPROC	tomography	650-660
27029445_en	FINDING	positive role of pharmacological preconditioning	934-982
27029445_en	FINDING	efficacy of pharmacological preconditioning	5-48
27029445_en	PHYS	perfusion	595-604
27029445_en	FINDING	efficacy of pharmacological preconditioning	101-144
27029445_en	PHYS	hemodynamically	285-300
27029445_en	FINDING	improved significantly results of the surgery	666-711
27029445_en	FINDING	significant changes in patient's state	724-762
27029445_en	PHYS	patient's state	747-762
27029445_en	FINDING	improvement was correlated with the less number of asymptotic post-surgery ischemic strokes	803-894
27030096_en	LABPROC	chemical toxicological analysis	5-36
27030096_en	LABPROC	measurements of pH, time and frequency of extraction	827-879
27030096_en	CHEM	sertindole	40-50
27030096_en	CHEM	Sertindole	54-64
27030096_en	FINDING	time and frequency of extraction	847-879
27030096_en	CHEM	extracts	1147-1155
27030096_en	DISO	schizophrenic	135-148
27030096_en	DISO	intoxication	176-188
27030096_en	ANATOMY	organs	1277-1283
27030096_en	ANATOMY	plasma	1291-1297
27030096_en	ANATOMY	blood	1285-1290
27030096_en	ANATOMY	blood	1927-1932
27030096_en	CHEM	sertindole	447-457
27030096_en	LABPROC	sertindole extraction from solutions	447-483
27030096_en	ANATOMY	biological materials	297-317
27030096_en	PHYS	pH	843-845
27030096_en	LABPROC	sertindole liberation from the extracts	1359-1398
27030096_en	CHEM	sertindole	710-720
27030096_en	CHEM	extracts	1568-1576
27030096_en	CHEM	organic solvent	790-805
27030096_en	CHEM	electrolyte	814-825
27030096_en	ANATOMY	contents gastric	1004-988
27030096_en	LABPROC	UV spectrophotometry	896-916
27030096_en	ANATOMY	intestinal contents	993-1012
27030096_en	CHEM	sertindole	931-941
27030096_en	ANATOMY	liver	951-956
27030096_en	ANATOMY	kidneys	958-965
27030096_en	ANATOMY	brain	967-972
27030096_en	ANATOMY	heart	974-979
27030096_en	ANATOMY	intestinal	993-1003
27030096_en	FINDING	efficiency of sertindole extraction from solutions	433-483
27030096_en	LABPROC	isolation from biological objects	524-557
27030096_en	LABPROC	detection	559-568
27030096_en	CHEM	sertindole	1129-1139
27030096_en	LABPROC	TLC	1162-1165
27030096_en	LABPROC	UV spectrophotometry	1167-1187
27030096_en	LABPROC	HPLC	1193-1197
27030096_en	LABPROC	quantitative determination in the extracts	574-616
27030096_en	CHEM	sertindole	1232-1242
27030096_en	ANATOMY	internal organs	1268-1283
27030096_en	ANATOMY	blood plasma	1285-1297
27030096_en	ANATOMY	urine	1303-1308
27030096_en	LABPROC	HPLC	1326-1330
27030096_en	CHEM	sertindole	1359-1369
27030096_en	LABPROC	isolation of sertindole from solutions	697-735
27030096_en	LABPROC	Isolation of sertindole	918-941
27030096_en	LABPROC	TLC-screening	1419-1432
27030096_en	LABPROC	TLC	1458-1461
27030096_en	LABPROC	UV spectrophotometric	1463-1484
27030096_en	LABPROC	HPLC techniques	1490-1505
27030096_en	CHEM	sertindole	1550-1560
27030096_en	CHEM	sertindole	1629-1639
27030096_en	ANATOMY	liver	1660-1665
27030096_en	ANATOMY	brain	1670-1675
27030096_en	INJURY_POISONING	acute poisoning	1698-1713
27030096_en	ANATOMY	kidneys	1723-1730
27030096_en	ANATOMY	stomach	1732-1739
27030096_en	ANATOMY	intestines	1745-1755
27030096_en	LABPROC	determination of sertindole in the extracts	1533-1576
27030096_en	ANATOMY	heart	1812-1817
27030096_en	CHEM	sertindole	1834-1844
27030096_en	CHEM	sertindole	1872-1882
27030096_en	FINDING	maximum amounts of sertindole	1610-1639
27030096_en	FINDING	accumulated in smaller quantities	1760-1793
27030096_en	ANATOMY	blood plasma	1927-1939
27030096_en	LABPROC	spectrophotometry	899-916
27030096_en	FINDING	Maximum efficiency of the sertindole extraction	1846-1893
27030096_en	LABPROC	sertindole extraction	1872-1893
27030096_en	CHEM	neuroleptic	85-96
27030096_en	CHEM	solutions	474-483
27030096_en	LABPROC	detection of intoxication with this medication	163-209
27030096_en	LABPROC	isolation from the biological materials	278-317
27030096_en	CHEM	extracts	608-616
27030096_en	CHEM	solutions	726-735
27030096_en	CHEM	solvent	798-805
27030096_en	LABPROC	detection of sertindole in the extracts	1116-1155
27030096_en	CHEM	extracts	1250-1258
27030096_en	CHEM	extracts	1390-1398
27030096_en	INJURY_POISONING	poisoning	1704-1713
27030096_en	FINDING	did not contain sertindole	1818-1844
27030096_en	ANATOMY	plasma	1933-1939
27030096_en	LABPROC	spectrophotometry	1170-1187
27030096_en	LABPROC	spectrophotometric	1466-1484
27030332_en	FINDING	Resistance to protease inhibitors	1-34
27030332_en	CHEM	protease inhibitors	15-34
27030332_en	DISO	hepatitis C	96-107
27030332_en	DISO	chronic hepatitis C	88-107
27030332_en	FINDING	sustained virologic response	830-858
27030332_en	DISO	liver cirrhosis	523-538
27030332_en	CHEM	protease inhibitors	199-218
27030332_en	CHEM	peginterferon	578-591
27030332_en	CHEM	ribavirin	612-621
27030332_en	DISO	obesity	648-655
27030332_en	DISO	insulin resistance	663-681
27030332_en	CHEM	PIs	220-223
27030332_en	CHEM	PIs	731-734
27030332_en	CHEM	boceprevir	736-746
27030332_en	CHEM	telaprevir	754-764
27030332_en	CHEM	simeprevir	776-786
27030332_en	DISO	chronic hepatitis C	225-244
27030332_en	PHYS	mutations	906-915
27030332_en	PHYS	mutations	988-997
27030332_en	DISO	CHC	246-249
27030332_en	FINDING	reducing drug susceptibility	1034-1062
27030332_en	DISO	CHC	1090-1093
27030332_en	CHEM	interferon-α	1135-1147
27030332_en	ANATOMY	liver	523-528
27030332_en	CHEM	PIs	1173-1176
27030332_en	CHEM	insulin	663-670
27030332_en	CHEM	inhibitors	24-34
27030332_en	CHEM	inhibitors	208-218
27030332_en	PHYS	mutations	1301-1310
27030332_en	DISO	hepatitis C virus (HCV) infection	428-461
27030332_en	FINDING	sensitive to interferon-α	1122-1147
27030332_en	DISO	infection	452-461
27030332_en	DISO	hepatitis C	233-244
27030332_en	DISO	hepatitis C	428-439
27030332_en	DISO	hepatitis	428-437
27030332_en	FINDING	ineffectively treated	551-572
27030332_en	DISO	cirrhosis	529-538
27030332_en	FINDING	efficiency of antiviral therapy	39-70
27030332_en	PHYS	virus resistance	138-154
27030332_en	CHEM	interferon-α	290-302
27030332_en	FINDING	failed to achieve a sustained virologic response	810-858
27030332_en	CHEM	protease	15-23
27030332_en	DISO	hepatitis	96-105
27030332_en	FINDING	efficiency of antiviral therapy	162-193
27030332_en	CHEM	protease	199-207
27030332_en	DISO	hepatitis	233-242
27030332_en	CHEM	interferon	1135-1145
